Nov 2016

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.



PO BOX 106 954, AUCKLAND CITY 1143<br />

Email: info@nzoptics.co.nz Website: www.nzoptics.co.nz<br />

NOVEMBER <strong>2016</strong><br />

NP4: A2160859511<br />

World’s First and Only Water<br />

Gradient MULTIFOCAL contact lens




As the Specsavers network of 370 New Zealand and Australian stores continues to<br />

experience significant growth, opportunities abound in metro and regional locations<br />

for career focussed optometry and dispensing professionals.<br />

For those taking a fresh look at what Specsavers offers as a working<br />

environment, the scale and format of our store locations continues to evolve<br />

with exciting results for our partners, our teams and our patients. Take<br />

Specsavers Ringwood as an example, recently recognised at the Australian<br />

Retail Awards as the outstanding retail design project of the past year. It is<br />

more than double the size of its previous location in the same shopping centre,<br />

with six consulting rooms, 12 dispensing desks, a contact lens teaching zone<br />

and four pre-testing rooms. Its investment in the latest retail and optometric<br />

technology is exemplary, offering a glimpse of the future.<br />

And now, as we look to the next phase of growth, we want to talk to you<br />

about our plans – and hear about yours. Our growth really can be your<br />

opportunity, whether you are looking at a store partner or an employed role -<br />

at every level of experience.<br />

To get the conversation started, contact Chanelle Coates on 0800 717 350 or by email on chanelle.coates@specsavers.com<br />

Retail<br />

Store Design<br />

Award<br />

<strong>2016</strong><br />

Retail<br />

Employer<br />

of the Year<br />

2015<br />

Overall<br />

National<br />

Supreme Winner<br />

2015<br />

ANZ Customer<br />

Service Excellence<br />

Award<br />

2015<br />

Franchise<br />

Innovation<br />

Award<br />

2015<br />

NZ Franchise<br />

System of<br />

the Year<br />

2014<br />

Retail<br />

Innovator<br />

of the Year<br />

2014<br />

Multichannel<br />

Retailer<br />

of the Year<br />

2014<br />

Roy Morgan<br />

Research<br />

No. 1 for eye tests<br />

2014<br />

FCA International<br />

Franchisor<br />

of the Year<br />

2014<br />

FCA Social<br />

Responsibility<br />

Award<br />

2014<br />

2 NEW ZEALAND OPTICS <strong>Nov</strong>ember <strong>2016</strong>

J&J to acquire AMO<br />

US-based healthcare company Johnson & Johnson is<br />

to acquire Abbott Medical Optics (AMO), a whollyowned<br />

subsidiary of fellow US healthcare firm<br />

Abbott Laboratories, for US$4.325 billion in cash.<br />

The acquisition includes AMO’s products in its three<br />

business divisions: cataract surgery, laser refractive surgery<br />

and consumer eye health. This includes AMO’s advanced<br />

laser vision (LASIK) technologies, dry eye drops and<br />

multipurpose solutions and hydrogen peroxide cleaning<br />

systems for contact lens patients.<br />

“Eye health is one of the largest, fastest growing and<br />

most underserved segments in health care today,” said<br />

Ashley McEvoy, J&J’s company group chairman responsible<br />

for J&J’s Vision Care companies, in a statement. “With<br />

the acquisition of Abbott Medical Optics’ strong and<br />

differentiated surgical ophthalmic portfolio, coupled with<br />

our world-leading Acuvue<br />

contact lens business, we<br />

will become a more broadbased<br />

leader in vision care.<br />

Importantly, with this<br />

acquisition we will enter<br />

cataract surgery – one of the<br />

most commonly performed<br />

surgeries and the number<br />

one cause of preventable<br />

blindness.”<br />

Boston-based financial<br />

markets analysts Trefis<br />

issued a statement saying,<br />

for J&J, the move was a<br />

good one. “As far as J&J<br />

is concerned we consider<br />

the transaction to be a<br />

good strategic move for its<br />

existing Vision Care division.<br />

We believe that there is<br />

enough potential in this<br />

segment which the company<br />

can tap into with a larger<br />

product portfolio.”<br />

The world vision care<br />

market is currently<br />

estimated at US$68bn and is<br />

expected to grow at around<br />

5% per annum. Areas of<br />

potential growth include<br />

the contact lens market<br />

Hoya launches Yuniku<br />


Causing a buzz among the media in the<br />

Silmo pressroom in Paris was news about<br />

lens company Hoya launching Yuniku, billed<br />

as the world’s first 3D printed tailored eyewear,<br />

designed entirely around the optimum lens for the<br />

wearer’s prescription and lifestyle.<br />

Speaking to NZ Optics at Silmo, Dave Nicoll,<br />

Hoya’s sales development manager, EMEA, says<br />

Yuniku was in development for two years following<br />

advancements in 3D technology, which finally<br />

made it possible.<br />

“The idea behind it is to make it vision centric.<br />

In the past the frame has defined the position of<br />

the lens, so it will never be optimum doing that.<br />

But with Yuniku, knowing the prescription and the<br />

lifestyle functional needs of the consumer, we can<br />

identify the optimum position of the lens and then<br />

design the frame to maintain that.”<br />

Optometrists and dispensing opticians who are<br />

interested in adopting Yuniku for their practices,<br />

will be trained to use the special Yuniku scanner<br />

which, after plugging in the patient’s prescription<br />

and functional lifestyle needs, allows them to help<br />

the patient choose which lens they want, which<br />

coatings and which frame design, size, texture<br />

and colour. If a frame size or design does not allow<br />

the lens to be in the optimum position, it will<br />

automatically be removed from the catalogue, so<br />

the patient never has that choice, says Nicoll.<br />

Practices will be given a sample set, so patients<br />

can feel the weight (only about 10g) and strength<br />

of the 3D-printed frames, before virtually trying<br />

them on, and playing with colour, size, texture and<br />

shape, through the system.<br />

Hoya’s Yuniku system in action<br />

Johnson & Johnson’s HQ in New Brunswick, New Jersey in the US<br />

– with just 11% of Americans wearing contact lenses<br />

today, compared with 64% who wear glasses (US National<br />

Eye Institute, September <strong>2016</strong>) – and the developing<br />

world, where increasing affluence means wider access to<br />

corrective lenses. There is also the ageing population to<br />

consider, said J&J in its statement, with the World Health<br />

Organisation estimating the total number of cataractaffected<br />

eyes to be “at least” 100 million.<br />

In 2015, AMO reported US$1.1bn in sales across its<br />

three divisions, with sales rising 6.2% year-on-year in the<br />

second quarter of <strong>2016</strong>, driven largely by demand around<br />

cataract surgery. In July, to great fanfare, AMO received<br />

FDA approval for its Tecnis Symphony range of intraocular<br />

lenses, a completely new class of IOL providing superior<br />

vision across a broad range of distances ( NZ Optics<br />

September <strong>2016</strong>).<br />

Abbott Laboratories’<br />

agreed to the sale after<br />

actively and strategically<br />

shaping its portfolio to focus<br />

primarily on cardiovascular<br />

devices and expanding<br />

diagnostics, so away from<br />

its vision care side. As part<br />

of this new focus, it agreed<br />

to acquire cardiac device<br />

specialist St. Jude Medical in<br />

April for US$25 billion.<br />

Johnson & Johnson’s eyehealth<br />

business was worth<br />

US$2.6bn in 2015. It said<br />

the acquisition will better<br />

position the company to<br />

reach patients in cataract<br />

surgery, laser refractive<br />

surgery and over the counter<br />

consumer eye health;<br />

three categories of care it<br />

currently has no, or a very<br />

limited, portfolio within.<br />

The agreement,<br />

announced in September,<br />

is subject to antitrust<br />

clearance and other US<br />

regulatory requirements,<br />

and is expected to close in<br />

the first quarter of 2017. ▀<br />

Dave Nicoll demonstrates Hoya’s new Yuniku 3D tailored eyewear system<br />

“What we’re bringing to optometrists is a new<br />

solution,” says Nicoll. “Frames are part of that<br />

solution, 3D manufacturing is part of the solution,<br />

and the software and lens design and manufacture<br />

is part of the solution.”<br />

Yuniku is the result of a partnership between Hoya<br />

and Belgium company Materialise, which provides<br />

3D printing software and services on a global scale;<br />

most recently achieving fame for creating a 3D<br />

printed heart for a baby born with holes in its heart<br />

from congenital heart disease in New York.<br />

Yuniku currently includes 12 different styles and<br />

will be priced at the premium end of the spectrum,<br />

says Nicoll. “It is absolutely the most personalised<br />

optical solution in the world.”<br />

Development has been top secret and given<br />

it was only unveiled at Silmo Paris at the end of<br />

September, it’s too early to know how the market<br />

will take it. But interest was strong at Silmo among<br />

the industry, as well as the media, so Hoya is<br />

expecting big things, says Nicoll.<br />

“I’ve been in optics 30 years and I’ve only ever<br />

seen two game-changing technologies and this is<br />

one of them, the other was freeform lens design.<br />

This is that big.”<br />

For more about Silmo Paris <strong>2016</strong>, see p17-19. ▀<br />

While the cat is away …<br />

Lesley has been gallivanting around<br />

Europe this month, visiting SILMO<br />

among other things, leaving me<br />

at the helm of the Good Ship Optics<br />

(very trusting she is!) Thankfully, it’s<br />

been a busy month full of events and<br />

activities, so I’ve not even had a minute<br />

to get lonely or worry about what<br />

might fill the pages of the magazine.<br />

Spring, it seems, has swept in a new<br />

era of change and hot on the heels of<br />

the Lensworx closure, Johnson and<br />

Johnson have announced they will<br />

buy Abbott Medical Optics. While we<br />

won’t see any practical change until<br />

the sale goes through in 2017, we<br />

have taken a short look at what we<br />

know so far (see story this page).<br />

Of course the high-rolling feature<br />

this issue, that everyone is turning the<br />

page for, is the summer sun-health<br />

special (p11-15). I’d like to extend<br />

huge thanks to Dr Peter Hadden, Dr<br />

David Worsely and Elisha Dudson for<br />

their contribution and for adding a<br />

wealth of clinical knowledge to our<br />

understanding about summer eye<br />

health. I’m sure you will also agree<br />

there are some stunning frames<br />

Silmo’s Australasian media contingent: Lesley<br />

Springall, Insight’s Coleby Nicholson and<br />

Mivision columnist Michael Jacobs<br />


Optimel<br />

Antibacterial<br />

Manuka eye drops<br />

Eaglevision<br />

Punctal Plugs, Gauges and<br />

Dry Eye Management<br />

Mastrota Expression Paddle<br />

0800 338 800 • Ralph Mob. 021 990 200<br />

designsforvision.co.nz<br />


- many of which were on display<br />

at the recent Visionz conference<br />

(full coverage in December), and<br />

exceptional style tips from the lovely<br />

Jo Eaton to boot.<br />

Of course I couldn’t let Lesley get off<br />

scott free, so don’t forget to turn to<br />

p18 for her round up of Silmo <strong>2016</strong> and<br />

some of the new tech and frame styles<br />

coming your way. While we are talking<br />

about overseas adventures, don’t<br />

forget to check out Dr Penny McAllum’s<br />

Niue trip on p23, and Devashini<br />

Devanandan’s review of her experience<br />

volunteering with VOSO in Samoa.<br />

VOSO feature again on p21, where you<br />

can check out the pictures from the<br />

Dine by Donation fundraising event at<br />

Meredith’s restaurant in Auckland.<br />

There’s so much in this issue, I<br />

don’t want to spoil some of the great<br />

surprises! I hope you enjoy reading<br />

and as always, please send your<br />

feedback to editor@nzoptics.co.nz<br />

Blephasteam<br />

Moist heat<br />

therapy<br />

Eye Eco<br />

Tranquileyes & DERM<br />

moist-heat therapy<br />

<strong>Nov</strong>ember <strong>2016</strong><br />

Jai Breitnauer, Editor, NZ Optics<br />

DV841-1016<br />



News<br />

in brief<br />


A European industry and academic consortium is working on a<br />

four-year project to reduce the size and cost of optical coherence<br />

tomography (OCT). The OCTChip (ophthalmic OCT on a chip)<br />

project is using photonic integrated circuits to produce a coin-sized<br />

retinal scanner to improve the screening and diagnosis of retinal<br />

diseases. Being so small the scanner can easily be transported to<br />

elderly patients, new-born infants and remote locations. Professor<br />

Wolfgang Drexler,<br />

head of the Centre<br />

for Medical Physics<br />

and Biomedical<br />

Engineering at the<br />

Medical University<br />

of Vienna, is<br />

leading the project.<br />


The ODOB issued a reminder to TPA optometrists that they are not<br />

authorised to prescribe controlled drugs. “It has come to the Board’s<br />

attention that there may be some confusion…To be clear, there are<br />

no circumstances under which an optometrist, in the optometrist<br />

(TPA endorsement) scope of practice or otherwise, may prescribe a<br />

controlled drug.”<br />


A team at the University of Houston have developed non-invasive<br />

glucose sensing contact lenses that sample glucose levels in tears,<br />

not blood. Though work still needs to be done to understand<br />

the correlation between tear and blood glucose levels, the more<br />

important finding is that the structure is an effective mechanism<br />

for using surface-enhanced Raman scattering spectroscopy,<br />

said Associate Professor Wei-Chuan Shih from Houston’s<br />

NanoBioPhotonics Group. “Everyone knows tears have a lot to mine.<br />

The question is whether you have a detector that is capable of<br />

mining it, and how significant is it for real diagnostics.”<br />


Four visually-impaired<br />

Paralympian 1500m<br />

runners clocked faster<br />

times than their Olympic<br />

counterparts it’s been<br />

revealed. Winner of<br />

the T13 1500m final,<br />

Abdellatif Baka from<br />

Algeria, set a new<br />

Paralympic world record<br />

of 3 minutes and 48.29<br />

seconds, and now holds<br />

the fastest 1500m time recorded by any athlete in Rio. Olympic gold<br />

medallist Matthew Centrowitz from the US was 1.7 seconds slower<br />

than Baka as well as the second, third and fourth (Baka’s brother<br />

Fouad) place Paralympian runners.<br />


The Royal Australasian College of Surgeons (RACS) and the<br />

University of Otago Medical School have signed a landmark Letter<br />

of Agreement aimed at building respect and improving patient<br />

safety in surgery and strengthening the education of medical<br />

students. This is the first agreement signed between RACS and a<br />

university, and the first New Zealand collaboration under the Action<br />

Plan: Building Respect, Improving Patient Safety. The Agreement<br />

paves the way for a continuous focus on respect as a cornerstone<br />

of the profession and comes in the wake of continued complaints<br />

about sexual harassment and bullying.<br />

100 YEARS OF LIGHT<br />

Centenary congratulations to the US-based Optical Society (OSA),<br />

which has been championing all things relating to the science of<br />

light since October 1916. Over the last century The Optical Society<br />

and its 19,275 global members have been at the forefront of<br />

innovations that have changed our lives: barcodes making shopping<br />

a breeze; MRIs detecting injury and disease; cameras capturing life<br />

on Facebook and Instagram; telescopes discovering Pluto was a<br />

dwarf planet; and laser and lens technology restoring sight.<br />


Famous illustrator Quentin Blake<br />

has donated eight one-of-a-kind<br />

art pieces from his collection of<br />

illustrations for Roald Dahl’s books to<br />

the UK’s Stoke Mandeville hospital’s<br />

ophthalmology waiting area. The gift<br />

was in response to a request from<br />

consultant ophthalmologist Dr Sarah<br />

Maling who contacted The Roald<br />

Dahl Museum to see if they could<br />

provide some pictures to brighten<br />

up the dull and grim waiting area,<br />

which she thought was particularly<br />

unwelcoming for children. “We were<br />

hoping for a few posters,” Dr. Maling told Ophthalmology<br />

Times. “Quentin Blake felt that was not enough and gave us these<br />

eight absolutely phenomenal pictures.” ▀<br />

ILS steps up for Lensworx<br />

Christchurch-based Independent Lens<br />

Specialists (ILS) has come to the<br />

rescue of Lensworx’s customers and<br />

picked up all Lensworx’s contracts, following<br />

the company’s liquidation in August (see NZ<br />

Optics October issue).<br />

The companies had a long-standing<br />

relationship with both being co-distributors<br />

for Kodak lenses in New Zealand. ILS will now<br />

be the sole distributor and has employed<br />

Lensworx’s former managing director<br />

Albie Hanson to help service the ILS’ Kodak<br />

contracts, especially in the North Island, and<br />

manage other parts of ILS’ business.<br />

“This will allow us to concentrate better on<br />

promoting Kodak products and the Kodak<br />

Lens Vision Centres, as well as the excellent<br />

range of ILS optical products,” said Hanson.<br />

“It will also make a much stronger platform<br />

to provide the marketing and technical<br />

knowledge to practices with dedicated<br />

hands-on support that is needed to develop<br />

the world-leading Kodak Lens model.”<br />

Support for the Kodak Lens Vision Centres<br />

Thanks from a<br />

gentleman<br />

On Sunday September 25th, more than 50,000 dapper<br />

motorbike riders in more than 500 cities across 90<br />

countries donned their cravats, oiled their moustaches,<br />

dusted off their tweeds and rode their classic and vintage-styled<br />

motorcycles to raise funds and awareness for men’s health.<br />

Participants in the Distinguished Gentleman’s Ride (DGR) have<br />

more than doubled since it was launched in Sydney in 2012 to<br />

combat the often-negative stereotype of men on motorcycles,<br />

bring motorcycle communities together and support a worthy<br />

cause.<br />

Christchurch-based Glenn Bolton, director of Independent Lens<br />

Specialists (ILS), was one such Distinguished Gentlemen. He was<br />

ably supported in his cause by many of the country’s eye health<br />

professionals and wished to pass on his thanks.<br />

“A big thanks to all of you who sponsored me in the<br />

Distinguished Gentleman’s Ride. Your support helped New<br />

Zealand become the 6th highest fund raiser, while I managed to<br />

become the 110th highest fundraiser in the world.<br />

“I know many of you have old bikes tucked away in the<br />

garage, so get them ready for the DGR 2017.”<br />

Monies raised from this year’s event will go to support<br />

research into prostate cancer and people working to support<br />

men’s mental health.<br />

For more about the DGR go to www.gentlemansride.com ▀<br />

retail programme, which Lensworx had<br />

begun to roll out earlier this year, will be<br />

based out of Auckland, said Hanson. The<br />

programme offers independent practices<br />

the opportunity to partner with Kodak and<br />

use the brand, which is owned underlicence<br />

by Californian company Signet<br />

Armorlite, either in a small way or through<br />

comprehensive whole-of-practice branding<br />

and marketing support.<br />

“I partnered with ILS many years ago on<br />

Kodak distribution,” said Hanson. “I am<br />

very happy to be involved with the new<br />

arrangement. I think the model we have<br />

now is going to be much stronger and more<br />

proactive”<br />

Safety Eyewear and the Kodak frame<br />

range and retail programme will also be<br />

available through ILS, which is currently<br />

going through the process to become fully<br />

certified for the processing of prescription<br />

safety eyewear through the transfer of<br />

Lensworx certification.<br />

“We are very happy to have Albie on the<br />

team as a full time rep,” said ILS director<br />

Glenn Bolton. “Albie has worked hard over<br />

the years developing the Kodak brand.<br />

Kodak lenses are widely distributed in the<br />

UK and Europe via independent optometry<br />

practices and Albie will be working closely<br />

with the independents here to support<br />

them.<br />

“Independent Lens Specialists will<br />

continue to offer our own Alpha Freeform<br />

product range and AR coating service, which<br />

Albie will also be offering to practices as<br />

part of his new role, allowing us, more<br />

than ever, to provide the best service to<br />

independent optometry.”<br />

Run by Bolton and John Clemence, ILS<br />

is well-known in the industry as the only<br />

laboratory in New Zealand to manufacture<br />

freeform progressives and to offer AR<br />

coating and specialised edging on their MEI<br />

robotic edger.<br />

All Kodak enquiries should now be<br />

directed to ILS, with Albie Hanson as the<br />

first point of contact, said Bolton. ▀<br />

A dapper Glenn Bolton taking part in the <strong>2016</strong> Distinguished Gentleman’s Ride<br />

Video-streaming sunnies<br />

Millennial-friendly messaging service and social media platform Snapchat is<br />

gearing up to launch “Spectacles”. The new smart sunglasses are capable<br />

of recording and streaming ten second video clips or “snaps” that can be<br />

transferred directly to the Snapchat app.<br />

The California-based company announced Spectacles at the start of October and<br />

has renamed itself Snap Inc. to reflect its expansion into consumer hardware.<br />

Describing the US$130 Spectacles product as a “toy” aimed at teenagers, Snap<br />

CEO and co-founder Evan Spiegel, in an interview with the Wall Street Journal,<br />

said watching the footage of a hike he did wearing a prototype pair of<br />

Spectacles was like seeing your own memory. “It was unbelievable. It’s one<br />

thing to see images of an experience you had, but it’s another thing to have<br />

an experience of the experience. It was the closest I’d ever come to feeling<br />

like I was there again.”<br />

However, the announcement was met with distain and hostility by some<br />

commentators. The potential for privacy invasion is of great concern to<br />

the public, it seems, with commentators making reference to the hostile<br />

reaction to Google Glass, also capable of recording video, which saw<br />

some wearers banned from certain shops, bars and restaurants,<br />

putting people off the product. ▀<br />

www.nzoptics.co.nz | PO Box 106954, Auckland 1143 | New Zealand<br />

For general enquiries, please email info@nzoptics.co.nz<br />

For editorial and classifieds, please contact Jai Breitnauer, editor, on 022 424 9322 or editor@nzoptics.co.nz.<br />

For advertising, marketing, the OIG and everything else, please contact Lesley Springall, publisher, on 027 445 3543 or lesley@nzoptics.co.nz.<br />

To submit artwork, or to query a graphic, please email lesley@nzoptics.co.nz.<br />

NZ Optics magazine is the industry publication for New Zealand’s ophthalmic community. It is published monthly, 11 times a year, by New Zealand Optics 2015 Ltd. Copyright is held by<br />

NZ Optics 2015 Ltd. As well as the magazine and the website, NZ Optics publishes the annual New Zealand Optical Information Guide (OIG), a comprehensive listing guide that profiles the<br />

products and services of the industry. NZ Optics is an independent publication and has no affiliation with any organisations. The views expressed in this publication are not necessarily<br />

those of NZ Optics (2015) Ltd.<br />

4 NEW ZEALAND OPTICS <strong>Nov</strong>ember <strong>2016</strong>

<strong>Nov</strong>ember <strong>2016</strong> NEW ZEALAND OPTICS<br />


Frith & Laird celebrate 50<br />

years<br />

Manurewa-based optometrists Visique<br />

Frith and Laird celebrated its 50th<br />

birthday on Saturday 8 October, with<br />

a well-attended party at its premises on Great<br />

South Road, Auckland.<br />

Frith and Laird was established by optometrists<br />

Mike Frith and Knox and Heather Laird, who<br />

actually took over a branch of George Read and<br />

Sons, a city-wide practice founded in the early<br />

1900’s. Mike Frith and Knox Laird were part of<br />

the first intake of optometry students at the<br />

University of Auckland, under the stewardship<br />

of the late Professor Ted Grosvenor from the<br />

USA. After qualifying, Mike developed what<br />

was to become a life-long passion in low vision,<br />

starting the low vision clinic at Greenlane Clinical<br />

Centre, while Knox went on to become the first<br />

optometrist in New Zealand to gain his PhD.<br />

Heather also has a special interest in low vision.<br />

The three diligently ran the practice, which has<br />

served several generations of Maurewa families<br />

– many of whom were at the party – weathering<br />

the changes in the economy, the developing<br />

suburb and optometry itself. In 2000, Frith and<br />

Laird became a member of the Visique group, and<br />

in 2010 both Mike and Knox decided to retire,<br />

handing the reigns over to Heather Laird and<br />

new additions to the practice, Hadyn Treanor and<br />

Robert Ng.<br />

“A lot has changed in 50 years; the way we<br />

Mike Frith, Heather Laird, Hadyn Treanor and Robert Ng<br />

The 2017<br />

Optical<br />

Information<br />

Guide (OIG)<br />

is being put<br />

together now<br />

The <strong>2016</strong> Frith and Laird team<br />

practice and how we are perceived as an industry.<br />

We are proud of our legacy,” said Hadyn in a<br />

speech at the celebration. “We’ve seen big change<br />

in the last 10 years with optometrist’s becoming<br />

more recognised by the government and the<br />

wider community in healthcare. We’re being<br />

given more responsibility around prescribing and<br />

diagnosing, but we’ve had to fight for the right to<br />

do things young optometrists take for granted.”<br />

Hadyn recognised that optometrists like Mike,<br />

Knox and Heather have walked a revolutionary<br />

path, and that current practitioners need to<br />

change their outlook to make the most of the<br />

rights and responsibilities optometry has been<br />

given.<br />

“The health sector is under a lot of stress. There’s<br />

only so much the hospital can cope with. If we<br />

can share that burden it is in everybody’s best<br />

interests.”<br />

The Visique Frith and Laird’s team would like to<br />

thank all those who have shared the journey with<br />

them, and for those who will support them over<br />

the next 50 years.<br />

Editor’s note: It was really lovely to see so many<br />

local people, many of whom had been attending<br />

the practice since they were children, and were<br />

like family to the optometry team at the practice.<br />

In Heather’s own words, it’s great to be able to<br />

celebrate something so positive. Congratulations<br />

team! ▀<br />

Shamir expansion: New<br />

appointments, new partners<br />

Tony Egerton has been appointed National<br />

Sales Manager (Australia) for Shamir.<br />

A well-known personality in the Aotearoa<br />

optics industry, Egerton was previously a sales<br />

rep for Shamir New Zealand, and will continue to<br />

assist Donald Crichton in that role.<br />

“It’s a brand new role. [Australia] used to<br />

handle most of the sales, but Shamir has grown<br />

substantially, and we’ve just expanded our lab<br />

in Brisbane,” said Paul Stacey, Shamir’s ANZ<br />

chief executive. “It made sense to have someone<br />

dedicated to that role.”<br />

This change also means that Shamir are<br />

able to focus more strategically on their New<br />

Zealand business, said Stacey.<br />

“We haven’t had the<br />

resources until now, but<br />

finally Shamir are able<br />

to cultivate a greater<br />

presence in New Zealand.”<br />

With that in mind,<br />

Stacey was also pleased<br />

to announce that from<br />

the start of October,<br />

Shamir has been<br />

working in partnership<br />

with Independent<br />

Lens Specialists (ILS) in<br />

Christchurch.<br />

“We produce Australianmade<br />

and certified lenses,<br />

and our lab is really<br />

well set up,” explained<br />

Stacey. “ILS also have<br />

a really well set-up lab<br />

and experienced staff. It<br />

made sense that we would work together, and<br />

encourage independent businesses to blossom.”<br />

Until now, only a small range of Shamir<br />

products have been available in New Zealand,<br />

but thanks to this new partnership, Shamir<br />

premium lenses and multi-coatings will now<br />

be available to the New Zealand market, with<br />

fittings on site in Christchurch.<br />

“We’ve worked very hard and even managed<br />

to secure overnight delivery with a courier<br />

company,” said Stacey. “Customers can place an<br />

order via Donald or directly with ILS.”<br />

ILS will continue to run their own lines, and<br />

offer Shamir’s specialist products in tandem. ▀<br />

Demonstrating their new camaraderie, Shamir’s Tony Egerton and Donald Crichton flank ILS directors<br />

Glenn Bolton and John Clemence at Visionz <strong>2016</strong><br />

Ben Sherman now in NZ<br />

Phoenix Eyewear has introduced a new brand<br />

to its portfolio and to New Zealand, Ben<br />

Sherman.<br />

Phoenix had been looking for a brand to replace<br />

Superdry (now distributed through Specsavers)<br />

and had begun brainstorming a number of ideas<br />

before going to Silmo last year, says Phoenix’s<br />

Mark Collman. Top of the list was Ben Sherman<br />

as Collman (already a fan in the clothing<br />

department) says he admired the brand’s style<br />

and spirit.<br />

“Ben Sherman epitomises ‘Cool Britannia’ -<br />

sharp styling, strong heritage, iconic brand. The<br />

Ben Sherman shirt and brand have been adopted<br />

by almost every youth culture or style movement<br />

of the last five decades. What more reason would<br />

you need to give it a go? Most of my friends have<br />

Ben Sherman polos or t-shirts and wear them<br />

with pride.”<br />

An iconic British brand, Ben Sherman was born<br />

in Brighton in 1963. Its colourful, button-down<br />

collared shirts - an invention of founder and<br />

designer Arthur Benjamin Sugarman - quickly<br />

became popular among the smart young men in<br />

the “mod” movement and jazz musicians of the<br />

day. Today this British lifestyle brand sells apparel,<br />

accessories and footwear worldwide and remains<br />

popular with celebrities counting electronic music<br />

group BS High Disclosure’s Res BS Pos.pdf 1 20/11/2015 brother-duo 15:55 Howard and Guy<br />

Lawrence, Gary Barlow, 50 cent, American actor<br />

Jesse Eisenberg and English actor Tom Sturridge<br />

among its supporters.<br />

Spurred on by what he knew about the brand, at<br />

Silmo 2015, Collman met with brand owner Fabris<br />

Lane, an Anglo-Italian eyewear company and<br />

affiliate of FGX International, a division of Essilor,<br />

whose other brands include Oliver Goldsmith,<br />

Hook LDN and Accessorize. He says he was so<br />

impressed with the brand’s latest collection and<br />

future direction he pretty much signed it up on<br />

the spot. However, given the brand’s parentage,<br />

there was some considerable tooing and froing<br />

before Phoenix could secure exclusive rights to<br />

Ben Sherman in New Zealand and introduce the<br />

brand at Visionz a couple of weeks ago.<br />

The brand is a particularly good fit with the New<br />

Zealand market says Collman: “British brands<br />

seem to translate very well into the NZ market,<br />

as does Brit culture. We share many of the same<br />

influences in apparel, pop music, TV shows and<br />

movies. I personally feel Brit brands work better<br />

than most other style influences. The eye shapes,<br />

colours and brand recognition all seem to click<br />

with our local consumers, especially the men.”<br />

Now available in New Zealand, the Ben Sherman<br />

range from Phoenix Eyewear comes in 10 optical<br />

styles (in three colours each) and eight sunglasses<br />

(also in three colours). ▀<br />

Make sure you’re listed in New Zealand’s<br />

only comprehensive guide to all things<br />

optical. Contact Susanne Bradley at<br />

susanne@nzoptics.co.nz and secure your<br />

listing or, for even more impact, take a<br />

full page ad and get your first listing<br />

absolutely free.<br />

Don’t delay, contact us today.<br />

C<br />

M<br />

Y<br />

CM<br />

MY<br />

CY<br />

CMY<br />

K<br />

Contact: susanne@nzoptics.co.nz<br />

6 NEW ZEALAND OPTICS <strong>Nov</strong>ember <strong>2016</strong>

Introducing DAILIES TOTAL1 ® Multifocal contact lenses –<br />

THIS IS WHY correcting<br />

presbyopia will never be the same<br />


>80%<br />

>80%<br />

33%<br />

WATER CONTENT (%) 3<br />

NEAR<br />




TECHNOLOGY 1–3<br />

The world’s first and only Water Gradient lens<br />

designed to give presbyopic patients the ultimate<br />

lens-wearing experience.<br />

Seamless Vision Correction 4<br />

Industry-leading Precision Profile Design<br />

is built in to deliver clear, uninterrupted vision 4<br />

+<br />

Exceptional Comfort 5,6<br />

Unique Water Gradient Technology<br />

to reduce end-of-day dryness* 5,6<br />

NEW<br />


*Based on in vitro measurement of unworn lenses.<br />

References: 1. Thekveli S et al. Structure-property relationship of delefilcon A lenses. Cont Lens Anterior Eye. 2012;35(Supp 1):e14. 2. Angelini T et al. Viscoelasticity and mesh-size at the surface of hydrogels characterised<br />

with microrheology. Invest Ophthalmol Vis Sci 2013;54:E-Abstract 500. 3. Dunn A, Uruena J, Huo Y. Lubricity of surface hydrogel layers. Tribol Lett 2013;13(2):371-378. 4. Alcon data on file, 2013. 5. . Pérez-Gómez I,<br />

Giles T. European survey of contact lens wearers and eye care professionals on satisfaction with a new water gradient daily disposable contact lens. Clin Optom. 2014;6:17-23. 6. Alcon data on file, 2014. Based on an<br />

ANZ survey of 61 eye care practitioners fitting 248 patients in DAILIES TOTAL1 ® contact lenses (assessed 1st October, 2014).<br />

See product instructions for wear, care and safety information.<br />

© <strong>2016</strong> <strong>Nov</strong>artis. Alcon Laboratories (Australia) Pty Ltd. 10/25 Frenchs Forest Road East, Frenchs Forest, NSW 2086, Australia Ph: 1800 224 153. 109 Carlton Gore Road, Ground Floor, Newmarket, Auckland 1023,<br />

New Zealand Phone: 0800 101 106. ALC0619 10/16 NP4:A21606498033<br />

<strong>Nov</strong>ember <strong>2016</strong><br />



Focus on<br />

Eye Research<br />

What’s ‘the next big thing’ in<br />

eye research?<br />

PALEJWALA N, JIA Y, GAO SS, ET AL. (2015).<br />





RETINA, 35, 2204-2211.<br />

One instrument that I was most excited to get at<br />

the start of the year was a Zeiss OCT angiography<br />

(OCTA) machine; I know that there is also at least<br />

one other similar machine by a different company<br />

around and I suspect there are quite a few more<br />

who have got them or are looking at getting them<br />

of whom I am blissfully unaware. I suspect also<br />

that many optometrists who have purchased or<br />

are in the process of purchasing OCT machines will<br />

be thinking very carefully about whether they get<br />

this feature. Hence I think it is timely to talk about<br />

what it may or may not show. What OCTA does<br />

do, of course, is show up the retinal and choroidal<br />

vasculature in immense detail, without the need for<br />

a potentially toxic dye as we use to use in standard<br />

fluorescein angiography (FFA), and it takes less<br />

than a minute to do so. However, it does not show<br />

leakage and, being so new, we are still finding our<br />

way with its potential applications.<br />

This article was from a supplement in the journal<br />

Retina entirely devoted to this new imaging<br />

modality, which goes to show the excitement around<br />

it. I thought it was intriguing mainly because it<br />

demonstrated that OCT angiography can pick up<br />

choroidal neovascularisation (CNV) in eyes with AMD<br />

before leakage starts (ie. when it is nonexudative);<br />

presumably this will mean earlier and better<br />

treatment with fewer overall injections. They had 32<br />

eyes at high risk of CNV, because of the presence of<br />

active CNV in the other eye. Two were found to have<br />

nonexudative CNV not visible with FFA in their other<br />

eye. This is, of course, quite a low pick up rate, but<br />

not for the patients concerned, who will be having<br />

regular OCT examinations anyway since their other<br />

eye is being treated. Interestingly, one of these CNVs<br />

only slowly grew, so whether it really represents<br />

sinister pathology is unknown. However, although<br />

these nonexudative membranes are not visible on<br />

standard FA they do have a histological correlate.<br />

SZURMAN P, BODEN K, JANUSCHOWSKI K. (<strong>2016</strong>).<br />




RETINA, 36, 1786-1790.<br />

Just when you thought scleral buckling was dead<br />

and buried (except for dialyses), along comes a new<br />

buckling technique. This article particularly sparked<br />

my interest because I had recently been made aware<br />

of a study involving a new hydrogel intraocular<br />

tamponade, a study which I declined getting<br />

involved in because it is a Phase I trial (ie. safety and<br />

efficacy, which means this is the first human trial)<br />

– I think I might wait a bit before experimenting<br />

on my patients! This material provides a temporary<br />

buckle that goes away, so the side effects of<br />

long-term refractive change and late exposure<br />

with inflammation and an irritated patient can be<br />

avoided, and which I’m sure most readers have seen<br />

in the past. The advantages would include avoiding<br />

a vitrectomy (for those patients who do avoid it),<br />


with its risks, which of course is cataract, and better<br />

closure of the break, particularly an inferior one<br />

which can be hard to tamponade with gas in a<br />

vitrectomy.<br />

There were 21 patients included in this first human<br />

study using this buckling material, although<br />

admittedly 15 of these patients had a simultaneous<br />

vitrectomy, which perhaps helped in the repair<br />

of their detachment. Of those patients, 20 were<br />

successfully reattached after their surgery;<br />

interestingly, however, the one patient who didn’t<br />

go flat did not have a simultaneous vitrectomy, so<br />

perhaps we shall have to wait before we decide if<br />

this technique is really valuable or not.<br />


(<strong>2016</strong>). UVEAL MELANOMA: FROM DIAGNOSIS<br />


CANCER, 122, 2299-312.<br />

A great review article on one of my favourite topics!<br />

This is an excellent overview update on uveal<br />

melanoma. It is not original science but rather a<br />

review; nevertheless, it is an excellent review and<br />

one I would highly recommend to any registrars<br />

who wished to read in one place all they needed to<br />

know about uveal melanoma. Unfortunately, being<br />

not in the ophthalmic literature it is not one that<br />

many in this profession would have seen, hence I<br />

felt the need to include it in this journal review.<br />

One of the things it reviews are the recent studies<br />

looking at treatment of the metastases of uveal<br />

melanoma. Historically, we have basically been unable<br />

to do anything useful except slightly prolong disease<br />

free survival (DFS) and delay death. Now that we are<br />

able to look at the different mutations expressed and<br />

pathways activated by uveal melanoma there is hope<br />

that if we can target several of them at the same<br />

time we might be able to cure this disease by medical<br />

therapy. This article summarises all the recently<br />

completed trials looking at doing this. Unfortunately,<br />

the bad news is that none have to date provided a<br />

cure! Nevertheless, hope springs eternal ... but so<br />

far the only therapy with good long-term survival is<br />

surgical excision of liver metastases, which is possible<br />

only in under 10% of patients.<br />

It also gives an excellent overview of the clinical<br />

presentation of uveal melanoma and the<br />

therapeutic options. Unfortunately, transpupillary<br />

thermotherapy, which a decade ago seemed to<br />

hold so much promise, remains associated with an<br />

unacceptably high recurrence rate (as high as 20%)<br />

and no other new local therapies have emerged<br />

in the last 15 years that really are any better than<br />

what I learned when I was a fellow. ▀<br />


Dr Peter Hadden practises at<br />

Eye Institute Remuera and New<br />

Lynn, Retina Specialists and<br />

Greenlane Clinical Centre in<br />

Auckland, subspecialising in<br />

vitreoretinal surgery and adult<br />

chorioretinal tumours, as well<br />

as performing cataract surgery.<br />

Outside ophthalmology, he<br />

enjoys the company of his five<br />

children and doting wife!<br />

US grant awarded to New<br />

Zealand researchers<br />

Professor Paul Donaldson and Dr Ehsan<br />

Vaghefi, based at the University of Auckland,<br />

received a National Eye Institute (NEI) major<br />

research grant in August.<br />

Professor Donaldson (physiology) and Dr Vaghefi<br />

(optometry) were awarded funding of US$432,000<br />

from the NEI in the United States in collaboration<br />

with Professor Thomas White from the State<br />

University of New York, for five years. Their<br />

collaboration aims to examine the effects of aging<br />

on the lens transport systems that determine<br />

ion and water homeostasis, water content and<br />

therefore the optical properties of the normal<br />

and cataract lens. It is hoped the results of their<br />

work can be used to identify pharmacological<br />

interventions with a view to restoring the agerelated<br />

degeneration of water transport activity<br />

and optical properties observed in the human lens.<br />

Professor White’s group in the US will focus<br />

on the use of animal models to identify<br />

pharmacological interventions, while the Auckland<br />

group will look at the ability of these interventions<br />

to alter lens optics with non-invasive magnetic<br />

resonance imaging (MRI) and optical modelling<br />

approaches.<br />

In a statement, the University of Auckland<br />

acknowledged the high ranking (3rd percentile) of<br />

this project by the assessing committee, in a highly<br />

competitive international funding environment, is<br />

testament to the strength and innovation of the<br />

collaboration, which was facilitated by Professor<br />

White’s recent sabbatical at the University of<br />

Auckland. The project also provides funding for<br />

two PhD stipends, one in clinical optometry and<br />

the other in bioengineering/medical imaging<br />

Peptide study published<br />

In other news from the Faculty of Medical<br />

Sciences, Dr Cindy Guo and colleagues have<br />

published a peptide intervention study using a<br />

model that produces signs of age-related macular<br />

degeneration. The paper Connexin43 Mimetic<br />

Peptide Improves Retinal Function and Reduces<br />

Inflammation in a Light-Damaged Albino Rat<br />

Model appears in the online, peer reviewed journal<br />

Investigative Ophthalmology and Visual Science.<br />

This technology is licensed to CoDa Therapeutics<br />

in the USA. The peptide is now entering preclinical<br />

development. ▀<br />

New certificate in glaucoma<br />

In October, the<br />

Australian College<br />

of Optometry (ACO)<br />

announced the launch<br />

of their new Advanced<br />

Certificate in Glaucoma,<br />

(ACG ACO). This six-month<br />

post graduate level course<br />

provides optometrists<br />

across Australia and<br />

New Zealand with the<br />

opportunity to undertake<br />

comprehensive higher<br />

level study in this specific<br />

area, the college said in a<br />

statement.<br />

“The certificate has been<br />

under development for<br />

approximately 12 months.<br />

An advisory committee<br />

of ophthalmologists,<br />

optometrists and ACO<br />

staff have worked hard over this time to<br />

facilitate a comprehensive syllabus,” said<br />

Jolanda de Jong, general manager professional<br />

development & membership for the ACO. “We<br />

then engaged respected, knowledgeable and<br />

experienced lecturers to deliver the content.”<br />

De Jong said this new online, comprehensive<br />

course is designed to act as a refresher for<br />

therapeutically-qualified optometrists, who<br />

have completed previous study into glaucoma,<br />

as well as all<br />

other registered<br />

optometrists<br />

with an interest<br />

in glaucoma.<br />

As far as the<br />

ACO are aware,<br />

there are no<br />

other similar<br />

courses offered<br />

in Australasia.<br />

“The ACO<br />

believes that<br />

the provision<br />

Jolanda de Jong<br />

Roman Serebrianik is on the advisory committee for the certificate and he is the Head of<br />

Primary and Specialist Eye Care Services at the Australian College of Optometry (ACO)<br />

of a comprehensive glaucoma course would<br />

benefit the level of understanding across the<br />

profession in glaucoma, improve servicing of<br />

the general community and has the potential<br />

to improve and increase co-management<br />

with ophthalmologists,” said De Jong. “Other<br />

comparable courses don’t offer the clinical<br />

component or the level of depth of the ACO<br />

Advanced Certificate in Glaucoma. We have<br />

built a comprehensive postgraduate level<br />

course with a practical clinical focus. One major<br />

point of difference is that it is an academically<br />

rigorous course, however there is flexibility for<br />

students in the online delivery model.”<br />

The six-month syllabus covers four didactic<br />

modules at a postgraduate level. Students<br />

will access 68 CPD (therapeutic) points for re–<br />

registration purposes in Australia and CE points<br />

are currently under application in New Zealand.<br />

“Given that one in eight Australians over 80<br />

will develop glaucoma there is definitely a need<br />

for a high level understanding of glaucoma to<br />

improve outcomes for the ageing population,”<br />

said de Jong. ▀<br />

Young Optometrists New Zealand<br />

The Young Optometrists networking<br />

group in Australia has been active for<br />

around six years, but in New Zealand<br />

no one has stepped up to the cause – until<br />

now. Rotorua-based Natasha Smyrke and<br />

Cambridge-based Devashini devanandan,<br />

(along with Ashley Gray, who has since moved<br />

to the UK), launched their own group for<br />

young optometrists’ earlier this year.<br />

“We actually came up with the idea<br />

before we even knew what was happening<br />

in Australia,” said Smyrke, who is keen<br />

to see their reach expand due to the<br />

incredible amount of interest they’ve<br />

had so far. “When we heard about Young<br />

Optoms Australia we phoned the Sydney<br />

branch, and they met us for coffee during<br />

a visit to Auckland. We’re now affiliated<br />

with them.”<br />

While the group are getting guidance<br />

and support around their start-up from<br />

their more experienced colleagues over the<br />

ditch, they’re keen to express this group is<br />

definitely doing its own thing.<br />

“We want this to be an open, inclusive<br />

group for all New Zealand-based<br />

optometrists who have graduated in the<br />

last 10 years,” said Smyrke. “Early meetings<br />

in Auckland and Hamilton have had good<br />

interest, and issues people have raised are<br />

things like having a safe space to share case<br />

histories and a strong voice in the NZAO.”<br />

Smyrke says this endeavour isn’t just<br />

about supporting optometry graduates<br />

as they embark on their career, but about<br />

preserving the hard-won status of the<br />

profession as a whole.<br />

“I think there can be a lot of apathy<br />

among young graduates, who take<br />

things like TPA for granted. But the older<br />

generation fought hard for that. By creating<br />

a network we can increase support and<br />

understanding around our profession and<br />

carve our own path.”<br />

If you are interested in joining Young<br />

Optometrists New Zealand, you can do so<br />

via their Facebook page – www.facebook.<br />

com/groups/YoungOptomsNZ ▀<br />

The Auckland crowd: front Left to right Natasha Smyrke, Ashley Gray. Back Left to right Veeran Morar,<br />

Devashni Devanandan, Robyn Sterling, Sarah Denny, Zane Stellingwerf, Grace Elliot and Ayah Hadi<br />

8 NEW ZEALAND OPTICS <strong>Nov</strong>ember <strong>2016</strong>

The final Grand Round of <strong>2016</strong><br />

Wednesday 21 September saw the last in<br />

the Eye Doctor’s series of Grand Rounds<br />

for <strong>2016</strong>, held at <strong>Nov</strong>otel Ellerslie. There<br />

was a great turnout of 41 people, a reminder of<br />

the enduring popularity of these Bausch + Lombsponsored<br />

educational talks. Eye Doctor’s are also<br />

celebrating their 10-year anniversary and thanked<br />

the audience for being part of their success story.<br />

From baby rashes to strabismus surgery<br />

Dr Shuan Dai opened the evening with an interesting<br />

case of a six-week old baby presenting with skin<br />

rashes and watering eyes since she was two<br />

weeks old. There was no family history of any eye<br />

conditions. The child was irritable and crying with<br />

a swollen right eye, poor red reflex, and an IOP<br />

of 34mmHg. There was hyphema with no other<br />

causes and this led to the diagnosis of Juvenile<br />

Xanthogranuloma – the most common condition<br />

causing spontaneous hyphema in children.<br />

The condition is characterised by benign cutaneous<br />

histiocyte granulomatous inflammation with 10%<br />

involvement of eye and adnexa. It usually presents in<br />

the first 12 months, and the rash looks like yellowish<br />

slightly raised skin lesions that take a few months to<br />

disappear once treatment begins. It’s a self-limiting<br />

disease though raised intraocular pressure can cause<br />

permanent visual damage unless treated. After two<br />

months using a topical steroid and eye pressure<br />

lowering drops, the IOP came down to 17mmHg.<br />

Signs of amblyopia will need ongoing treatment.<br />

Dr Dai also showed some slides from his ‘working<br />

holiday’ to China, and talked about the new<br />

strabismus surgery techniques he was invited<br />

to present at the ophthalmology conference he<br />

attended in China. He showed excellent surgical<br />

outcome with transposition of superior rectus muscle<br />

to lateral rectus for correcting esotropia in patients<br />

with chronic 6th nerve palsy. The most amazing part<br />

is the restoration of nearly full-range movement<br />

to the eye, he said. Dr Dai showed some video of<br />

pre and post-op patients who had a full range of<br />

movement just a few weeks after surgery.<br />

Scleral thining<br />

Dr Penny McAllum opened with the topic of the<br />

blue/grey tinge to a patient’s eye caused by scleral<br />

thinning. This can be congenital or acquired. If<br />

congenital, it could be Ehlers Danlos Syndrome,<br />

an inherited collagen disorder – ask your patient<br />

to bend back their fingers to see if they have<br />

hyper extendable joints, she said. If their joints are<br />

normal, it could be osteogenesis imperfecta (brittle<br />

bone disease), another collagen defect – check<br />

your patient’s teeth, as people with this condition<br />

often have teeth abnormalities. Another condition<br />

causing the problem could be Marfan syndrome,<br />

a fibrillin disorder resulting in the patient being<br />

unusually tall, with long limbs, fingers and neck,<br />

some heart defects. Lens subluxation is present in<br />

75% due to weak zonules.<br />

Acquired scleral thinning could be the result<br />

of necrotising scleritis/scleromalacia due to<br />

rheumatoid arthritis. The main treatment is oral<br />

Prednisone or other oral immunosuppressant<br />

agents for active disease. Another uncommon<br />

acquired cause is radiation from pterygium<br />

surgery, which can cause scleral melting many<br />

years later. Fortunately, it’s no longer used in New<br />

Zealand. It can also be caused by eye whitening<br />

surgery using mitomycin C, particularly popular<br />

in Korea. Other causes of thin sclera include large<br />

eyes, such as in high myopes or buphthalmos<br />

from congenital glaucoma. A blue or grey scleral<br />

appearance can also result from staining with<br />

some drugs, like tetracyclines, after many years<br />

of regular use. Look for grey, brown or even green<br />

staining of their teeth, skin and nails as well.<br />

Dr McAllum then talked about the interesting<br />

case of a three-year-old Indian boy with yellow<br />

eyes, a sore throat, cough and a fever. He was<br />

diagnosed with jaundice and strep throat – but<br />

what was causing the jaundice? It’s not usual with<br />

strep throat.<br />

She explained that Jaundice is caused by high<br />

levels of bilirubin in the blood stream, a yellow<br />

breakdown product from haemoglobin. There are<br />

three types of jaundice – haemolytic<br />

(increased red blood cell breakdown),<br />

hepatocellular (when the liver is not<br />

functioning properly), and obstructive<br />

(when there is a blockage in the bile<br />

ducts, between liver and intestines),<br />

which is the most common but usually<br />

in adults. Dr McAllum’s patient had<br />

a condition called G6PD deficiency, a<br />

common genetic condition in African,<br />

South Asian and Middle Eastern people,<br />

triggered by some sort of stress on the<br />

body. The patient was in haemolytic<br />

crisis due to his G6PD deficiency,<br />

triggered by the strep throat. It can also<br />

be triggered by aspirin, antimalarial<br />

drugs, some antibiotics and fava<br />

(broad) beans. Once the cause of the<br />

crisis has been removed, the condition<br />

settles on its own.<br />

Dr McAllum said this example served<br />

as a reminder that sometimes you see<br />

things in the eyes that reflect what is<br />

happening elsewhere in the body.<br />

Retinal vasculitis<br />

Retinal vasculitis was the topic<br />

presented by Dr Mark Donaldson.<br />

Clinical signs include perivascular<br />

whitening, haemorrhage in the retina,<br />

a few cells in vitreous, and leakage. Systemic signs<br />

include diabetes, IBS, and smoking.<br />

Dr Donaldson talked us through the case of a fit<br />

asymptomatic 60-year-old woman referred with<br />

retinal haemorrhages. Ultra-wide fluorescein<br />

angiography demonstrated ischemic retina, a<br />

complication that could lead to neovascularisation<br />

and blindness. All possible systemic causes of<br />

vasculitis eliminated the diagnosis defaults<br />

to Eale’s disease with photocoagulation<br />

being recommended. The case succinctly<br />

demonstrated the diagnostic pathways followed in<br />

understanding patients with vasculitis.<br />

Cirrus OCT angiography<br />

Dr Andrew Riley reviewed the Cirrus OCT<br />

angiography, which Eye Doctors purchased after<br />

assessing its potential.<br />

Dr Riley talked about the machines capabilities.<br />

With advancements of live-tracking and faster<br />

Dr Andrew Riley, Stephen Hill, Hue Bullen and Gary Filer<br />

Dr Mark Donaldson, Cindy Tse, Lily Chang, Elkie Wong, and Dr Shuan Dai<br />

acquisition time we can now see the doppler<br />

effect of movement, he said. We actually see the<br />

erythrocyte movement so can map the vessels.<br />

However, he said it does not directly show<br />

leakage. Dr Riley said he is excited about what<br />

this technology provides. Abnormal vessels in<br />

diabetic macular oedema and vein occlusion were<br />

presented and definitions of macular ischaemia<br />

explored. Choroidal neovascularisation from<br />

myopic, trauma and age-related changes can<br />

be identified and mature nets highlighted. The<br />

cases highlighted how OCT angiography has a<br />

bright future not just in diagnosis but also in<br />

improved treatment decisions. This is likely to<br />

reduce considerably the need for fluorescein<br />

angiography, said Dr Riley, adding he envisaged<br />

wider scanning areas with time. Other conditions<br />

are being explored with this technology and optic<br />

nerve vasculature and choroidal circulation are two<br />

where we are just learning, he said. ▀<br />

Bradley Pillay, Dr Penny McCallum and Sonia Swan<br />

Chris Earnshaw and Stuart Campbell<br />

VSP wearables study<br />

Introduced<br />

<strong>Nov</strong>ember 2014<br />

“OptiMed NZ have now sold over 50 Takagi<br />

700GL Slit Lamps”<br />

Slitlamp Microscope<br />

700GL<br />

See your patients’ eyes<br />

in a new light.<br />

VSP Global announced it is<br />

launching a major academic study<br />

and consumer pilot test with the<br />

latest version of the company’s techembedded<br />

eyewear, called Level. The<br />

study is in partnership with University of<br />

Southern California (USC) Center for Body<br />

Computing (CBC),<br />

VSP Global’s innovation lab, The Shop,<br />

debuted an early version of the prototype<br />

in 2015 as Project Genesis— touted as<br />

the first wearable to seamlessly integrate<br />

health-tracking technology into the<br />

temple of an optical frame. A partnership<br />

with USC CBC followed soon after.<br />

“Our partnership with VSP Global will<br />

accelerate research and discovery as to how to<br />

create digital health products and experiences<br />

that will elevate, enhance and expand the lives<br />

of users,” said USC CBC founder and executive<br />

director Dr Leslie Saxon. “This study is the first<br />

of its kind and will provide a crucial roadmap<br />

for validating future products and platforms<br />

and for understanding overall consumer health<br />

engagement.”<br />

The pilot study, launched in September<br />

with USC employees, is being managed by<br />

USC CBC in partnership with USC Roski Eye<br />

Institute. Participants receive a Level frame<br />

and accompanying smartphone app that<br />

allows them to track their activity. The app<br />

also syncs with the VSP Global’s Eyes of Hope<br />

initiative, allowing participants to accrue points<br />

for reaching daily step goals. Once a certain<br />

number of points are achieved, that user<br />

will automatically trigger the donation of a<br />

comprehensive eye exam and a pair of glasses to<br />

someone in need.<br />

VSP’s tech-embedded eyewear Level<br />

“As a community-based not-for-profit, we’re<br />

curious not only about the technology and how<br />

it can benefit the individual utilising it, but<br />

also about the motivations that drive certain<br />

behavior,” said Jay Sales, co-lead of The Shop.<br />

“Connecting Level to our Eyes of Hope initiative<br />

was a perfect way to explore how technology<br />

within a platform as common as eyewear could<br />

increase health and wellness as well as empathy<br />

and opportunity for someone in need.”<br />

Though still in prototype mode, the technology<br />

embedded within the Level frames—including a<br />

gyroscope, accelerometer and magnetometer—<br />

will track a wearer’s steps, calories burned,<br />

and activity time. Users will be able to locate<br />

misplaced frames through the app’s “Find My<br />

Glasses” feature.<br />

It is hoped the study will provide useful feedback<br />

on how individuals interact with the device, which<br />

will inform future strategies for the prototype.<br />

Select eye care providers within the VSP network<br />

will also have an opportunity to test and provide<br />

feedback about the Level experience. ▀<br />

Optional Extras<br />

• Camera Adapter With Yellow Filter<br />

• Adjustable Inclined Eye Piece<br />

• Inclined Eye Piece Adapter<br />

• Yellow Filter<br />

For further information or to order a Takagi Slit Lamp today<br />

Ph: 0800 657 720 info@optimed.co.nz<br />

Craig 0275 657 200 or Robert 0275 657 720<br />

t 012 3456 7890<br />

f 012 3456 7890 e user@yoursite.com<br />

<strong>Nov</strong>ember <strong>2016</strong><br />



Exciting programme for RANZCO’s 48th Congress<br />

Your toothbrush should be the only thing<br />

left to pack for RANZCO’s landmark annual<br />

calendar event, kicking off in just a couple<br />

of weeks in Melbourne. Here’s NZ Optics need to<br />

know guide.<br />

Location<br />

The majority of the Congress will be held at the<br />

Melbourne Convention Centre on South Wharf.<br />

However, the graduation and awards ceremony<br />

and president’s reception on the Sunday will<br />

be held at Myer Mural Hall on Bourke Street.<br />

This chic, Parisian style ballroom was originally<br />

designed by Sydney Myer to host lavish parties<br />

and private fashion shows, and is named after<br />

the eight unique murals that adorn the walls.<br />

The Congress Dinner will be held on Tuesday<br />

evening in the Olympic room at the Melbourne<br />

Cricket ground, offering unique views of Yarra<br />

Park. Guided tours of the stadium will also be<br />

available.<br />

Programme<br />

The Congress promises a selection of lectures,<br />

rapid-fire presentations and poster sessions with<br />

a line-up of international speakers that include<br />

Professor Gerard Sutton from Vision Eye Institute<br />

Australia, Professor Maarten Mourits from the<br />

Melbourne: Host to RANZO’s <strong>2016</strong> Congress<br />

Department of Ophthalmology at the Academic<br />

Medical Centre, Netherlands, Professor Keith<br />

Martin from the University of Cambridge and<br />

Dr Fiona Costello from the University of Canada,<br />

among others. There will be a Practice Managers<br />

conference, GP and optometry workshops and<br />

professional development sessions. Special<br />

guests include Dr Helen Szoke, CEO of Oxfam<br />

Australia, who will be speaking at the RANZCO<br />

Graduation Ceremony. There will also be a<br />

number of non-scientific sessions running<br />

alongside the Scientific Congress. These sessions<br />

include Ethics, Training and Professionalism and<br />

Cultural Awareness in Practice.<br />

Getting social<br />

Don’t miss the welcome event in the exhibition<br />

hall, with hawker-style food bars and wine<br />

on offer. Outside of the awards ceremony and<br />

the main dinner, there will also be a Practice<br />

Managers’ dinner, a Young Fellows dinner, a<br />

Senior and Retired Fellows dinner and a Registrar<br />

Networking Event. If you find yourself with a<br />

little free-time and fancy exploring Melbourne<br />

you can download a series of self-guided walks<br />

from www.thatsmelbourne.com.au. They will<br />

guide you through Melbourne’s cobbled laneway<br />

districts and Victorian arcades, full of history and<br />

– in many cases – captivating street art, not to<br />

mention the enticing alfresco eateries.<br />

See you there! ▀<br />

Dr Fiona Costello<br />

Prof Gerard Sutton<br />

Aye, eye sailor<br />

Celebrating<br />

milestones<br />


10,000<br />



350,000<br />


TECNIS and TECNIS Symfony are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. All other trademarks are the intellectual property<br />

of their respective owners. AMO Australia Pty. Limited. Level 3, 299 Lane Cove Road, Macquarie Park, NSW 2113. AMO Australia Pty. Limited (Incorporated in Australia)<br />

PO Box 401, Shortland Street, Auckland, 1140. © <strong>2016</strong> Abbott Medical Optics Inc. | www.AbbottMedicalOptics.com | WH AMO20403<br />

Optometrist Ian Perry, a partner at Specsavers Wanganui,<br />

moved to the Manawatu six years ago and loves the water.<br />

“I’ve been sailing since the age of 11,” says Perry. “The boat I<br />

most loved was the International Canoe which is a high performance<br />

single-handed boat that I sailed in my 20’s and is quite different! I’ve<br />

been crewing a 470 for the last few years.”<br />

Perry is a member of Sailing Wanganui which runs sail training for<br />

all ages, and is chairman of the Sailability Whanganui Trust, which<br />

offers sailing as a sport to the disabled community.<br />

“At an annual prize giving for Sailability Whanganui there was a<br />

presentation from two club members who had just returned from<br />

the 2013 Blind Sailing World Championships in Tokyo. Kiwi sailors,<br />

Phil Paterson, who is sighted, and Russell Lowry who is totally blind<br />

through retinitis pigmentosa.”<br />

Paterson suggested Perry might join them as a tactician for the next<br />

championship, so he was inspired to volunteer.<br />

“I began working with Phil, Russell, and Jonathan Godfrey,” says<br />

Perry. Godfrey, from Palmerston North, is totally blind from retinitis<br />

pigmentosa. “Although new to sailing, he was fit from martial arts<br />

and matched Russell’s strong competitive drive. Incredibly, we were<br />

offered a place at the Blind Sailing World Championships in Chicago.”<br />

With just a couple of months to train, the odds were against them –<br />

many of the other teams were very experienced and had been sailing<br />

together for years.<br />

“It was a big ask to put this team into such a high-level international<br />

competition,” says Perry, but it was an opportunity they weren’t<br />

prepared to turn down. “The biggest barrier was that we were training<br />

in winter with strong winds and the river in flood. We didn’t get to sail<br />

against another boat until the practice day of the regatta!”<br />

Perry’s biggest personal challenge was to verbalise all instructions<br />

and not touch any of the controls. “My role was to be the team’s eyes,”<br />

says Perry. “If I so much as touched the mainsheet or tiller we’d be<br />

penalised – that’s a big ask for an active and reflexive sailor.”<br />

When they arrived in Chicago they had two practice days and a<br />

deteriorating weather forecast, but the rough weather at least gave<br />

Perry’s team a fighting chance.<br />

“We had five races on the first day and were disappointed with our<br />

performance, but as the weather got worse the better we did!” he<br />

laughs. “The other teams were used to training in smooth conditions,<br />

while we’d had the brunt of Wanganui’s winter weather. In the last<br />

and roughest race we placed first!”<br />

Russell Lowry’s B1, (completely blind) team with Ian as tactician<br />

had to content themselves with that one win on the first day, but the<br />

B2 partially-sighted team of Dave Allerton and Dave Parker brought<br />

home a gold medal.<br />

“It was an amazing experience, although I found it mentally<br />

exhausting!” says Perry, who says the team have not decided if they<br />

will enter in 2017. “I sail to switch off, but as a tactician you have<br />

to be hyper-alert and giving constant verbal commands. It was<br />

an honour to spend time with the New Zealand and international<br />

teams though, and especially to work with Russell who has so<br />

much spirit.” ▀<br />

10 AMO20403_Tecnis_Symfony_CelebratingMilestones_FPAdv.indd NEW ZEALAND OPTICS <strong>Nov</strong>ember <strong>2016</strong>1<br />

7/10/16 10:15 am


Summer sun: don’t forget your eyes<br />


The highly successful Slip, Slop, Slap campaign,<br />

first launched in Australia in the 1980’s,<br />

didn’t include a reference to sunglasses<br />

for many years. In a part of the world where the<br />

percentage of damaging UV rays is generally<br />

known to be high, it seems crazy that eyes would<br />

be left out for so long.<br />

In New Zealand, the campaign has been known<br />

as Slip, Slop, Slap and Wrap (with the wrap referring<br />

to sunglasses), for many years, and is currently<br />

reaching out to the fourth generation of young<br />

sun seekers in the hope of reducing the number<br />

of preventable diseases – including melanoma –<br />

caused by unprotected exposure to the sun.<br />

It’s a delicate balance though isn’t it? As an<br />

exceptionally fair-skinned child growing up in<br />

the UK, my mum was so paranoid about the risks<br />

associated with the sun we rarely spent much<br />

time outdoors in the height of summer and didn’t<br />

holiday abroad until I was in my teens. The upshot<br />

of this is actually the reverse of what she hoped to<br />

achieve – in my twenties and early thirties, I was<br />

quite slap-dash with sun cream and barely wore<br />

sunglasses or protective lenses. It was only after<br />

developing a blister on my conjunctiva in 2013<br />

that I began looking into eye health and the sun,<br />

and realised just how thin is the wire we walk.<br />

Cataracts, cancer, dry eye, AMD … the list of<br />

eye-conditions that could possibly be affected<br />

by exposure to the sun goes on. And yet, reports<br />

have shown sun exposure can also help reduce<br />

myopia, counteract the negative effects of too much<br />

gaming, reduce the risk of diabetes (let’s face it, if<br />

you’re outside you’re probably active) and, according<br />

to one 2015 study, potentially counteract the<br />

symptoms of dry eye by increasing vitamin D*.<br />

Giving our clients good quality advice about<br />

caring for their eyes in the summer months has<br />

never been more vital, and this special feature is<br />

designed to help you do just that. I’d like to thank<br />

everybody who has contributed to this timely<br />

feature, in particular Drs Peter Hadden and David<br />

Worsely and Eleisha Dudson, for their articles. You’ll<br />

also find some style tips from the fabulous Jo Eaton,<br />

a product round up, and some industry news all<br />

related to summer eye wear and care.<br />

I hope you enjoy reading and, as always, please<br />

send us your feedback via editor@nzoptics.co.nz<br />

*Yildrim P, et al. Dry eye in vitamin D deficiency: more than an<br />

incidental association. Published in the International Journal of<br />

Rheumatic Diseases<br />

Selling sunnies: what your customers need to know<br />

Research conducted by The Vision Council in the US revealed<br />

that 48% of people regularly wear one or more pairs of<br />

non-prescription sunglasses, while 64% of people wear<br />

prescription glasses, suggesting a huge opportunity to upsell<br />

prescription sunnies.<br />

NZ Optics has tapped the minds of many specialists in the<br />

industry to provide the following five important facts if you have a<br />

patient (or ‘client’ as many of you now say you prefer to call them)<br />

interested in tinted or photochromic lenses:<br />

1. UV rating of normal lenses and CLs<br />

Your client will probably be interested to know their prescription<br />

lenses have some UV protection already.<br />

“The actual lens material blocks most of the UV from being<br />

transmitted ‘through’ the lens,” says Emma Gee, training<br />

manager for OPSM. “Different materials will block differing<br />

amounts, for example, polycarbonate blocks 99% without<br />

additional coatings.”<br />

However, while reassuring for your client, this doesn’t mean<br />

they can forget about sunglasses altogether.<br />

“Quality sunglasses provide 100% protection from UVA and<br />

UVB,” says Gee. “They provide visual comfort with tinting and<br />

optional polarisation. Certain sunglass tints can also help with<br />

increasing contrast in conditions such as cycling, golf and skiing.<br />

Sunglass frames are also much better suited in terms of their<br />

size and wrap to provide correct coverage for UV protection than<br />

an optical frame.”<br />

Your patients might also be interested to know about back-UV<br />

coatings that can be added to the back surface of the lenses to<br />

stop light coming around the edges and reflecting off the back of<br />

the lenses into the eye.<br />

Contact lenses also have built in UV protection but, says<br />

contact lens specialist Alex Petty, they are no substitute for<br />

wearing sunglasses. “The majority of contact lenses have UV<br />

protection, however, they will only cover the 14mm or so of the<br />

lens diameter. The conjunctiva, lids and lid tissue all needs UV<br />

protection to decrease the chance of skin cancer and UV related<br />

tissue degeneration.<br />

“Contact lens wearers will also still suffer from glare so<br />

sunglasses are an important part of improving the visual<br />

experience when outside,” he says.<br />

2. Sunnies have standards<br />

Your clients need to understand the quality of sunglasses they<br />

buy from you, compared with the quality they buy from a nonoptical<br />

business, varies dramatically. Even if your client isn’t<br />

interested in purchasing prescription sunglasses, there is important<br />

information you should pass on to them to protect their eye health.<br />

A practice needs to make sure its clients know their sunglasses<br />

meet NZ standards (AS/NZS 1067:2003) with UV 400 protection,<br />

says Mark Gaunt from Zeiss, and that the eyes are covered enough<br />

to protect them from incidental light entering the eye - a good hat<br />

helps here.<br />

“If they make the wrong choice, they may be doing more harm<br />

than good,” he says. “If they purchase a pair without UV400nm<br />

protection their pupils may enlarge and cause harm from the extra<br />

UV being transmitted into their retina.”<br />

Many sunglasses are labelled as having UV protection, but that<br />

doesn’t mean they have the right protection for New Zealand<br />

or for anywhere for that matter. Your client needs to know the<br />


• Retro shapes made with ultra-modern materials<br />

• Metal and acetate fronts<br />

• Optimum wearing comfort<br />

• An absolute design classic<br />

<strong>Nov</strong>ember <strong>2016</strong><br />




NZ standard is voluntary; in fact, there is no standard<br />

sunglasses have to meet, and the price of the sunglasses<br />

doesn’t necessarily reflect the quality of the UV<br />

protection. Glasses claiming they are UV400 should also<br />

be avoided, says Gaunt, unless they also state they meet<br />

the above standard, as there is no universally accepted<br />

definition of what UV400 actually means.<br />

3. Choosing frames<br />


Just like optical glasses, your clients need to be advised<br />

on the right sunglass frames for their face shape, lifestyle<br />

and purpose.<br />

Sporty-types and those who do a lot of driving or<br />

work outside, might prefer wrap-style frames that<br />

give a greater area of coverage and have a darker tint<br />

or reflective lenses for added clarity outside, while<br />

those who wear sunglasses more casually might prefer<br />

something that fits with their own sense of style – such<br />

as oversized frames or vintage. If your client expresses<br />

any concerns over losing their<br />

sunglasses or where they might keep a<br />

second pair, then photochromic lenses<br />

that change with the environment are<br />

probably the better lifestyle choice.<br />

The same style tips you’d use for<br />

helping a patient chose prescription<br />

lenses work for sunglasses. For example,<br />

a rounder face would benefit from<br />

square-shaped sunglasses to balance<br />

their face shape, while oval faces<br />

shouldn’t wear glasses that are too<br />

wide. And a good thing to remember<br />

is if your client has a strong affiliation<br />

with a particular style of frames, they<br />

can probably have tinted lenses fitted in<br />

those frames too.<br />

4. Clip ons/over glasses<br />

For the customer who sees sunglasses<br />

as pure necessity, the resurgence of<br />

‘over glasses’ and clip-ons is no doubt a<br />

dream come true. Coverspecs are wraps<br />

that go over the top of your clients<br />

existing glasses, and they are approved<br />

by the Cancer Society of New Zealand –<br />

giving protection along the side of the<br />

frame as well as over the lens. Other<br />

brands include Cocoons eyewear and<br />

Horizons eyewear.<br />

Alternatively, clip-ons – available from<br />

a number of different suppliers – are<br />

armless frames with sunglass lenses<br />

that clip on to your clients’ existing<br />

glasses. They fold up when not in use so<br />

they don’t have to be removed (and are<br />

less likely to be misplaced).<br />

5. Photochromic lenses are just as useful<br />

inside as out<br />

Photochromic lenses, like Transitions and Hoya Sensity, are<br />

really great for those people who just want a pair of glasses<br />

for all occasions, without having to remember to take out<br />

their sunnies or accessories.<br />

“Transitions lenses are not sunglasses. But for patients<br />

looking to find an everyday lens they can wear from<br />

morning to night, indoors to outdoors, Transitions lenses<br />

will be the lens to recommend,” says Stuart Cannon,<br />

Transitions Optical general manager, Asia-Pacific.<br />

“Outdoors, Transitions lenses block 100% UVA and UVB<br />

rays from the sun and also help protect our wearer’s eyes<br />

from glare and harmful blue light.”<br />

These lenses are also useful indoors. Transitions<br />

Signature VII lenses block at least 20% of harmful blue<br />

light indoors – up to two times more than standard<br />

clear lenses – while still being clear, and more than<br />

85% outdoors. Transitions XTRActive help provide more<br />

protection everywhere they are needed, blocking at least<br />

34% of harmful blue light indoors and 88-95% outdoors,<br />

according to a recent study.<br />

Sunlight exposure<br />

and AMD<br />

Dr David Worsley*<br />

Whether, and to what degree, sunlight exposure is an age-related<br />

macular degeneration (AMD) risk factor is controversial. Although visual<br />

perception occurs between wavelengths 380-760 nm, the retina/retinal<br />

pigment epithelium (RPE) complex is exposed to light from 320nm and above.<br />

Wavelengths below 320nm, including most UVA and UVB, are blocked by the<br />

cornea and crystalline lens.<br />

Laboratory studies provide evidence to suggest a vulnerability to sunlight<br />

exposure. Wavelengths beween 400-760nm absorbed by retinal/RPE proteins, such<br />

as melanin and lipofuscin, can lead to cell damage. The RPE is prone to oxidative<br />

stress, especially from UV and blue light, with DNA damage, alteration of RPE<br />

cell size and movement. The age-related increase in both number of lipofuscin<br />

granules in human RPE cells and in their photoreactivity may impose a greater risk<br />

of oxidative damage in the aged RPE, suggesting a light-sensitive mechanism in<br />

the development of AMD. Blue light related photoreactivity of melanosomes also<br />

increases with age. Blue<br />

light exposure in an<br />

experimental rat model<br />

of dry AMD induces<br />

retinal injury.<br />

The retina possesses<br />

inherent protection<br />

against sunlight<br />

damage via antioxidant<br />

enymes, light<br />

absorbing pigments<br />

such as melanin and<br />

flavoproteins, and the<br />

shedding of damaged<br />

photoreceptor outer<br />

segments.<br />

Epidemiological<br />

Does UV contribute to AMD?<br />

evidence for light<br />

exposure as an AMD risk<br />

factor is inconclusive<br />

and only a few studies report a positive association. One of the best, the Beaver<br />

Dam Eye Study (BDES), found that exposure to summer sun as teenagers through<br />

to the thirties was associated with later development of early AMD. Estimated<br />

ultraviolet-B exposure and historical markers of sun sensitivity were not<br />

associated. An inverse association was found between the level of protection from<br />

sunlight via use of brimmed hats and sunglasses and AMD, but only in men. Follow<br />

up five-year incidence of early AMD confirmed this association; however the 10-<br />

year incidence study showed few significant associations between environmental<br />

light and incidence and progression of early AMD. A recent analysis of long-term<br />

data from the BDES found some evidence that light eye or hair colour combined<br />

with sunlight exposure is associated with increased risk of developing early<br />

AMD. The link may be a genetically determined lower level of photo-protective<br />

eumelanin. Other studies have similar findings; for example the Chesapeake<br />

Bay Waterman Study found late AMD to be associated with long-term high blue<br />

light exposure. An Australian study found that sensitivity to sunburn may be a<br />

risk factor. In contrast to these studies, several case-control studies have failed to<br />

show associations between sunlight exposure and AMD. Several studies showed<br />

a lowered risk of AMD. A review of the literature in 2012 noted these conflicting<br />

findings but by met-analysis found overall evidence in favour of an association.<br />

We need to be cognisant of the inherent<br />

weaknesses of epidemiology studies dealing<br />

with a complex exposure. Issues include<br />

challenges in measuring acute and chronic<br />

lifetime exposure and the effect of potential<br />

confounding variables, such as sun sensitivity<br />

and sun avoidance behaviours. Furthermore,<br />

each study evaluates a different population<br />

(ethnic and genetic makeup) with different<br />

confounding factors and located in a variety of<br />

geographical areas with very different exposure<br />

intensities.<br />

In conclusion, the literature is conflicting. That<br />

doesn’t provide a practical solution for advising<br />

your patient. So my take on the controversy<br />

is that the data does not support a strong<br />

association of sunlight exposure and AMD, but<br />

a modest effect can’t be ruled out. Therefore<br />

it is reasonable to advise simple measures to<br />

reduce potential risk. A wide-brimmed hat will<br />

drastically reduce sun exposure. Sunglasses<br />

will give additional protection. However, strict<br />

wearing of sunglasses is not indicated, indeed<br />

there are some circumstances where tinted<br />

lenses may have a functional impact for an AMD<br />

patient with reduced macular function.<br />


– BUILD TO<br />



EYEWEA R<br />

* Dr David Worsley is<br />

an ophthalmologist at<br />

Hamilton Eye Clinic and<br />

Waikato Hospital. He is a<br />

retina specialist with an<br />

interest in AMD and sits on<br />

the medical advisory board<br />

for MDNZ.<br />

12 NEW ZEALAND OPTICS <strong>Nov</strong>ember <strong>2016</strong>

Choroidal melanoma: a spotter’s guide<br />


There are not many truly life-threatening<br />

ocular conditions, but choroidal melanoma<br />

is certainly one of them. Overall, about 50%<br />

of people diagnosed with it will, in the fullness<br />

of time, die from it, so one can certainly say that<br />

it is something no one wants to miss. Missing it<br />

has been the subject of lawsuits in the USA and,<br />

even in New Zealand, this diagnosis has graced<br />

the adverse comments section of our Health and<br />

Disability Commission, wondering if “x failed to<br />

provide services with reasonable care and skill…”.<br />

Luckily, that happened 16 years ago (before my<br />

time, may I add!), but we certainly don’t want it to<br />

come up again. So how can we avoid that?<br />

Obviously the first step is not to miss the<br />

diagnosis. Unfortunately, although melanoma is<br />

rare, naevi are not and sometimes the differences<br />

can be subtle. Furthermore, the only time when<br />

maybe we might be able to make a difference to<br />

the prognosis, ie. reduce the risk of metastatic<br />

disease in the future, is if we can catch and treat<br />

melanomas when they’re small, which of course is<br />

when they are most easily confused for naevi.<br />

One study found that, for small indeterminate<br />

pigmented tumours, ie. ones that might be<br />

naevi or might be melanoma, there was a 5%<br />

cumulative chance of metastatic death for<br />

each of the following risk factors: margin at the<br />

disc, lipofuscin, symptoms and subretinal fluid.<br />

Therefore if you’ve got all four there’s a 20%<br />

chance you’ll be dead in a few years.<br />

Some bright spark then came up with a<br />

mnemonic to help people remember what to look<br />

for if you think you’ve seen a naevus but don’t<br />

want to miss a small melanoma (small being less<br />

than 2.5mm thick). That mnemonic is “To find<br />

small ocular melanoma”. This stands for thickness,<br />

fluid, symptoms, orange pigment and margin at<br />

the disc. Naturally of course others subsequently<br />

pointed out that this didn’t really cover everything;<br />

ophthalmologists routinely do an ultrasound<br />

(B-scan) on all such lesions and therefore we<br />

routinely add two letters to this, looking for<br />

hypoechogenicity and characteristic shapes (as<br />

well as the thickness, which ultrasound is very<br />

good at measuring). Then of course, documented<br />

growth is another risk factor. Fortunately many<br />

of you probably don’t have ultrasound anyway so<br />

you don’t have to remember those two letters, but<br />

do remember to look at old photos to see if it has<br />

changed.<br />

It might be helpful at this juncture to go over<br />

what each of these “suspicious features” actually<br />

are:<br />

T is for thickness<br />

If it’s more than 2mm thick, that’s a bad sign. This<br />

suspicious feature actually is best appreciated by<br />

ultrasound, since on ultrasound you can measure it<br />

very easily, as previously mentioned. But if you’ve<br />

got OCT, you can switch on “enhanced depth<br />

imaging” (EDI) or push the OCT machine forward<br />

so that the image flips and you can get a pretty<br />

image of the choroid and usually you can measure<br />

the thickness of the tumour on this, but only if it’s<br />

less than about 1mm thick.<br />

F is for fluid<br />

Subretinal fluid is a danger sign. Naevi can often<br />

have a bit of fluid over the top of them, which<br />

doesn’t matter, but if it’s leaking fluid around it,<br />

that’s bad (unless of course it’s from something<br />

else, like a choroidal neovascular membrane, which<br />

you can get with naevi). Often you can see this<br />

around the tumour or, if you get the patient to look<br />

down, you might notice an inferior serous retinal<br />

detachment. However, even a small bit of fluid is<br />

important to spot and so if you’ve got a camera,<br />

try putting it on autofluorescence; if it’s leaking<br />

fluid, this will show up white beside the tumour.<br />

OCT of course also comes in handy here, as it will<br />

show fluid directly.<br />

S is for symptoms<br />

If your patient has an itchy eye, that’s a symptom<br />

but it really doesn’t have anything to do with<br />

whether there’s a naevus or melanoma in the<br />

fluid. Pain doesn’t matter either (unless it’s huge,<br />

melanoma is not associated with pain, and most<br />

people would suspect that something’s amiss if<br />

you have a really massive melanoma that takes up<br />

the whole eye. The symptoms that really matter<br />

are visual loss (not attributable to some other<br />

cause, of course), field loss or flashes. The flashes<br />

that you get with melanoma are different from the<br />

Moore’s lightening streaks of vitreoretinal traction.<br />

They tend to last longer, maybe a few minutes,<br />

move slowly around, sometimes in circular<br />

Pic 1&2. A small choroidal melanoma. Note the visible subretinal fluid and orange<br />

pigment (lipofuscin). This patient was also symptomatic, with blurred vision and<br />

flashing lights, as this tumour was under the fovea.<br />

patterns, sometimes like a lava lamp, and aren’t<br />

always temporal but instead can be anywhere. Ask<br />

the patient if they’ve noticed any funny lights if<br />

you’re wondering about melanoma.<br />

O is for orange pigment<br />

Orange pigment, ie. lipofuscin, is bad. Sometimes<br />

it can be hard to see – it doesn’t stand out as<br />

well as drusen against a dark background like a<br />

melanoma, but is easier to see with an indirect<br />

(where it kind of looks like someone’s got an<br />

orange pepper shaker and shaken it across the<br />

tumour). On autofluorescence, which you may<br />

have on your camera, it shows up very obviously<br />

as very light white spots over the tumour. One<br />

caveat, however, RPE changes and drusen, both of<br />

which are good signs (see below), can also show<br />

up light on autofluorescence, but RPE changes<br />

look more “geographic” (like how scattered islands<br />

might look on a black and white map) and drusen<br />

just don’t light up as much – no one said that<br />

autofluorescence was completely straight forward!<br />

M is for margin at the disc<br />

This one’s easy. If the tumour is at the disc, or<br />

within a disc diameter of the disc, then that’s a<br />

suspicious feature.<br />

Pic 3 (above). A colour photo and EDI OCT of a melanoma. Note the lipofuscin (orange pigment) on the tumour, the obvious tumour in the<br />

choroid on EDI and the subretinal fluid above it which extends outside the borders of the tumour. Pic 4 (below). A colour photo and fundus<br />

autofluorescence (FAF) image of a peripapillary melanoma. Note how the fluid shows up very brightly just below the melanoma. The central,<br />

thickest part of the melanoma is dark, indicating RPE changes, but they aren’t very marked.<br />

There are also a couple of signs that imply it’s<br />

just a naevus. Drusen over the surface of it or RPE<br />

changes such as hyper or hypopigmentation either<br />

over the top of the tumour or around it, imply that<br />

it’s been there a long time. That of course means<br />

that it’s probably a naevus, as melanomas usually<br />

haven’t been there a long time (or else they’d be<br />

bigger). Melanomas are usually much more evenly<br />

coloured and have a very distinct border without<br />

RPE changes around them (for some reason,<br />

some people seem to have the impression that an<br />

indistinct border is bad; this is distinctly untrue).<br />

There are also other pigmented things in the eye;<br />

choroidal freckles, melanocytomas and CHRPEs<br />

to name a few. Often also choroidal neovascular<br />

membranes look pigmented too. Little spots<br />

of pigment also are common in the retina. The<br />

key thing with most of these is that they don’t<br />

have the above features, except for pigmented<br />

scleral crescents beside the optic disc, commonly<br />

temporally – but these are flat and don’t have any<br />

of the other features.<br />

The bottom line has to be that, at the least, any<br />

pigmented tumour with any of the suspicious<br />

features mentioned has to be seen by an<br />

ophthalmologist, except for little spots of pigment<br />

that are otherwise completely benign looking<br />

beside the disc. Those with suspicious<br />

features will be offered treatment, but<br />

it depends on how suspicious it is, how<br />

worried the patient is and how badly<br />

treatment of it will affect the vision as to<br />

whether treatment will be delivered. If it<br />

is watched, the standard recommendation<br />

is to see it again in three months and then<br />

once a year, to look for growth. This is often<br />

done by optometrists and the main thing<br />

here really is to make sure you look back<br />

at the old photos to make sure it hasn’t<br />

changed. Sometimes even with photos it<br />

can be hard – if a photo is overexposed, it<br />

might make the very thin pigmented border<br />

of the tumour invisible and then, on a<br />

subsequent normally-exposed photo, it will<br />

look bigger. If you have autofluorescence,<br />

make sure you do take an autofluorescence image<br />

at the start because often the borders can be<br />

much easier to see and less open to problems with<br />

exposure than standard photos. Photos taken with<br />

a red filter can also be useful, for the same reason;<br />

they image pigmented choroidal tumours better<br />

since they are less absorbed in the overlying retina<br />

and RPE.<br />

Good luck then with spotting naevi! And if you’re<br />

thinking of buying a camera, consider one that<br />

does autofluorescence; it’s useful in many other<br />

conditions with fluid and RPE changes too, like<br />

macular degeneration and dystrophies. ▀<br />


* Dr Peter Hadden practises<br />

at Eye Institute Remuera and<br />

New Lynn, Retina Specialists<br />

and Greenlane Clinical Centre<br />

in Auckland, subspecialising<br />

in vitreoretinal surgery and<br />

adult chorioretinal tumours,<br />

as well as performing<br />

cataract surgery.<br />

<strong>Nov</strong>ember <strong>2016</strong><br />




Sunnies for summer ‘16/17<br />

rocco by Rodenstock<br />

It was first seen in the 60s, and then suddenly disappeared like it was<br />

swallowed up by the earth, but then rocco by Rodenstock returned to<br />

the scene in 2014. In a retro design and wrought with ultramodern<br />

materials, the eyewear is mainly something for trendsetters and the<br />

fashion conscious. The yellow rocco circle is the typical distinctive<br />

mark and gives each pair of glasses an individual dab of colour.<br />

Maui Jim<br />

Maui Jim got its start in 1980 as a small company selling sunglasses<br />

on the beach in Lahaina, Hawaii. Seeing a need in the market for<br />

technology that could combat intense glare and harmful UV while<br />

bringing the brilliant colours of the island to life, we engineered<br />

the revolutionary PolarizedPlus2 lens. Incorporated into seven new<br />

sunglass styles, our Classic Collection was introduced. We now offer<br />

over 125 styles of sunglasses, 100% of which are polarized and<br />

protect from 100% of UVA and UVB rays.<br />

Euro Optics<br />

Adidas continues to offer many sunglasses in the performance<br />

essential range that are all easy to RX and can be used in sun-rx<br />

packages. The top selling model is the Whipstart which is the lead<br />

sunglass campaign featuring Sonny Bill Williams. New models<br />

include the Jaysor and Horizor. In the more sport specific range<br />

Adidas is pleased to release the Zonyk (with photo chromatic<br />

mirrored lenses) as worn by Nairo Quintana who was 2nd in this<br />

years’ Tour De France. The new Barker’s sunglass range features six<br />

models each in two colours and all are easy to glaze. Inface also offers<br />

amazing quality fashion sunglasses for this summer.<br />

Serengeti<br />

rr309, wholesale price on<br />

request<br />

With comfort at the heart of the design, the Serengeti Slim Collection<br />

features an ultra-thin frame made from premium Grilamid TR90<br />

nylon and incorporates spring hinge temples for an easy custom fit.<br />

The Grilamid TR90 ensures a super durable frame that is so light,<br />

that you may forget you’re wearing anything at all. The classic<br />

styling and minimalist design of the Slim collection partnered with<br />

Serengeti’s superior glass lenses will not only have you turning heads<br />

but opening your eyes to the experience that is Serengeti. The slim<br />

collection features models Positano, Ostuni and Rapallo.<br />

Tail Slide, RRP $309<br />

Phoenix Eyewear<br />

Kate Sylvester’s new Spring Summer ’16 sunglass collection<br />

introduces Marie, Lee, Jacqueline and Françoise. These four new<br />

classic yet contemporary shapes feature a soft, tonal colour palette<br />

including honey, vanilla chip and olive. Kate’s favourite is the Lee in<br />

honey as she loves how it infuses the aviator style with femininity.<br />

The Jacqueline style is really taking off and is sure to become a best<br />

seller this season. All Kate Sylvester sunglasses come with beautiful<br />

polarised lenses and are also glazeable.<br />

BTP International<br />

Adidas Zonyk, RRP $279<br />

Are you aware that fashionable sunglasses are available with<br />

lenses fitted to your power? <strong>Nov</strong>a is a global brand spread over 45<br />

countries worldwide. <strong>Nov</strong>a’s extensive sunglass collection provides<br />

classic Italian styles catering to different age groups and lifestyles.<br />

Prescription <strong>Nov</strong>a sunglasses are provided with <strong>Nov</strong>a Rx lenses which<br />

are processed by the latest free-form technology. <strong>Nov</strong>a RX lenses<br />

helps to give perfect natural vision for a better and active lifestyle.<br />

Lee, RRP $345 - $368<br />

Positano RRP $345<br />

Sasha, wholesale $120<br />



// Up to 72% thinner and 45% lighter than traditional prescription lenses, built with NXT technology<br />

and Trivex material, VARIO Drive Thin Design brings together the most cutting-edge advancements<br />

in the optical industry<br />

// Photochromic and Spectral Control® technologies in every lens let you discover infinite colors in any<br />

light condition with stunning visual acuity; optional Polarization technology eliminates surface glare<br />

// Available in 99% of prescriptions, progressive and single-vision lenses, ranging from +6 to -8 total<br />

power (Cyl -4.00)<br />

MODEL // CATERINA 8430<br />



CONTACT: BOLLE@BOLLE.CO.NZ OR 0800 2655 369<br />


14 NEW ZEALAND OPTICS <strong>Nov</strong>ember <strong>2016</strong>

General Optical<br />

Founded in 1976, during the Golden Age of Munich<br />

(Modern Creation München), the German brand<br />

MCM crafts luxury leather goods and apparel for<br />

the world’s most seasoned travellers.<br />

MCM Eyewear is a unique collection where<br />

dynamic design meets with the artisanal heritage of<br />

the Brand. The iconic MCM elements – the Visetos<br />

pattern, the classic brass plate, the studs and<br />

vibrant colours – are also the main features of this<br />

new Eyewear Collection where strong and unusual<br />

Transitions<br />


Transitions range of adaptive lenses provides<br />

choices for all ages and lifestyles. Compatible with<br />

almost any frame and lens material, they are a<br />

great solution for all patients throughout the year,<br />

and especially during summer! Transitions lenses<br />

adapt continuously through varying light conditions<br />

Contact lenses and summer<br />


With the warming spring and summer<br />

seasons approaching, we see an<br />

increase in both new and existing<br />

patients coming in for their contact lens review.<br />

When renewing the patient’s script, we also have<br />

the opportunity to emphasise good contact lens<br />

routines and offer advice about new products<br />

tailored for their specific needs.<br />

Allergies in spring and summer<br />

With spring we see the uncanny sight of thick<br />

yellow pine pollen resting on every surface<br />

outdoors. This is the harbinger of pollens to come.<br />

The pine pollen though, due to its large size, is not<br />

as big an allergy concern for allergy sufferers as<br />

the smaller grass pollens that come later in the<br />

season 1,2 . If we want patients who suffer from<br />

these allergies to continue successful contact lens<br />

wear, then there are a few things we should be<br />

advising.<br />

Artificial Tears We know for sensitive eyes that<br />

preservative free artificial tears are a great option.<br />

There is recent research suggesting that inflamed<br />

and dry eyes settle quicker with drops that contain<br />

hyaluronic acid 3,4,5 . For patients with dry eyes<br />

and allergies, recommending hyaluronic acid eye<br />

drops could help provide better comfort. Examples<br />

of preservative-free artificial tears containing<br />

hyaluronic acid include Hylofresh and Systane<br />

Hydration.<br />

Medicated Drops Oral antihistamine tablets<br />

dry the eye out which can further exacerbate<br />

an allergic eye. Therefore, for some contact lens<br />

wearers, a topical medication can be a great<br />

adjunct. I often talk to patients about the use<br />

of Patanol over the summer. Because Patanol<br />

is a preventer (mast cell stabiliser) and treater<br />

(antihistamine) it works really well when using<br />

twice a day, prior to and after contact lens<br />

removal. From my clinical experience I advise that<br />

Patanol should not be used immediately prior<br />

to sleep as the patient could wake with stingy<br />

eyes due to the lack of tear pump occurring while<br />

asleep. Patanol is best used at least 15 minutes<br />

before sleep and then artificial tears just prior to<br />

sleep.<br />

Travelling<br />

One key thing to discuss with patients is their use of<br />

contact lenses while flying. Patients usually know<br />

they shouldn’t wear their contact lenses on long<br />

haul flights, but they often don’t fully understand<br />

why. Believe it or not, it’s not because their contact<br />

lens solution is limited to 100mls or because toilets<br />

on planes are unhygienic! Rather it is due to the<br />

cabin pressure and oxygen levels. Aeroplane cabin<br />

pressures can be likened to being on a mountain<br />

at an altitude of 1800-2400m 6 . At this level there<br />

is about 76-81% oxygen pressure compared to<br />

sea level 7 and with the eye shut the oxygen levels<br />

at the corneas drop by 60-75% 8 . This can be<br />

uncomfortable and risky for the eye, especially as<br />

there is usually some sleeping involved on long haul<br />

flights. It’s also good to remind patients that as well<br />

as skin and lip dryness from flying, eyes are affected<br />

too.<br />

Contact lens options<br />

For both allergies and travelling there is the obvious<br />

option of daily disposables.<br />

I have many patients who are on what I call “dual<br />

prescriptions”. They have their “usual” lenses for<br />

their day-to-day lives, and then run a second daily<br />

disposable prescription for travelling. This means<br />

MCM range RRP $500<br />

shapes are combined with colourful prints and<br />

modern embellishments.<br />

The brand is modern, progressive, cosmopolitan<br />

and aspiring: while embracing the past and its<br />

German origins it looks toward the future.<br />

outdoors, enhancing the wearer’s vision and<br />

reducing their eye fatigue. Additionally, they offer<br />

well-rounded protection from the sun’s harmful<br />

rays. Outdoors, the lenses not only block 100% of<br />

UVA/UVB rays, but they also help protect eyes from<br />

glares and harmful blue light from the sun, which<br />

emits more than 100 times the intensity of blue<br />

light than electronic devices and digital screens.<br />

there is no need to worry about solutions while<br />

travelling, especially for those sensitive patients<br />

who use a hydrogen peroxide care system. The<br />

hassle of travelling with AOsept has provided me<br />

with some interesting stories; including the demise<br />

of a mobile phone, drowned by a river of semineutralised<br />

AOSept from a knocked-over case!<br />

For dailies there are now more options than<br />

ever with the latest releases including Oasys<br />

1-day, Alcon Dailies Total 1, Cooper Myday and<br />

Bausch and Lomb Biotrue. With all the options<br />

now available there is really no reason why you<br />

shouldn’t be able to find a compatible contact lens<br />

for your patient.<br />

Orthokeratology (ortho-k) For some adults who<br />

suffer dry and irritable eyes, wearing contact lenses<br />

throughout the day is just not an option. For these<br />

patients it can be worth considering ortho-k.<br />

New ortho-k designs with larger optic zones,<br />

multifocal, and astigmatism options now make<br />

ortho-k a viable option for more patients who are<br />

intolerant to daily contact wear.<br />

Ortho-k can be an effective myopia progression<br />

control option in children. The understanding of<br />

how ortho-k slows myopia progression has brought<br />

about new designs, that are further improving the<br />

efficacy of myopia progression control in ortho-k.<br />

Ortho-k should also be part of any myopia<br />

control discussion with younger patients and their<br />

caregivers. With summer’s increased daylight and<br />

potential for outdoor activities, it is also a great<br />

time to discuss recent research about myopia<br />

progression and light exposure. Research suggests<br />

that 60-90 mins of outdoor activity a day is likely to<br />

help slow myopia progression 9 . As good an excuse<br />

as any to get out and enjoy some backyard cricket,<br />

beach outings and BBQs!<br />

References<br />

1. Zealand, Allergy New. A-Z Allergies. s.l. : www.allergy.org.<br />

nz/A-Z+Allergies/Pollen+allergy.html, 2010.<br />

2. Crump, Vincent St Aubyn. Pollen Allergy and Cross-Reactions<br />

in New Zealand. s.l. : www.allergyclinic.co.nz/pollen_allergy.<br />

aspx, 2014.<br />

3. A randomized, controlled study of the efficacy and safety of<br />

a new eyedrop formulation for moderate to severe dry eye<br />

syndrome. F, Chiambaretta. s.l. : Eur J Ophthalmol. <strong>2016</strong> Jul<br />

20:0. doi: 10.5301/ejo.5000836., <strong>2016</strong>.<br />

4. Efficacy and safety of two new formulations of artificial<br />

tears in subjects with dry eye disease: a 3-month,<br />

multicenter, active-controlled, randomized trial. PA,<br />

Simmons. s.l. : Clin Ophthalmol. 2015 Apr 15;9:665-75. doi:<br />

10.2147/OPTH.S78184. eCollection 2015., 2015.<br />

5. Comparison of treatment with preservative-free versus<br />

preserved sodium hyaluronate 0.1% and fluorometholone<br />

0.1% eyedrops after cataract surgery in patients with<br />

preexisting dry-eye syndrome. D, Jee. s.l. : J Cataract Refract<br />

Surg. 2015 Apr;41(4):756-63. doi: 10.1016/j.jcrs.2014.11.034.<br />

Epub 2014 Dec 5, 2015.<br />

6. WHO. International travel and Health: Cabin air pressure. s.l.<br />

: www.who.int/ith/mode_of_travel/cab/en/, <strong>2016</strong>.<br />

7. Baillie, K. Altitude air pressure calculator. s.l. : www.altitude.<br />

org/air_pressure.php, 2010.<br />

8. 8. Oxygen transmissibility corneal Oxygen. Weissman, B. A.<br />

s.l. : Contact Lens Spectrum, Volume: 30 , Issue: <strong>Nov</strong>ember<br />

2015, page(s): 25-29, 55 , 2015.<br />

9. Light exposure and physical activity in myopic and<br />

emmetropic children. SA, Read. s.l. : Optom Vis Sci. 2014<br />

Mar;91(3):330-41. doi: 10.1097/OPX.0000000000000160.,<br />

2014.<br />


* Eleisha Dudson is an<br />

optometrist at Stevenson,<br />

Sangster and Matthews in<br />

Wellington, and has a special<br />

interest in orthoK<br />

Style-Eyes<br />

BY JO EATON*<br />

et’s talk about sunglasses<br />

L trends for summer<br />

<strong>2016</strong>/17. Things finally<br />

seem to be shifting from<br />

the gigantic acetate frames<br />

that have dominated the<br />

past several years. Here’s a<br />

rundown of what you can<br />

expect this season.<br />

Frame shapes<br />

Rounder shapes are still a<br />

popular choice.<br />

Phil Thomas at Edel-Optics<br />

says, “This summer, we shall see glasses in<br />

panto or butterfly styles everywhere… Men<br />

and women alike are going for round frames<br />

with lenses that are slightly flattened at the<br />

top. …This year, the glasses will not be quite as<br />

oversized as last year.”<br />

Interesting geometric shapes are also in many<br />

collections.<br />

Colours<br />

Pastel colours are coming through again. Gold<br />

and rose gold are popular in metal frames.<br />

Lenses<br />

In non-prescription glasses, flat-look lenses are<br />

having their moment in the sun.<br />

Mirrored lenses are big again this year. Super<br />

are offering unusual colours to choose from,<br />

such as bright pink mirror lenses.<br />

Transitions<br />

Transitions has been working on marketing with<br />

well-known opticians, bloggers and designers<br />

in the States in an effort to banish the daggy<br />

reputation of photochromic lenses. They’re<br />

pushing the fact the lenses clear when you walk<br />

out of UV light a lot faster than they used to.<br />

Coyote DeGroot of Labrabbit Optics in Chicago,<br />

fashion blogger Leandra Medine of Man Repeller<br />

and eyewear designers Coco & Breezy have been<br />

some of the stars of the resulting campaign.<br />

Check out the lookbook at www.transitions.<br />

com/en-us/look-book/<br />

Clips<br />

Clip-on sunglass fronts, to be fitted over a<br />

related pair of prescription spectacles, have been<br />

making a quiet comeback for the past several<br />

years and they’ve finally dropped the dorky<br />

sports-dad feel. You’ll find them everywhere<br />

from Luxottica brands like Oliver Peoples to<br />

avant-garde Korean brand Gentle Monster,<br />

through to many affordable brands.<br />

Metal frames<br />

With smaller frames making<br />

a comeback, metal frames are<br />

also on the way back in.<br />

Karen Walker has just<br />

released a range of metal<br />

frames making use of<br />

negative space, as if they are<br />

outlines of her classic acetate<br />

styles. It’s very clever!<br />

As with spectacles, there is a<br />

move towards smaller metal<br />

frames in sunglasses for this<br />

season. Check out AM Eyewear’s NOJ and Chico<br />

frames and RVS Eyewear’s Palladium range.<br />

Luxury<br />

High-end eyewear brand Barton Perreira are<br />

leading the way with sunglasses this year. Their<br />

beautiful frame Belvedere is small, round and<br />

comes with a clip.<br />

Their rectangular Rango frame combines both<br />

metal and acetate in a very masculine way,<br />

while Beauregard does the same for femmes.<br />

The real stunner of their latest collection,<br />

however is the Boleyn frame, of which they<br />

say, “[Its] name inspiration becomes very<br />

apparent once seen, as it has a metal top half<br />

and a plastic bottom, a reverse of the norm in<br />

which the plastic half is traditionally on the<br />

top. The metal has a filigree of very intricate<br />

detail that evokes the distinctive car grills of<br />

the past, it can be thought of as a spin on an<br />

aviator, creating a unisex frame for the fashion<br />

forward.”<br />

Bold and unusual<br />

If you’re going to go for big acetate sunglasses<br />

this season, they have to look bonkers. Brands<br />

leading the way here include Fakoshima, Stella<br />

McCartney and Super.<br />

You do you<br />

Something I particularly love about <strong>2016</strong> is, that<br />

while there are definite themes emerging as<br />

trends, anything is acceptable as long as they are<br />

worn with confidence. I’ve noticed sunglasses<br />

styles associated with every decade from the<br />

past 60 years worn lately without a sideways<br />

glance from the arbiters of style! So, as my<br />

friends are fond of saying, you do you!<br />

* Jo Eaton is a native Wellingtonian, now studying optical<br />

dispensing in Melbourne. She runs eyewear fashion blog,<br />

Eye Heart Glasses’.<br />

<strong>Nov</strong>ember <strong>2016</strong><br />





In the annals of history there exists a number of<br />

important discoveries that were conceived over<br />

a few beers. Arthur Holmes and his colleagues<br />

developed the theory of continental drift whilst<br />

sipping cocktails in Hawaii. Watson and Crick<br />

unravelled the mysteries of DNA’s double helix in<br />

the now-famous Eagle Tavern in Cambridge. Trivial<br />

Pursuit, the Iron-Man triathlon and even Harry<br />

Potter’s fictional sport Quidditch are all famous<br />

ideas that may not have come to be without the<br />

influence of a chilled alcoholic beverage.<br />

The following innovation is not one of these.<br />

Picture this scenario: on a balmy summer’s evening<br />

last year, a colleague and I decided a quenching ale<br />

was just the ticket after a long Friday of checking<br />

eyeballs. My final appointment of the day was a<br />

scleral contact lens fitting for a chap with advanced<br />

keratoconus. Once I had finished regaling my fellow<br />

optometrist with tales of the complexity of the case<br />

our conversation (rightly) turned to weekend plans.<br />

Given the heat, a swim at the local beach was on<br />

the agenda. “That patient of mine would have a<br />

tough time checking the water for sharks!” I laughed<br />

sympathetically. “Did you not design his sclerals<br />

to see underwater too?” my colleague retorted.<br />

Chuckles simultaneously turned to quiet speculation<br />

as metaphorical light-bulbs switched on above our<br />

heads. What if it could be done ...?<br />

Water-wear<br />

One of the few limitations of day-wear contact<br />

lenses are the difficulties when swimming. In my<br />

younger years I would dive and swim with lids<br />

clenched tight for fear of my soft dailies drifting<br />

away (Fig 1.). Three years ago I had laser refractive<br />

eye surgery and still I get a guilty kick when opening<br />

my eyes underwater to experience the (blurry)<br />

wonders beneath the waves. This freedom is one<br />

of the main reasons I recommend orthokeratology<br />

lenses to patients who enjoy the water. Goggles are<br />

all good, but they have their limitations: fogging<br />

of the lens, water influx, discomfort, field of view,<br />

and those lovely compression marks visible after<br />

removal. Plus, you’d never see a trendy surfer<br />

waiting for the next set with a pair of goggles<br />

strapped on. Wouldn’t it be neat if we could design<br />

a scleral lens swimming goggle that could offer<br />

great vision in and out of the water instead?<br />

Several high-fives later we calmed down, ordered<br />

another round and extra napkins, and got serious.<br />

First things first: would a scleral lens stay in an open<br />

Fig 1. One from the family album: Me as an 11-year-old soft contact lens<br />

wearer demonstrating the clenched-eye diving technique that I had perfected<br />

Fig 2. Is than an RGP lens? Or a pneumatic retinopexy gone wrong? No, this<br />

ladies and gentleman, is a scleral swimming goggle<br />

eye underwater? We decided yes: the large surface<br />

area provides ample surface tension (when was the<br />

last time you were able to pull a scleral or hybrid<br />

lens straight off the eye without a suction tool?<br />

Clue: it’s not easy) and the lids should provide an<br />

additional barrier.<br />

Second: how do we get around the issue of<br />

the vergence changes when a rigid contact lens<br />

is moved from air to water? As most of you will<br />

appreciate when underwater the human eye<br />

becomes severely hyperopic, by approximately 40<br />

diopters, due to the cornea being almost entirely<br />

neutralised. A traditional rigid lens would behave<br />

similarly. Simply adjusting the contact lens front<br />

curvature to focus correctly underwater would<br />

lead to a colossal level of myopia when above the<br />

surface. Not ideal. One solution would to create a<br />

monovision-type set up, with one lens designed for<br />

vision in air and the other for vision underwater.<br />

Again highly impractical.<br />

Eureka!<br />

Then it hit us. Why not make a tiny goggle for each<br />

eye? Create the lens with a completely flat front<br />

and back surface, and insert the lens with an air<br />

gap, rather than filled with solution, so that the air/<br />

cornea refractive interface, and therefore the power<br />

of the eye, remained the same in air and water! In<br />

theory it would work perfectly. We left the bar that<br />

night with a sense of purpose rarely experienced by<br />

slightly-inebriated eye care professionals.<br />

First thing on Monday morning I called Graeme<br />

Curtis at Contact Lens Corporation in Christchurch.<br />

“Was it even possible?” I asked. This lens would have<br />

quite possibly the flattest base curve ever created<br />

on a rigid lens, with essentially a radius of infinity.<br />

It is testament to the technology of modern day<br />

lathes (not to mention Graeme’s patience with<br />

seemingly foolish requests) that his reply was “Sure,<br />

let’s give it a try”. I heavily modified the parameters<br />

of a trial scleral lens using rigid lens design software<br />

Eyespace to match the cocktail napkin diagrams we<br />

had sketched previously. Regrettably ‘infinity’ was<br />

not a BOZR value I could input, so I had to settle on r<br />

= 99999mm. You read that correctly: Our lens had a<br />

100 metre base-curve radius.<br />

Weird science<br />

As I opened the courier parcel from CLC you could<br />

have cut the tension with a knife. As it turned out<br />

the parcel’s contents; possibly the world’s first<br />

scleral swimming goggle, was the weirdest<br />

contact lens I had ever seen. The completely<br />

flat 6mm optic gave the lens a sinister<br />

appearance: It looked more like a part from<br />

a Terminator than something a water-sports<br />

enthusiast would wear. After the initial<br />

excitement subsided, human trials began.<br />

Much like Australian Dr Barry Marshall, who<br />

drank a petri dish filled with the bacterium H.<br />

Pylori to prove the cause of stomach ulcers,<br />

in the name of science I bravely inserted the<br />

dry scleral lens onto my left eye.<br />

Initial impressions were positive. For those<br />

of you who have not worn a well-fitting<br />

scleral lens they are surprisingly comfortable.<br />

I could feel this lens a little more than usual<br />

due to the abrupt junction at the optic zone<br />

edge but it was not irritating. And I could see!<br />

I could happily make out the 6/6 line on the<br />

chart due to my plano unaided refraction.<br />

Topography over the lens confirmed a front<br />

surface power equalling zero diopters;<br />

the lens was as flat as a pancake. OCT<br />

and anterior photography highlighted<br />

the unusual shape of the lens (Fig 3.) and<br />

confirmed ~250μm of central clearance -<br />

important when the lens is 35D flatter than<br />

alignment.<br />

However, things did not stay hunky-dory<br />

for long. After a few minutes my vision<br />

started to blur; I was struggling to see 6/12.<br />

Under the slit-lamp the rear surface of the<br />

lens was misting up like a bathroom mirror.<br />

We removed the lens and added a lubricant<br />

drop to the lens bowl prior to insertion. This<br />

helped for about five more minutes but the<br />

blur slowly returned. Only this time the lens<br />

was starting to become quite uncomfortable.<br />

Fig 3 & 4. OCT and slit lamp appearance of the flat scleral lens profile on eye<br />

Fig 4.<br />

Inspection showed the lens was fitting well in the<br />

peripheral area and still had adequate clearance. I<br />

managed to keep the lens in the eye for a further<br />

ten minutes, before the pain and significant blur<br />

necessitated removal.<br />

We created a monster<br />

Rather than relief, my first emotion was concern:<br />

the vision in my left eye was still very hazy: I was<br />

only reading 6/36 in my guinea-pig eye! The cornea<br />

was clear and uninflamed however instillation<br />

of sodium fluorescein revealed a subtle patchy<br />

negative staining of the central epithelium. Further<br />

investigation with corneal topography showed<br />

very irregular central mires (Fig 5.). Realisation<br />

dawned: we had created a corneal exposure<br />

scenario mimicking the pathophysiology of<br />

patients with conditions like Bell’s Palsy, thyroid<br />

orbitopathy, restrictive eyelid disease and nocturnal<br />

lagophthalmos. Even a healthy eye with excellent<br />

tear film function will experience significant visual<br />

problems and discomfort when the lids are not<br />

regularly smoothing and spreading fresh tears over<br />

our fragile corneal surface.<br />

A case of one of my colleagues highlights this<br />

concept in a similar way. At routine aftercare a<br />

happy keratoconic patient noted that from time<br />

to time his lenses would be very painful and<br />

irritable for the duration of the day. The lens was<br />

fitting beautifully and in the chair his eyes looked<br />

pristine. The patient was asked to return wearing<br />

his lens if the irritation arose. A few weeks later<br />

the patient returned with a very red eye. One look<br />

explained his troubles - poor insertion technique<br />

had trapped a bubble of air under his lens (Fig 6.).<br />

As the bubble was for the most part off the optic<br />

axis he was unaware of it. Following removal,<br />

a kidney-shaped depression was evident at the<br />

site of the bubble, with dense epithelial staining<br />

within its confines (Fig 7.). Needless to say it is<br />

important to educate scleral lens patients to check<br />

for bubbles after insertion with the aid of a mirror<br />

and sometimes a penlight. Like a stone trapped<br />

in a shoe, even a small pocket of air will gradually<br />

cause problems.<br />

In the end it took roughly an hour for my vision<br />

to return to normal. Despite my scare I gamely<br />

tried the scleral lens one further time, except with<br />

a soft bandage lens worn beneath. The discomfort<br />

was not noticeable but vision became equally poor<br />

as the soft lens surface desiccated slowly. It was to<br />

be the last time that the scleral goggle would ever<br />

be worn.<br />

Reinventing the wheel<br />

The novel concept of using an air gap under the<br />

lens had ultimately proven the design’s downfall.<br />

So disappointing (and not to mention traumatic)<br />

Fig 5. The exposure keratopathy induced by the air-filled scleral lens.<br />

Note the distorted mires seen on topography<br />

Fig 6 & 7. Epitheliopathy and inflammation caused by a trapped bubble<br />

under a well-fitting scleral lens. Images: Lachlan Scott-Hoy<br />

Fig 7.<br />

was the outcome that the lens was never even<br />

tested underwater. With our luck it would have<br />

just floated off anyway!<br />

It may seem like a waste of time to publish an<br />

account of this fruitless escapade. However, I think<br />

failures in science can also be viewed as learning<br />

opportunities. Rome wasn’t built in a day after all.<br />

I discovered:<br />

Contact lens technology is progressing at an<br />

incredible rate and more and more is possible<br />

when designing rigid lenses.<br />

A healthy lid-wiper should not be<br />

underestimated in patients with irritation and<br />

dryness symptoms. Neither should the absence of<br />

obvious clinical problems preclude patients from<br />

a diagnosis of dry eye. As I personally found out<br />

symptoms can far exceed signs.<br />

We are not born with two eyes as a handy<br />

surplus should one be blinded through<br />

irresponsible self-experimentation.<br />

And perhaps the most important life lesson we<br />

glean from this tale, the grander a pub idea is, the<br />

more miserably it will fail!<br />

On that sour note thank you for your support<br />

this year. Have a safe and happy holiday period. I<br />

look forward to entertaining with further specialty<br />

contact lens reports in 2017. ▀<br />


*Alex Petty is a New Zealand<br />

optometrist based in<br />

Tauranga with a particular<br />

interest and knowledge in<br />

speciality contact lenses,<br />

ortho-k and myopia control.<br />

16 NEW ZEALAND OPTICS <strong>Nov</strong>ember <strong>2016</strong>

SPECIAL FEATURE: SILMO <strong>2016</strong><br />

A spectacle of choice<br />

Silmo <strong>2016</strong> wowed with the pure breadth of options on display. Lesley Springall<br />

shares some highlights from her first visit to one of Europe’s most popular<br />

international optical fairs.<br />

The sheer scale of Silmo Paris, the annual<br />

European optical fair held just outside<br />

France’s capital city, surely must be daunting<br />

to most, but especially to the novice fair attendee.<br />

Two huge, purpose-built exhibition spaces,<br />

with row upon row of 950 different size stands<br />

– most cleverly decorated to stand out from<br />

their neighbours as they vie for attention from<br />

nearly 34,000 visitors – at first seems like a test of<br />

orienteering. But by the second day, even a novice<br />

such as myself was counting down the stand<br />

numbers like a pro.<br />

It was hard to identify themes at this year’s show<br />

as there seemed to be just about everything on<br />

display in terms of frame colours, materials (I’ve<br />

never seen so many buffalo horns) and frame<br />

shapes. If there was a standout, however, it was<br />

the return of round – large round and, especially<br />

for men, small round, somewhat retro-looking<br />

frames. Colour was everywhere, with some brave<br />

designers even presenting frames in those trickiest<br />

of facial-match colours, yellow and green. Blue was<br />

Eye catching displays at Silmo <strong>2016</strong><br />

particularly popular, however, with clever patterns<br />

(on metal or acetate) now the norm.<br />

The other key themes from this year’s fair were<br />

customisation, innovation and authenticity<br />

with French and Italian frame makers reeling off<br />

their “we really are, really made” in France/Italy<br />

credentials, as soon as you start talking to them.<br />

Both are less than impressed by their governments’<br />

decision to award “made in France/Italy” labels to<br />

any manufacturer who simply designs or makes just<br />

part of their frames in the country.<br />

As for innovation, Silmo has always been a<br />

showcase for new materials and advancements<br />

in frame technology, but it seemed like nearly<br />

everyone had a new way of dealing with the old<br />

hinge and screw technology at this year’s fair. The<br />

technology on display from the lens and equipment<br />

manufacturers was equally fascinating. But of<br />

particular interest was Silmo’s Experience Store,<br />

which featured the latest technologies on offer<br />

to draw patients into practices and keep them<br />

entertained. This included hologram greeters<br />

Silmo Paris: what an experience!<br />


There was a palpable sense of anticipation<br />

as we walked from the train across the<br />

forecourt to Silmo. Sporting a limp,<br />

courtesy of a collision with a fare jumper<br />

hurdling the metro gate, I was not exactly sure<br />

what to expect.<br />

The show was as big as everyone had<br />

promised; at times a bit overwhelming. The<br />

two large halls dedicated to Silmo at the Parc<br />

des Expositions exhibition centre in Paris Nord<br />

Villepinte had definite themes; Hall 5 seemed<br />

colourful with flamboyant frame designers and<br />

stands, while Hall 6 had clinical equipment and<br />

lots of brands, which were less familiar to me,<br />

plus all the lens suppliers.<br />

Making contact with frame designers from the<br />

other side of the globe gave me insights into the<br />

story of the products we stock and use to help<br />

our patients on a daily basis. For me, however, the<br />

true high point was the one-on-one time I spent<br />

with some of our key brands: Alan Peterson from<br />

Monoqool kindly spent a fascinating hour talking<br />

to me about his vision for the company and the<br />

challenges of developing his 3D printing process.<br />

Technology and customisation featured<br />

everywhere. I talked with a young IT whiz about<br />

his app to put virtual stock onto customers faces.<br />

There were frames made from paper and lens<br />

cloths made from recycled PET bottles. At the<br />

Hoya stand, Hoya executives were scanning faces<br />

to design a customised lens with a 3D printed<br />

frame, optimising Hoya’s lens’ performance (see<br />

separate story). I am not sure if people will want<br />

customisation at the expense of choice in frames,<br />

however, though it was a nice touch to see all<br />

Hoya’s staff wearing the frames, giving a uniform<br />

effect similar to the French Morel team, who were<br />

all sporting bright yellow sneakers!<br />

The stands at Silmo Paris ranged from highly<br />

creative to slick; with orange Dutch cows,<br />

American milk bars (complete with rock and roll<br />

dancers) and a British double decker red bus; all<br />

of which is impossible to experience without<br />

considering our own street appeal.<br />

For me, Silmo also highlighted how crowded<br />

the optical frame market is. The idea of selecting<br />

unique brands at a fair on this scale might give<br />

you the sense of unlimited choice. I suspect it<br />

is very easy, too easy, to order out-there new<br />

designs, which may prove less than successful in<br />

your own practice. So for this kiwi optom at least,<br />

we will continue to enjoy the selection curated by<br />

our own trusted suppliers.<br />

and a variety of frame<br />

simulation technologies<br />

from table top displays<br />

to wall-hanging<br />

technologies and freestanding<br />

screens in a host<br />

of sizes. Often wrapped<br />

up closely with innovation<br />

was customisation, with<br />

a number of companies<br />

offering new ways for<br />

practices to customise<br />

their frame and lens<br />

offerings to patients<br />

(see below and the Hoya<br />

story on p3). All of which clearly demonstrated that<br />

innovation is thriving in the industry.<br />

NZ Optics’ Lesley Springall talking frames with Xavier Garcia<br />

Paperstyle<br />

Demonstrating this innovation, and something<br />

a little bit different from the host of acetate,<br />

wood, horn and metal frame manufacturers,<br />

was Paperstyle, a South Tyrolean brand of paper<br />

eyewear, made entirely by hand.<br />

Through a patented process, premium paper<br />

(15 to 18 sheets) is pressed, glued, vacuum-dried<br />

and shaped with special milling machines. The<br />

outcome is amazing; a moldable, durable, but very<br />

lightweight product that can be customised to<br />

whatever the customer desires, with many using<br />

their own photographs as the basis of their, highly<br />

personalised, new frame designs.<br />

Monkey Glasses<br />

Another frame brand that caught my eye was<br />

Monkey Glasses, with its “Save the Orangutan”-<br />

themed stand, complete with jar of yummy<br />

banana lollies, this six-year old Danish company<br />

majored on its environmental, sustainable and<br />

biodegradeable credentials. Monkey Glasses’<br />

frames are handmade and are manufactured from<br />

a special biodegradable material - cotton acetate<br />

- that can look like wood, horn or even crystal. To<br />

add to the feel-good factor, and the story that can<br />

be sold to environmentally-minded patients, is the<br />

knowledge that a percentage of every frame sold<br />

goes to support the work of Danish conservationist<br />

Lone Dröscher Nielsen’s who’s working to save the<br />

orangutans in Borneo; even the cases are made<br />

from recycled paper.<br />

Area 98<br />

Area 98 prides itself on being a “braver” brand<br />

company, featuring brands such as La Matta,<br />

Kaos and, the rather mind-blowing detailing and<br />

handmade individualism of Coco Song, inspired<br />

by the opulence of ancient Chinese dynasties,<br />

incorporating feathers, silks, lacquers, leaves and<br />

even flowers in its temples.<br />

La Matta’s new collection, launched at Silmo (and<br />

available in New Zealand through BTP) is described<br />

as “an anthem to the modern and sensual woman. A<br />

mysterious woman who likes to transform herself, by<br />

showing her personality through the accessories she<br />

wears.” The slightly accentuated temples, giving an<br />

unusual cat-eye effect, in animal-themed acetate, are<br />

decorated with small, coloured inserts at the hinges.<br />

Kaos’ new Silmo range, meanwhile, focused on<br />

colour and detail, designed to appeal to a younger<br />

audience, with their squared, rounded and oval<br />

shapes, alternating with contrasting shades or<br />

absolute black.<br />

Area 98’s Michela Del Tin, while demonstrating<br />

the latest handmade offerings from Coco Song,<br />

featuring feathers and silks embedded into the<br />

acetate temples and semi-precious stones such<br />

as lapis lazuli, said Area 98 was formed from the<br />

merging of three companies: Area 98 which is Italian,<br />

and its subsidiary company in Hong Kong, and the<br />

company’s main US distributor, Poets Eyewear. The<br />

design is divided between Italy and Hong Kong.<br />

Both La Matta and Coco Song sport very powerful<br />

decoration on the temples, but La Matta, with its<br />

animal prints, is more for the provocative, strong<br />

woman, while Coco Song is more for the elegant,<br />

dreaming woman, said Del Tin. “La Matta really<br />

wants to break the rules; there is a lot in the frames<br />

and it takes inspiration from jewellery…Kaos is the<br />

younger brother of La Matta, more unisex in style,<br />

but still colourful…they are all unified by colour.”<br />

One of La Matta’s new styles<br />

launched at Silmo<br />

Fitting Box<br />

In the Experience Store section, Fitting Box<br />

was busy demonstrating Owiz Street, it’s latest<br />

innovation in augmented reality virtual try-on<br />

technology. Designed to grab attention in a<br />

practice’s window, Owiz Street transforms the<br />

window into an interactive experience, remotecontrolled<br />

from the passing shopper’s or patient’s<br />

own smartphone. The mounted display acts<br />

like a mirror, recognising the viewer’s face and<br />

allowing them to virtually try on any eyewear<br />


William Morris’ Robert Morris and Claire McDonald<br />

*Claire McDonald is an optometrist and co-owner of McDonald<br />

Adams in Warkworth. This was her first visit to Silmo.<br />

Phone: 0508 FRAMES (372 637)<br />

<strong>Nov</strong>ember <strong>2016</strong><br />



SPECIAL FEATURE: SILMO <strong>2016</strong><br />


they select from the practice’s own range. Other<br />

products in its Owiz range include Plugin, which<br />

adds a practice’s digital frame catalogue to its<br />

website or Facebook page; Web, a web-to-store<br />

turnkey website, compatible with tablets and<br />

smartphones; and Mirror, a touchscreen mirror<br />

which allows your customer to virtually try on<br />

different frames in your collection either through<br />

a standalone mirror or iPad.<br />

WOOW, Face à Face, ProDesign and Inface<br />

Four large, very popular stands clustered around a<br />

crossroads made up the Design Eyewear Group: the<br />

French brands Face à Face, (classical architectural<br />

influence), and its younger, more affordable<br />

sister, created in 2014, WOOW. Then, the more<br />

minimalist (less flamboyant), but still eye catching<br />

Scandanavian ranges from ProDesign Denmark and<br />

Inface.<br />

Though the Design Eyewear Group had a host of<br />

staff on hand to help with enquiries, there never<br />

quite seemed to be enough and there was even a<br />

queue for Face à Face, which unusually had a totally<br />

enclosed stand, where admittance was by invite<br />

only for buyers.<br />

Distributed by Eyes Right Optical in Australia and<br />

New Zealand, the Eyes Right team Gaye Wymond,<br />

son Mark and daughter Lisa, were hard at work<br />

buying exciting new stock for the coming season.<br />

Face à Face – Akiko 2<br />

William Morris<br />

William Morris’ popular and busy stand was<br />

dominated with an iconic British double-decker red<br />

bus that doubled as a selling and ordering platform<br />

(the top floor of the bus), office and storage room<br />

and made it crystal clear to the whole show what<br />

the company was all about.<br />

The wonderful founder and designer Robert<br />

Morris (he thought his middle name, William,<br />

sounded more British) was on flamboyant form<br />

WOOW’s colourful stand Sabine Pretz from PaperStyle Michela Del Tin, shows off Coco Song’s amazing frames<br />

welcoming Kiwi optometrist Claire McDonald and<br />

myself to the stand as if we were long lost friends.<br />

Centre stage was William Morris’ new Wills<br />

collection, aimed at a younger audience, the<br />

collection has a retro look and is light and carefully<br />

crafted in easy-to-wear shapes and energetic<br />

colours, to show off the wearer’s personality, but<br />

with a feel that treats older children more as adults.<br />

“Kids don’t want to be kids,” said Morris. “We<br />

are targeting kids between 9 and 12 who want to<br />

look like their grown-up brother or sister, so there’s<br />

nothing childish about our kid’s range…it’s very<br />

sophisticated.”<br />

Another highlight was the company’s new Autumn<br />

and Winter collection, which takes its inspiration<br />

from the heart of London and is backed by an eyecatching<br />

advertising campaign featuring British<br />

bulldog Quincy. These British credentials are key<br />

to the success of the brand and Morris says one<br />

of things he’s most-proud of is being selected as<br />

the only eyewear brand in the UK to be allowed to<br />

be part of the GREAT Britain campaign, allowing<br />

it to use the “FASHION IS GREAT Britain” logo and<br />

imagery, and be part of the country’s drive to<br />

reposition itself as a vibrant, inspiring and innovative<br />

place; an honour it beat several other well-known<br />

British brands such as Victoria Beckham and Paul<br />

Smith for and will hold for the next five years.<br />

Xavier Garcia<br />

Xavier Garcia himself, took time out to show some<br />

of his new Autumn-Winter collection, featuring<br />

seven new acetate designs and four new metal<br />

designs, grouped together as “the Skin collection”,<br />

because they are made from thin metal sheets<br />

known as “skins”.<br />

He says he’s often asked by journalists what his<br />

inspiration is for each new collection to which<br />

he likes to reply: “There is no inspiration, there is<br />

always work, work, work.” But he says he has been<br />

inspired by metal in this collection, and particularly<br />

the use of layering with the metal skins, so that the<br />

design becomes part of the structure. His “Heidi”<br />

model, for example, features a round shape with a<br />

double bridge and a clever inner “skin” on the top<br />

bar of the bridge; “Helen” uses skins along the front<br />

to evoke the “flutter of dragonfly’s wings”; while<br />

“Landa” has a distinctly masculine air created by the<br />

inner skin, which lines the bar at the front, creating<br />

a colour contrast.<br />

Xavier Garcia’s “Heidi” frame demonstrating his metal “skins” design<br />

Jono Hennessy<br />

Jono Hennessy Sceats, his son Jasper and Peter<br />

Grunfeld were manning the Jono Hennessy<br />

stand at Silmo and attracting a lot of attention<br />

particularly for the Australian company’s new<br />

Carter Bond styles, featuring fine wood-look<br />

profiles with split metal temples in natural<br />

finishes. The company’s “upside down round<br />



✖ character<br />

✖ quality<br />

✖ impetuosity<br />

For more, contact Cardinal Eyewear at www.cardinal.co.nz<br />

18 NEW ZEALAND OPTICS <strong>Nov</strong>ember <strong>2016</strong>

Jono Hennessy Sceats and his son, and brand manager, Jasper<br />

eye” was particularly eye catching and would suit<br />

anyone, agreed Hennessy Sceats. On the Jono<br />

Hennessy side, the company was using more<br />

combination constructions, featuring interesting<br />

temples and changing some of the colours to<br />

matt finishes, so it’s a more modern finish. “The<br />

big thing that’s happening is everything is round<br />

now, and smaller rounds,” says Hennessy Sceats.<br />

“And everything has to have more detailed<br />

construction now, which is a worldwide trend<br />

to distinguish the quality of the frames and<br />

make the patient feel special.” The company now<br />

exports more than 50% of its range to Europe and<br />

says Silmo is its key sales fair.<br />

TO BE CONTINUED…with so much to see,<br />

we couldn’t fit it all in. Part II of Silmo<br />

<strong>2016</strong> will be in our December issue.<br />

Silmo endures, expands<br />

Given the terrible<br />

Paris terrorist<br />

attacks at the<br />

end of last year, Silmo<br />

organisers had feared<br />

its flagship exhibition,<br />

showcasing more than<br />

1,350 optical industry<br />

brands, would not attract<br />

anywhere near the same<br />

numbers as last year,<br />

especially as many other<br />

shows in the region had<br />

poor visitor numbers in the<br />

preceding months.<br />

But the optical industry<br />

is obviously a hardy lot<br />

as visitor numbers were<br />

down just 1.3% on last<br />

year, to 33,791, including<br />

56.5% from abroad and<br />

43.5% from France. Plus,<br />

given the obvious activity<br />

on most stands, it looks like orders are unlikely to<br />

be affected and could even be up on last year, says<br />

director Éric Lenoir.<br />

Last year’s show saw the launch of a new concept,<br />

new image and new look, so changes to this year’s<br />

show were more minor, he says, with tweaks to do<br />

with hospitality and layout as part of the organisers’<br />

continual focus to improve the experience for both<br />

visitor and exhibitor alike. There was, however,<br />

more focus on the “phygital” - convergence of<br />

physical and digital – exhibition side, with an<br />

expanded Experience Store, demonstrating how<br />

optometry businesses, and those who serve them,<br />

can incorporate more digital solutions into their<br />

practices, allowing them to “get smarter” about<br />

how they serve their patients and increase revenues.<br />

Sporting the latest trend in his own eyewear -<br />

round, retro-looking frames from Lafont - Lenoir<br />

says next year’s show from 6-9 October, 2017,<br />

however, will be something special as it will be the<br />

50th anniversary of Silmo Paris; a company he is<br />

still completely passionate about after working for<br />

it for more than 21 years, having joined straight<br />

Silmo Sydney event organiser Gary Fitz-Roy with Silmo director<br />

Eric Lenoir<br />

from college. “I love it. We<br />

are dealing with fashion,<br />

technology, health. It is<br />

a brilliant mix, and even<br />

though it’s a big show, with<br />

a lot of people, it’s a small<br />

family. The optics world<br />

is not that big in terms of<br />

world turnover, but it’s so<br />

creative, so innovative and<br />

every season there is always<br />

a surprise, and it’s a serious<br />

product – because if I didn’t<br />

have my glasses I couldn’t<br />

see you,” he laughs.<br />

Silmo overseas<br />

He is also excited about<br />

Silmo’s international<br />

expansion. After just two<br />

years Silmo Istanbul - a<br />

joint venture with a Turkish<br />

optics media company<br />

and Silmo’s first foray abroad – has made all its<br />

targets, has most, if not all, of the local companies<br />

exhibiting and is now attracting interest from other<br />

countries in the region, including the Middle East,<br />

Africa and North-East Asia. While the new Silmo<br />

Sydney show is set to launch in March next year.<br />

Exporting the brand gives Silmo an opportunity<br />

to grow, says Lenoir. It also helps Silmo Paris attract<br />

more visitors as the exhibitors at Silmo Istanbul, for<br />

example, are the wholesalers and distributors from<br />

the region and thus the most likely visitors to Paris.<br />

He’s expecting the same to happen with Silmo<br />

Sydney. There’s a lot of opportunity in the region<br />

as the market, both for small and new exhibitors<br />

and the level of choice on show for the practices<br />

and stores themselves, has been a bit controlled by<br />

the Australian Optical and Wholesalers Association<br />

(ODMA), which, until 2017, had run the main show<br />

in the region every two years, he says.<br />

Silmo is looking at other areas for expansion,<br />

including South East Asia and South America, both<br />

of which are currently poorly served in the optics<br />

arena, says Lenoir. ▀<br />

<strong>2016</strong> Silmo d’Or<br />

Awards<br />

Silmo’s <strong>2016</strong> Silmo d’Or Awards night was<br />

a festive evening liberally fuelled with<br />

canapés and champagne. Belgian designer<br />

Alain Gilles and Silmo president Phillippe Lafont<br />

announced the awards, designed to recognise<br />

and reward the creativity and innovation of the<br />

industry, amid a cabaret of singing, dancing,<br />

visual light illusions and a bubble man at the<br />

Maison de la Mutualité in central Paris. The<br />

award winners were:<br />

● Children: KNCO for “Bili” by Karavan Kids<br />

Sport Equipment: Demetz for “Lazer-Run”<br />

● Low Vision: special prize: Visiole for “Go<br />

Vision”; Essilor for “My Eye”; and Ceciaa for<br />

“NuEyes”<br />

● Frame Technological Innovation: Oxibis Group<br />

for “77H” by Exalto<br />

● Premiere Classe prize: Pride Eyewear for<br />

“305 BL”<br />

● Material/Equipment: Netlooks for “Netlooks<br />

3D”<br />

● Vision: Essilor for its “Eye Protect System”<br />

● Sunglasses: Parasite Design for “Anti Retro X”<br />

● Optical Frame: Blake Kuwahara for “Khan”<br />

● Jury Special Prize: Kuboraum for “Maske E3”<br />

Pride Eyewear’s “305 BL”<br />

Kuboraum’s<br />

“Maske E3”<br />

Blake Kuwahara’s “Khan”<br />

More than 75 years after its creation,<br />

Lacoste has become a lifestyle brand<br />

which exemplifies elegance and comfort.<br />

Lacoste looks at life in an optimistic way by<br />

telling itself it is a beautiful sport: a sport in<br />

which you compete with elegance, show<br />

off your panache, and combine a quest for<br />

performance with an eye on elegance.<br />

L2773 BLUE<br />

L2771 HAVANA<br />

Contact GenOp today to find out how you<br />

can become a stockist.<br />

Toll free: 0800 141 444<br />

www.generaloptical.co.nz<br />

customerservice@genop.co.nz<br />

<strong>Nov</strong>ember <strong>2016</strong><br />



Orthokeratology Society of Oceania Conference <strong>2016</strong><br />


The Orthokeratology Society of Oceania (OSO)<br />

is the longest running group dedicated<br />

to the practice of fitting ortho-k contact<br />

lenses in the world. In September <strong>2016</strong>, Surfers<br />

Paradise played host to the 12th Biennial Congress<br />

of the OSO and combined this with the 5th<br />

Annual Congress of the International Academy of<br />

Orthokeratology and Myopia Control. Both of these<br />

independent, non-profit organisations exist to<br />

promote research, professional development and<br />

safe-practice in the field of orthokeratology and<br />

reduce the impact of the global myopia epidemic.<br />

The OSO conference is always a highlight of the<br />

calendar for me as it attracts a certain breed of<br />

highly passionate and motivated practitioners.<br />

Close to 300 orthokeratologists from around<br />

the world made their way to the Gold Coast this<br />

year, making it the largest OSO conference to<br />

date. It was especially pleasing to see a strong<br />

New Zealand contingent, which highlights the<br />

commitment Kiwi optometrists have to offering<br />

cutting-edge treatment options and long-term<br />

eye care to their patients. The meeting attracted<br />

international speakers from around the globe,<br />

including America, Europe and Asia as well as local<br />

experts from Australian and New Zealand-based<br />

universities and private practices.<br />

As always the content of the lectures was<br />

enlightening and each session was broken down<br />

into key areas including: myopia control, beginners<br />

and advanced orthokeratology fitting, problem<br />

solving, specialised ortho-k fitting, latest research<br />

and scleral lens fitting. It is perhaps no surprise<br />

that discussion around myopia control was the<br />

focus of many of these talks, as orthokeratology<br />

lenses are a key treatment in the fight against<br />

rampant myopia development in our children.<br />

Staggeringly, predictions suggest that 10% of the<br />

world’s population will have high myopia by 2050,<br />

a 4x increase in prevalence since 2000. As we know<br />

the risk of ocular disease increases dramatically at<br />

these levels of myopia. It is fortunate that these<br />

days we have the treatments to prevent someone’s<br />

retinal detachment or maculopathy later in life: as<br />

a profession we just need to start offering them.<br />

The main message I took home from the<br />

Congress is that reports out of Asia from<br />

practices and hospitals that have been controlling<br />

myopia for several decades suggest that the<br />

myopia control effect of atropine drops is overestimated.<br />

Speciality ortho-k lenses with small<br />

diameter treatment zones designed for the young<br />

progressing myope show significantly higher<br />

myopia control rates than conventional ‘adult’<br />

ortho-k lenses. These are the main treatment<br />

modality employed by these centres. It is<br />

imperative that we stay as updated as possible<br />

when it comes to myopia control. Simply fitting<br />

a standard orthokeratology lens or giving a<br />

prescription of 0.01% atropine may not be an<br />

optimal myopia control strategy for your young<br />

patients.<br />

The shock of the conference came at the<br />

conclusion of Australian ortho-k guru John<br />

Mountford’s lecture. Following a straight-talking<br />

and scientifically robust account of the modern<br />

advances of astigmatic ortho-k (including an<br />

amusing mis-credit of a photo to a certain Kiwi<br />

optometrist by the name of Alex Perry) John<br />

finished by saying it would be the last lecture<br />

he would ever give. John has been one of the<br />

pioneers of orthokeratology worldwide and was<br />

instrumental in starting the OSO several decades<br />

ago. He has researched and lectured extensively on<br />

the topic and is the principal author of the ortho-k<br />

bible Orthokeratology: Principles and Practice.<br />

John received a standing ovation from the floor<br />

followed by a heartfelt speech from OSO president<br />

Gavin Boneham thanking John for his commitment<br />

and passion over the years.<br />

The other uncanny quality about<br />

orthokeratologists is that they all know how to<br />

have fun! There were numerous opportunities<br />

for networking and letting one’s hair down<br />

throughout the conference, including a meet-thespeakers<br />

drinks by the exotic Marriott lagoon pool<br />

and the Gala Dinner held in the luxurious hotel<br />

ballroom on the Saturday night. The Gala Dinner<br />

had an Olympics theme and involved a range of<br />

‘events’ throughout the night that each country/<br />

table competed in. I’m sad to report that our New<br />

Zealand All Blacks table finished middle of the pack,<br />

but at least we beat Australia! Ortho-k Olympics<br />

powerhouse Latvia took out the gold medal.<br />

I would encourage anyone with an interest in<br />

speciality contact lenses or myopia control to<br />

attend the next conference in two years. It is truly<br />

a unique gathering of like-minded individuals and I<br />

challenge even the savviest practitioner to leave the<br />

conference without some insightful pearls of clinical<br />

wisdom to apply in their practice. Thanks to the OSO<br />

committee, including our NZ liaison Jagrut Lallu, for<br />

organising another successful event. I know I speak<br />

for a number of practitioners when I say we can’t<br />

wait for the next one.<br />

I also implore health care practitioners here<br />

in NZ; optometrists, ophthalmologists, general<br />

practitioners and paediatricians, to sit up and<br />

take responsibility for the young myopes in our<br />

community. I don’t believe it is good enough to<br />

ignore myopia progression in the 21st century.<br />

Simply prescribing single vision spectacles or single<br />

vision soft contact lens has been shown to worsen<br />

myopia progression and increase the risk of ocular<br />

disease later in life. If you are not confident or wellequipped<br />

to offer effective and proven myopia<br />

control treatment options to your patients, please<br />

refer these patients to a colleague who can assist<br />

them. A list of OSO members in New Zealand can<br />

be found at www.oso.net.au<br />

Clinical summary<br />

Myopia control<br />

Fabian Conrad from the Brian Holden Vision<br />

Institute shared some startling statistics about the<br />

myopia epidemic: 50% of the world population<br />

will be myopic by 2050, which carries a significant<br />

social and economic burden. Currently disease due<br />

to myopia is the #1 cause of blindness in Japan<br />

and Shanghai. Mathematically reducing the rate<br />

of myopia progression by 50% will decrease the<br />

amount of myopia over 5.00D by 97%.<br />

Zhi Chen, a physician from Fudan University<br />

Hospital in Shanghai, informed us that the choroid<br />

will change in thickness within hours to match<br />

the eye’s defocus. He cautioned against reading<br />

too much into axial length measurements as a<br />

decrease over time may not rule out an increase in<br />

myopia.<br />

Continuing the choroidal thickness theme<br />

our very own John Phillips from the University<br />

of Auckland shared some fascinating insights:<br />

-2.00D and +2.00D of blur changes choroidal<br />

thickness by 20μm after just an hour. Experiments<br />

suggest atropine prevents the choroidal thinning<br />

response, a clue to its mechanism as a myopia<br />

retardation agent. A novel multifocal ortho-k<br />

lens design caused an immediate and sustained<br />

increase in choroidal thickness when compared to<br />

a conventional lens. This highlights the potential of<br />

new ortho-k lens designs to combine with atropine<br />

drops for optimal efficacy of myopia control.<br />

Spanish optometrist and researcher Jacinto<br />

Santodomingo-Rubido showed that in a<br />

Melbourne based study 64% of young ortho-k<br />

patients had a total arrestment of myopia over 5+<br />

years. In a study of his own 33% of ortho-k patients<br />

had a decrease in axial length after eight years,<br />

although this was not statistically significant due<br />

to the low sample size.<br />

Francoise Rateau reflected on her experiences<br />

treating myopia with atropine in her private<br />

practice. She had found that 50% of her patients<br />

did not require further atropine drops to halt<br />

their progression beyond 15 years of age, and 70%<br />

beyond 18 years. She also observed that 0.01%<br />

atropine was not as effective for children younger<br />

than nine years or for patients with high myopia.<br />

Paul Gifford, an Australian researcher shared some<br />

of the undertakings he has been working on to<br />

offer online tools for the practitioner and public to<br />

understand myopia and how<br />

to prevent it. These are great<br />

resources and can be found at<br />

www.myopiaprofile.com and<br />

www.mykidsvision.org<br />

Rob Gerowitz, American<br />

practitioner, ran through some<br />

relevant research in the field of<br />

ortho-k and myopia control.<br />

Patients with two myopic<br />

parents have a 5x increased<br />

risk of myopia and the risk<br />

of microbial keratitis is 7.7<br />

incidences per 10,000 patient<br />

years, a similar figure to<br />

other overnight contact lens<br />

modalities. These risks can be<br />

decreased with correct hygiene<br />

and lens care behaviours.<br />

The Sydney Myopia Study<br />

showed that higher levels<br />

of time spent outdoors was<br />

associated with less myopia.<br />

Scott Read from QUT<br />

Optometry School described his<br />

novel study using wrist-band<br />

light meters. Myopes showed<br />

less light exposure than the<br />

non-myopes and there was<br />

59% faster axial eye growth<br />

in the children classified as<br />

having low-light exposure<br />

over the course of the study.<br />

He suggested children should<br />

still be encouraged to wear<br />

sunglasses outside as the lux<br />

OSO and IAO board members<br />

level behind a sunglass was still in excess of that<br />

received when indoors.<br />

Orthokeratology<br />

Helen Swarbrick, esteemed leader of the ROK<br />

research group at QUT, gave compelling evidence<br />

to prove that orthokeratology does not bend the<br />

stroma, but only changes the thickness of the<br />

epithelial layer. An insignificant 5μm increase in<br />

corneal thickness is observed after ortho-k wear<br />

which is consistent with ~1% corneal swelling due<br />

to hypoxic oedema.<br />

Kate Gifford, Optometry Australia president,<br />

showed us some of her PhD research looking into<br />

the binocular vision effects of orthokeratology.<br />

Her results showed that ortho-k lenses decreased<br />

accommodative lag and decreased esophoria,<br />

whilst increasing spherical aberration in the visual<br />

system. It is thought that these effects contribute<br />

to the myopia control effect of orthokeratology<br />

lenses.<br />

Randy Kojima, an academic from Vancouver who<br />

has lectured extensively on behalf of Medmont,<br />

highlighted some key aspects to using topography<br />

to fit rigid contact lenses. He illustrated how<br />

the elevation plot on a topography is crucial<br />

to predicting where a lens may decentre and<br />

suggested modification to lens parameters may<br />

be required when a perfectly fitting lens does not<br />

behave as expected.<br />

Jaume Pauné Fabré, another Spaniard and<br />

chairman of the European Ortho-K Fellowship,<br />

analysed the results of Eddie Chow’s study into a<br />

new myopia control orthokeratology lens design<br />

with a smaller aspheric back optic zone. His results<br />

showed that the treatment zone gave a better<br />

myopia control effect in low levels of myopia.<br />

Pieying Xie, director of the Beijing Beiyi<br />

Optometry and Ophthalmology Centre, showed<br />

evidence answering the question of what happens<br />

after long-term ortho-k lens wear is discontinued.<br />

There was no significant increase in myopia in<br />

these patients, giving us confidence that myopia<br />

will not ‘catch-up’ after cessation of treatment.<br />

Pat Caroline, associate professor at Pacific<br />

University College of Optometry, explored the<br />

myopia control optics of orthokeratology lenses.<br />

He reasoned that a lens with a larger ring of midperipheral<br />

corneal steepening leads to larger blur<br />

circles at the retinal level. This optical affect may<br />

have an effect on the dopamine-storing amacrine<br />

Kiwi delegates relaxing by the pool Sarah Stevens, John Phillips, Damien Koppens, Sarah Tait and<br />

Alex Petty<br />

Some kiwi and not so kiwi All Blacks: Andrew Sangster, Alex Petty,<br />

Stephanie Fox, Eleisha Finlay, Charl Lass (SA), Jake Brown (AUS).<br />

The Marriott lagoon pool<br />

cells in the peripheral retina. Increased dopamine<br />

in animal models has been shown to decrease<br />

axial eye growth, a clue to the mechanism of how<br />

peripheral myopic defocus may signal the eye to<br />

stop growing.<br />

Scleral lenses<br />

Steve Vincent, senior lecturer at QUT Optometry<br />

School, gave a fascinating insight into current<br />

research surrounding hyopixia and scleral lens<br />

wear. Although theoretical models predict most<br />

scleral lens designs should lead to hypoxia and<br />

resultant corneal oedema, clinical research<br />

suggests that oedema following scleral wear is<br />

less than 1.7%, approximately half that could be<br />

expected. Research has also shown that decreased<br />

lens thickness and decreased lens clearance had<br />

no effect on corneal swelling in a high Dk material.<br />

It should be noted that these tests were done on<br />

healthy eyes. The same conclusions may not be<br />

valid in a compromised cornea, the patients that<br />

often have the most to gain from scleral lens wear.<br />

Pat Caroline gave a second talk exploring<br />

the scleral shape and concluded that corneal<br />

astigmatism does not predict scleral toricity. The<br />

majority of patients have a scleral shape that is<br />

best fitted with a toric or quadrant specific scleral<br />

lens for centration and comfort. He also posed the<br />

idea that overnight scleral wear may be a great<br />

option to manage persistent epithelial defects. In<br />

these case the 10% overnight corneal oedema is<br />

acceptable if the post-lens tear film is replenished<br />

twice daily. ▀<br />

OSO President Gavin Boneham<br />

OSO NZ liaison Jagrut Lallu chairs the panel discussion with Nitesh<br />

Barot, Ken Kopp, Lachlan Scott-Hoy and Jaume Pauné Fabré<br />

Jason Anderson from Medmont showing the tear film analyis function<br />

of the E300 topographer. with Brian Naylor looking on.<br />

*Alex Petty is a New Zealand optometrist based in Tauranga with<br />

a particular interest and knowledge in speciality contact lenses,<br />

ortho-k and myopia control.<br />

20 NEW ZEALAND OPTICS <strong>Nov</strong>ember <strong>2016</strong>

Dining for VOSO<br />

Volunteer Ophthalmic Services Overseas (VOSO) was honoured<br />

to be the chosen charity during the month of October for<br />

Meredith’s Dine by Donation night, something VOSO had not<br />

been involved in before.<br />

Meredith’s, the intimate Dominion Road restaurant in Auckland<br />

owned and run by chef Michael Meredith, holds a regular Dine by<br />

Donation event every Tuesday to raise money for charitable groups and<br />

organisations across Auckland. The boutique dining location say they<br />

offer degustation only menu’s, paired with ‘superb wine’ and ‘inviting<br />

hospitality’.<br />

The first Tuesday of October saw the restaurant fully booked out<br />

by VOSO supporters, including Dr Shuan Dai, Darryl Eastbrook, Kylie<br />

Dreaver, John Tarbutt, Dr Rosie Murdoch and Maryanne Dransfield.<br />

Although, at the time of going to press, the full amount raised<br />

during the month of October had not yet been tallied, Meredith’s has<br />

indicated that Dine by Donation raises around $2000 each Tuesday for<br />

the chosen charity.<br />

“Michael Meredith is a wonderful man, who is also behind the<br />

Eat My Lunch project,” said VOSO secretary Kylie Dreaver, who was<br />

instrumental in organising the event. “The funds raised will be used for<br />

continuing the great work VOSO does next year. VOSO is planning to<br />

travel to Fiji, Samoa and Tonga.”<br />

Mike Frith, Ramana Malavarapu, Mark Dromgoole, Kylie Dreaver, Richard Johnson, Rosie Murdoch,<br />

John Tarbutt and Bob Kinnear<br />

Dreaver was overwhelmed by the positive response from the charity’s<br />

supporters and the great atmosphere.<br />

“The food was amazing and I have wanted to dine here for ages,” said<br />

Dreaver. “I am delighted so many people have come out to support<br />

VOSO. It is very appreciated.” ▀<br />

Brng Liang, Brn Duan, Hong Duan and Dr Shuan Dai<br />

First New Zealand ortho-k fellows<br />

Four New Zealand optometrists, Jagrut Lallu (Hamilton),<br />

Eleisha Dudson (Wellington), Alex Petty (Tauranga) and<br />

Shonit Jagmohan (based in Melbourne), were made fellows of<br />

the International Academy of Orthokeratology at the recent OSO<br />

and IAO congress in Surfers Paradise. These four orthokeratologists<br />

are the first New Zealanders to attain this honour.<br />

The FIAO (Fellow of the International Orthokeratology Academy)<br />

is the gold standard for practitioners of orthokeratology.<br />

Fellowship status in the academy is determined by practitioner<br />

experience and expertise and follows a rigorous case evaluation<br />

and testing procedure over the course of several years.<br />

Orthokeratologists who achieve fellowship status are committed<br />

to adhering to the highest standards of care in this specialty and<br />

are required to possess and demonstrate the highest level of<br />

knowledge, ethics and patient care with respect to the practice of<br />

orthokeratology. Fellows also serve as mentors and role models for<br />

new ortho-k practitioners.<br />

There are now a total of nine fellows of the academy in Australia<br />

and New Zealand, who join an international cohort of experts<br />

throughout the world. ▀<br />

The first NZ fellows of the International Academy of Orthokeratology (L to R) Shonit Jagmohan, Eleisha<br />

Dudson, Jagrut Lallu and Alex Petty with Gavin Boneham, OSO president who also was made a fellow<br />

(centre with tie) and new Australian fellow Celia Bloxsom (far right)<br />

Daryl Eastabrook, Helen Eastabrook, Joheen Dagg and Maria Pais<br />

John Tarbutt, Sandra Cameron, Helen Beckwith, Victoria Elias, Colin Beckwith, Hamish<br />

Caithness, Linda Tarbutt and Clint Bird<br />

Mike Frith, Phillippa Pitcher and Jasha Morarji<br />

<strong>Nov</strong>ember <strong>2016</strong><br />



New shore clinic for Auckland Eye<br />

Auckland Eye opened its new North Shore<br />

clinic and operating suite at 3 Fred<br />

Thomas Drive, Takapuna, at the end of<br />

August, followed by a launch celebration on 22<br />

September. Auckland Eye’s doctors work from<br />

14 clinics around the Super-city, and while this<br />

facility is brand new, it replaces a previous clinic<br />

in the Takapuna area.<br />

“I’ve had a surgery of some sort in Takapuna<br />

for the best part of 20 years,” says Dr Archie<br />

McGeorge. “But around 10 years ago we<br />

transferred most of our ‘North of the bridge’<br />

Drs John Russell, Jenni Waddell and John Arcus<br />

Xieda Man, Varny Ganesalingam, Naomi Bicheno and Alex Bicheno<br />

activity to Albany, where we had a hub. But we<br />

still had a small, 50sqm clinic at 2 Fred Thomas<br />

Drive, Takapuna, which was very popular.”<br />

When Dr McGeorge discovered, thanks to local<br />

optometrist Martin Davey, that a 400sqm site<br />

was to become available next door, at No 3 Fred<br />

Thomas Drive, he took the idea of creating a new,<br />

state-of-the-art hub in Takapuna to the other<br />

shareholders. To Dr McGeorge’s delight, his idea<br />

was supported.<br />

“Our previous premises were restricted to<br />

one person, there wasn’t much space, and<br />

any patients for surgery had to<br />

come down to Remuera,” says Dr<br />

McGeorge. “We’ve been wanting<br />

to develop operating facilities<br />

on the shore for a long time, and<br />

Takapuna is a great, centralised<br />

location – close to the bus station,<br />

the motorways, and we now have<br />

free parking for 34 cars.”<br />

The new, purpose-designed-andbuilt<br />

facility has four state of the<br />

art consulting rooms, plus a fully<br />

equipped operating theatre.<br />

“We’re starting with cataract<br />

surgery, which of course is a key<br />

service of ours, but we have the<br />

equipment here for a variety of<br />

operations, from diabetic laser to<br />

vitrectomy,” says Dr McGeorge. “By<br />

next year we expect to have the<br />

facilities required to cover all adult<br />

eye surgery at North Shore.”<br />

This will be good news for the<br />

often older demographic who<br />

may not wish to travel across the<br />

bridge. While the new clinic will<br />

serve Auckland as far north as<br />

Warkworth, there will still be a<br />

small, regional consulting clinic in<br />

Albany where the old hub used to<br />

be.<br />

Auckland Eye doctors working<br />

from the premises include Drs<br />

Stuart Carroll, Dean Corbett,<br />

Archie McGeorge, Yvonne Ng, Sue<br />

Ormonde and Alison Pereira, and<br />

the clinic is open five days a week.<br />

Prior to the opening,<br />

the site was blessed<br />

at a dawn ceremony,<br />

attended by staff and<br />

contractors on Friday<br />

26 August.<br />

During design, the<br />

team at Focusplan<br />

addressed common<br />

difficulties sight<br />

impaired often<br />

encounter. As a result,<br />

flooring materials,<br />

surface colours and<br />

lighting has been<br />

carefully selected to<br />

help guide patients<br />

through each space.<br />

The launch party<br />

saw around 100<br />

invited guests,<br />

including local GPs<br />

and optometrists,<br />

enjoy a short tour of<br />

the facility and hear<br />

Dr Corbett explain<br />

Auckland Eye’s plans for the future.<br />

“There’s plenty of room for expansion here,”<br />

says Dr McGeorge. “And we are looking forward<br />

Dr Dean Corbett and nurses Jillian and Miriam in the new theatre. The team were the first team to operate at<br />

Auckland Eye North Shore<br />

to offering a full range of ophthalmic services<br />

on the North Shore. This is a quantum leap from<br />

anything we’ve had on the shore before.” ▀<br />

Silmo Sydney organiser recognised<br />

Gary Fitz-Roy, managing director of<br />

Expertise Events, organiser of Silmo<br />

Sydney, was recognised as a Paul Harris<br />

Fellow, following the efforts of Expertise Events<br />

in facilitating a nationwide initiative to raise<br />

awareness to the risks of macular degeneration.<br />

Through the programme, Expertise Events<br />

distributed 500,000 Amsler Grid cards, a simple<br />

test people can use to see if they are at risk of<br />

macular degeneration. The cards were distributed<br />

at a number of needlecraft consumer events<br />

organised by Expertise Events in Australia.<br />

“We worked with Rotary Club Victoria member,<br />

Jeannie Handsaker, to distribute the cards at our<br />

craft events and set up a designated area where<br />

eye specialists had the opportunity to educate<br />

people on how to effectively complete the test,”<br />

said Fitz-Roy in a statement. “We recognised<br />

these events host the demographic most at risk<br />

of macular degeneration.”<br />

Established in 1957, The Paul Harris Fellow<br />

recognition acknowledges individuals who<br />

contribute, or who have contributions made<br />

in their name, of US$1,000 plus to The Rotary<br />

Foundation of Rotary International.<br />

See associated picture and Silmo story on p19 ▀<br />

CooperVision<br />

®<br />

experts in silicone hydrogel technology<br />

2006<br />

comf ilcon A<br />

2009 2009 2013 <strong>2016</strong><br />

enf ilcon A<br />

(UV)<br />

somofilcon A<br />

(UV)<br />

stenf ilcon A<br />

(UV)<br />

fanf ilcon A<br />

(UV)<br />

Biof inity® Avaira® clariti ® 1 day MyDay® cAir <br />

1999 <strong>2016</strong><br />

1999 2004 2005 2008 2011<br />

lotraf ilcon A<br />

lotraf ilcon B<br />

2004<br />

galyf ilcon A<br />

(UV)<br />

senof ilcon A<br />

(UV)<br />

naraf ilcon A<br />

(UV)<br />

delef ilcon A<br />

For more information on our extensive range of silicone hydrogel<br />

contact lenses, contact your CooperVision Business Development Manager.<br />

Live Brightly<br />

22 NEW ZEALAND OPTICS <strong>Nov</strong>ember <strong>2016</strong>

‘A celebration of research’<br />

The 10th annual HealtheX Conference<br />

was hosted by the Faculty of Medical and<br />

Health Sciences, University of Auckland, on<br />

9 September <strong>2016</strong>. Sponsored by the Auckland<br />

Medical Research Foundation (AMRF) and<br />

the Maurice and Phyllis Paykel Trust (MPPT)<br />

among others, the event was attended by over<br />

200 members of the University of Auckland<br />

community, including Vice Chancellor Professor<br />

Stuart McCutcheon and Deputy Vice Chancellor of<br />

Research Professor James Metson.<br />

This year saw around $15,000 worth of prizes on<br />

offer, including three AMRF travel awards, more<br />

than ever before at HealtheX, in what the Faculty<br />

called, ‘a day of celebration of student research<br />

conducted at the Faculty’.<br />

Among the winners were Hans Vellara and<br />

Himanshu Wadhwa from the Department of<br />

Helping<br />

Niue<br />

Eye Doctors’ and Counties Manukau<br />

specialist Dr Penny McAllum recently<br />

returned from her fifth trip to the island<br />

of Niue, where she helps provide eye care to the<br />

1400 residents.<br />

“There are usually two or three doctors on the<br />

island, which is quite a good ratio for the small<br />

population,” she says. “Niuean’s are also citizens<br />

of New Zealand, so they are entitled to treatment<br />

here as well, but by sending an eye team, more<br />

patients can have access to eye care close to<br />

home, eye disease can be identified at an earlier<br />

stage and a lot fewer patients need to travel for<br />

treatment.”<br />

Dr McAllum, together with Auckland Eye’s<br />

Dr Sarah Welch, were originally asked to help<br />

Niue by the late Dr David Murdoch, who had<br />

a particular passion for making sure underequipped<br />

Pacific regions had access to specialist<br />

eye care. Both have now been helping the island<br />

population since 2009, travelling to Niue every<br />

two years and performing mainly cataract and<br />

pterygium surgery, and providing intravitreal<br />

Avastin injections.<br />

They see patients with a variety of eye<br />

conditions, including a number of young people<br />

with keratoconus, some of whom have now been<br />

treated with cross-linking, says Dr McAllum.<br />

Last year two Counties Manukau DHB-based<br />

diabetic retinopathy photo-screeners, with a<br />

retinal camera, also came with the Niue eye<br />

team for the first time. This was a very successful<br />

addition to the service, so yearly photo-screening<br />

visits have now been instituted, with the full<br />

team undertaking surgery still on alternate years.<br />

“This year was a short trip, focused on diabetic<br />

Dr Penny McAllum, far right with Niuean colleagues Charmaine,<br />

middle, and Raina, left<br />

Ophthalmology. Vellara, whose supervisor is A/<br />

Prof Dipika Patel, was a runner up in the AMRF<br />

Doctoral Oral Presentation category for his In vivo<br />

orbital compliance in thyroid eye disease research.<br />

Wadhwa, whose supervisor is A/Prof Trevor<br />

Sherwin, was awarded second-runner up in the<br />

non-doctoral oral presentation award category,<br />

for research titled Investigating the use of corneal<br />

stem cell-enriched spheres in keratoconic corneal<br />

tissue repair.<br />

Spurred on by his success at Healthex, Wadhwa<br />

went on to win first prize for his oral presentation<br />

at the University of Auckland’s Exposure (postgraduate<br />

research) Exposition, on the same topic.<br />

Exposure is open to all currently enrolled research<br />

postgraduate students at UoA. The Healthcare Oral<br />

Competition, won by Wadhwa, was sponsored by<br />

Fisher and Paykel. ▀<br />

Over 80 patients were examined on this trip<br />

screening. It was just one diabetic photo<br />

screener, the Australia-based Niuean eye nurse<br />

and myself on this visit. We saw more than 80<br />

patients,” Dr McAllum said. “There was one lady<br />

with bad AMD and a young man with severe<br />

iritis. I referred half a dozen cataract patients<br />

back to New Zealand for treatment.”<br />

Dr McAllum always involves local doctors,<br />

whenever they are available. “The young man<br />

with iritis started treatment and responded well,<br />

but it was a good teaching opportunity for me to<br />

show the local doctors how to diagnose iritis and<br />

operate the slit lamp. This helps them manage<br />

eye patients between the team’s visits. We<br />

also keep in touch by email.”<br />

The vast majority of patients Dr McAllum<br />

saw this year were suffering from diabetic<br />

retinopathy. “Diabetes is a big problem in<br />

Niue, with about 250 diabetics in the small<br />

population. There seems to be a genetic<br />

predisposition to diabetes, but lifestyle and<br />

dietary factors also contribute.”<br />

Seven diabetic patients were referred back to<br />

New Zealand for laser or surgical treatment,<br />

while Avastin treatment was started with<br />

some others.<br />

During this trip, Dr McAllum was also<br />

interviewed by a local television crew, which<br />

featured the eye team on their news that<br />

night. “It was a great chance to get the word<br />

out in the community that diabetes can cause<br />

serious eye problems and that, as well as good<br />

control, it needs regular screening to catch it<br />

before vision is lost.”<br />

Dr McAllum says she really enjoys helping<br />

the Niueans in Niue. “Everyone is so friendly<br />

and it’s a lovely place to spend a few days. It’s<br />

a pleasure catching up with the many patients<br />

and staff who we now know quite well, and<br />

feeling like we’re making a difference to eye<br />

health in Niue.” ▀<br />

MDNZ public lecture on 9 <strong>Nov</strong>ember<br />

On 9 <strong>Nov</strong>ember, Macular Degeneration New<br />

Zealand will be hosting a free public lecture<br />

at the Auckland War Memorial Events<br />

centre and again on 15 <strong>Nov</strong>ember at the Grand<br />

Hall, Parliament, Wellington, to raise awareness of<br />

macular degeneration. The speaker will be Professor<br />

Alan Bird, a British ophthalmologist, internationally<br />

recognised as one of the pioneers of medical retina.<br />

He is a professor and consultant at the Institute of<br />

Ophthalmology at the Moorfields Eye Hospital in<br />

London, UK.<br />

Professor Bird’s talk, “The Treatment Revolution<br />

of AMD”, will take a look at how the management<br />

of AMD has changed, and is still changing,<br />

for the benefit of the patient – something he<br />

himself is very well versed in. Prof Bird created<br />

a multidisciplinary research team based at<br />

Moorfields that investigates monogenic retinal<br />

disorders and age-related macular disease.<br />

Investigative techniques include molecular genetics,<br />

electrophysiology, psychophysics, specialised<br />

imaging and morphology.<br />

This research resulted in<br />

the development of new<br />

technologies to define<br />

the clinical characteristics<br />

of retinal disease<br />

providing a clearer<br />

understanding of retinal<br />

degenerative diseases.<br />

Professor Alan Bird<br />

Prof Bird has also<br />

undertaken extensive<br />

international work in Africa on river blindness and<br />

in Jamaica on retinal changes in sickle cell disease.<br />

He has written more than 370 papers published<br />

in refereed journals as well more than 80 book<br />

contributions.<br />

The Auckland event is open to all optometrists,<br />

ophthalmologists and ophthalmic nurses, and for<br />

optometrists CPD points are being applied for. The<br />

lecture starts at 6:30pm and if you wish to attend<br />

you should email education@mdnz.org.nz. ▀<br />

VOSO visits Samoa<br />

Aside from the<br />

television<br />

advertisements<br />

showcasing tranquil<br />

island getaways,<br />

I knew very little<br />

about Samoa when<br />

I decided to take<br />

the opportunity to<br />

accompany John<br />

Tarbutt on VOSO’s<br />

annual optometric<br />

outreach trip to<br />

Samoa in August<br />

this year.<br />

We spent a week<br />

on the beautiful island of Savai’i; working<br />

at Safotu and Tuasivi hospitals; refracting,<br />

examining and giving out new and pre-loved<br />

spectacles we had brought with us from NZ.<br />

We were fortunate to be able to work with<br />

Samoa’s only resident optometrist, Fuiavailili<br />

Erna Takazawa, who is based in the capital<br />

Facilities in Samoa are very basic<br />

E Y E W E A R<br />



Devashini Devanandan hard at work<br />

Apia, as well as<br />

several welltrained<br />

eye nurses<br />

at the local<br />

hospitals. For most<br />

of the year, these<br />

nurses offer the<br />

only optometric<br />

and ophthalmic<br />

care to the island’s<br />

residents.<br />

We were also<br />

able to identify<br />

many cases of<br />

pathology which<br />

were referred<br />

for ophthalmic<br />

care when the next surgical team arrive on<br />

the island. With the lack of adequate eye<br />

care, many simple pathological cases, such as<br />

cataract, pterygia and diabetic retinopathy,<br />

were in their most advanced states; to a level<br />

which we would never see in NZ. While acutely<br />

aware of how much more I would be able to<br />

offer these patients if they<br />

were in my home practice<br />

in Waikato, their gratitude<br />

for our services provided<br />

the driving force to make<br />

this appeal a success.<br />

My week in Samoa was<br />

an eye-opening experience<br />

which enabled me to<br />

appreciate the true value<br />

of the care we offer as<br />

optometrists. It was a<br />

privilege to be able to<br />

help the lovely people of<br />

Savai’i, and I encourage any<br />

interested optometrists<br />

to volunteer their time for<br />

future outreaches should<br />

the opportunity arise. ▀<br />

*Devashini Devanandan is a<br />

Cambridge-based recent optometry<br />

graduate<br />


Get the latest models exclusively at<br />

(NZ) 0508 678 478 optiqueline.co.nz<br />

<strong>Nov</strong>ember <strong>2016</strong><br />



with<br />

Prof Charles McGhee<br />

& A/Prof Dipika Patel<br />

Series Editors<br />

Age-related macular<br />

degeneration: update<br />

Background<br />

Age-related macular degeneration (AMD) is the<br />

leading cause of blindness or severe irreversible<br />

visual impairment in people over 50, in the<br />

developed world. As of 2009, 49% of the current<br />

blind foundation registrations in New Zealand<br />

were for AMD 1 . The incidence, prevalence and<br />

progression of AMD increases with age and<br />

varies by ethnicity. In the Beaver Dam Eye<br />

Study, a primarily Caucasian population, the<br />

prevalence of AMD was 10% in individuals aged<br />

55 to 64 year rising to 46% for those aged ≥<br />

75 2 . The prevalence of AMD in Asians over 55 is<br />

estimated 6.8% 3 . AMD is comparatively rare in<br />

the Asian subcontinent and Hispanic populations<br />

and is virtually unknown in African, Maori and<br />

Polynesian populations. The subtype of AMD<br />

that is seen clearly differs between ethnicities.<br />

Whilst classical AMD is seen most commonly in<br />

Causasians, polypoidal choriovasculopathy (PCV)<br />

is the commonest type of AMD seen in Asians. In<br />

2014, the prevalence of AMD in New Zealanders<br />

aged 45-85 year age group was estimated to<br />

be 184,000, numbers which are projected to<br />

increase markedly to 208,200 by 2026 4 . With the<br />

impending demographic shift towards an aging<br />

population, AMD represents a significant and<br />

increasing burden on the health care provision in<br />

New Zealand in the coming years.<br />

Risk Factors and pathophysiology<br />

It has long been recognised that the likelihood of<br />

an individual developing AMD is the result of a<br />

complex interplay of genetic and environmental<br />

risk factors; factors which are probably<br />

cumulative with respect to the risk of developing<br />

the disease. Whilst the genetics of AMD are<br />

beyond the scope of this article it is clear that<br />

certain genetic anomalies carry a significant<br />

risk for affected individuals, the classic example<br />

being complement factor H polymorphisms.<br />

Gene products for CFH play an important role<br />

in the regulation of the host immune system<br />

and individuals who carry a CFH polymorphism<br />

therefore posses a dysfunctional and “over active”<br />

immune system. This risk is not insignificant, for<br />

example individuals who are homozygous for<br />

the Y420H risk allele of CFH are known to be 7x<br />

more likely to develop AMD compared to normal<br />

controls. These results suggest that inflammation,<br />

plays a significant although as yet ill understood<br />

role in the development of AMD. Apart from age,<br />

ethnicity and genetics – strong non-modifiable<br />

risk factors – numerous studies have identified<br />

cigarette smoking to increase the risk of<br />

developing AMD. Smoking significantly increases<br />

AMD risk in a dose response relationship with<br />

the relative risk increasing in proportion to<br />

the number of pack years 5 . Smoking cessation<br />

reduces the risk of progression and thus smoking<br />

cessation remains the single most effective<br />

population intervention to reduce the burden<br />

that AMD represents.<br />

The conventional hypothesis for the<br />

development of AMD holds that the primary<br />

event in the development of AMD is dysfunction<br />

of the RPE, with build-up of drusen, RPE<br />

atrophy, ischaemia of the outer retina and<br />

ultimately the production of VEGF and subretinal<br />

neovascularization. However this conventional<br />

hypothesis ignores the role of the choroid and in<br />

particular the role that the choriocapillaris plays<br />

in the maintenance of the Bruchs/ RPE complex<br />

and the outer retina. What is now clear is that<br />

irrespective of the mechanism a thin choroid, and<br />

in particular a thin inner choroid is a significant<br />

risk factor for the development of “classical” AMD.<br />

How “risk” CFH polymorphisms and smoking fits<br />

into this story remains a matter of conjecture<br />

but it is highly likely that inflammation plays<br />

a key role in the loss of the choroicapillaris.<br />

Whether this is the primary event, or the end<br />

game of AMD needs further study but the answer<br />

to this question has huge implications for the<br />

development of new therapeutic targets in both<br />

dry and wet AMD.<br />


Classification and natural history<br />

Most readers will be familiar with the classification<br />

of AMD and recognise that AMD encompasses<br />

a wide spectrum of disease. Dry AMD is<br />

characterised by the presence of one or more of<br />

the following: presence of at least intermediate<br />

size drusen (63 microns or larger in diameter),<br />

retinal pigment epithelium (RPE) abnormalities,<br />

reticular pseudodrusen and/or of geographical<br />

-atrophy (GA) of RPE. Wet AMD is characterised<br />

by the development of subretinal and intraretinal<br />

neovascularisation. Soft drusen and pigmentary<br />

abnormalities increase with age and strongly<br />

predict progression towards advanced AMD.<br />

The risk of progression of AMD also seems<br />

to accelerate the more advanced the disease<br />

becomes. Whilst approximately 15% of patients<br />

with early AMD developed large drusen at 10<br />

years the risk of advanced AMD developing over<br />

this time period was low. However if a patient has<br />

Intermediate AMD the five year risk of developing<br />

advanced AMD increases steeply to near 20%. It<br />

is also noteworthy that patients with reticular<br />

pseudodrusen have a particularly high propensity<br />

to develop advanced AMD. The risk of a patient<br />

who has advanced AMD in one eye, developing<br />

advanced AMD in the other eye is approximately<br />

50% at five years. In all cases the risk of progression<br />

to advanced AMD, is inversely associated with<br />

choroidal thickness.<br />

Prevention<br />

By far and away the single most effective<br />

preventative strategy for the development of<br />

advanced AMD is to stop smoking. The large and<br />

hugely influential AREDS studies demonstrated<br />

that antioxidant supplements may slow the<br />

progression of moderate AMD (soft drusen<br />

and pigmentary changes) to wet AMD but the<br />

therapeutic effects are sometimes overstated.<br />

Although the relative risk reduction for patients<br />

taking antioxidant supplements was around 25%<br />

in real terms the more important absolute risk<br />

reduction was smaller at around 8%. There have<br />

also been concerns raised by some that, in a small<br />

sub-set of patients, antioxidant supplements may<br />

actually accelerate AMD. However, generally one<br />

would still advocate antioxidant supplements in<br />

all patients with moderate AMD. There is currently<br />

no evidence to suggest AREDS supplements help in<br />

halting progression of dry AMD.<br />

The reported ability of lutein, xeothanine and<br />

mesoxanthine supplementation to increase the<br />

density of macular pigments is interesting and<br />

the results emerging from the clinical trials with<br />

subjects on these supplements report better<br />

subjective and objective measures of visual<br />

functioning compared to controls. However<br />

whether such interventions actually reduce the<br />

risk of the development of AMD remains uncertain<br />

and at the present time one can only say that their<br />

role is unknown.<br />

The drug treatment of dry AMD remains an<br />

exciting area of research with a number of<br />

neuroprotective and inflammatory modulating<br />

agents the subject of large clinical trials. The<br />

technologies underpinning stem cell transplants<br />

also continue to improve and show great promise,<br />

but at the time of writing the drug treatment of<br />

dry AMD remains a story of unfulfilled promises.<br />

Wet AMD treatment<br />

It is perhaps not too much of an exaggeration to say<br />

that the use of antiVEGF agents in ophthalmology<br />

has been one of the single greatest advances in<br />

modern medicine. Certainly the advent of the<br />

antiVEGF era has transformed the outcome of<br />

wet AMD with the improvement in visual acuity<br />

observed in the key note ANCHOR and MARINA<br />

trials extending out to five years and beyond 6,7 . The<br />

question of which antiVEGF agent to use (Avastin,<br />

Lucentis or Eylea) remains the subject of debate<br />

and the choice of which drug is used in which<br />

country may have as much to do with politics and<br />

economics as it does evidence. The key note trials<br />

demonstrated that regardless of the drug used,<br />

most patients with classical<br />

wet AMD did well and,<br />

at a population level at<br />

least, there was little to<br />

choose between the agents.<br />

However as always there<br />

are nuances; not every<br />

patient responds equally<br />

well to each drug and the<br />

treating clinician needs<br />

to be prepared to switch<br />

drugs early if the agent used<br />

proves to be ineffective. One<br />

exception is that Aflibercept<br />

is more effective than the<br />

other two agents at treating<br />

patients who have the PCV<br />

variant of AMD. Currently in<br />

New Zealand avastin is the<br />

first line treatment for wet<br />

AMD, Lucentis being the<br />

funded second line agent.<br />

In <strong>Nov</strong>ember, Pharmac will<br />

announce the results of<br />

their long-awaited review<br />

of antiVEGF agents and it<br />

is anticipated that they will<br />

add Eylea to this list. The<br />

drug treatment of wet AMD<br />

continues to evolve at a fast<br />

pace and whilst it is not<br />

possible to “pick a winner”<br />

at this time, what is certain<br />

is that new, longer-acting<br />

treatments will enter the<br />

market over the coming<br />

years.<br />

Putting the excitement of<br />

emerging drug treatments<br />

to one side, currently the<br />

greatest challenge for<br />

clinicians, particularly<br />

those in the public sector,<br />

is to provide the treatment<br />

patients need. Despite<br />

innervations such as<br />

utilising trained nursing<br />

staff to deliver injections,<br />

most public eye clinics are<br />

struggling to provide the<br />

treatments their patients need. In Auckland alone,<br />

we are now providing about 20,000 appointments<br />

annually to treat wAMD, a growth in demand that<br />

has not been matched by increased resources. It is<br />

widely accepted that under treatment of wet AMD<br />

is associated with worse outcomes and MDNZ and<br />

others continue to lobby central government and<br />

local DHBs for more resources.<br />

In summary the outlook for our patients with AMD<br />

has never looked better. Challenges do however<br />

remain. Early detection and treatment is crucial and<br />

MDNZ and others continue to work hard raising<br />

awareness of AMD. Once diagnosed patients,<br />

optometrists and general practitioners need an easily<br />

accessible “fast track” referral process to ensure<br />

treatment is delivered promptly. The availability of<br />

these “fast track” services are patchy and patients<br />

often have to rely on the private sector in the first<br />

instance to get prompt treatment. Thereafter, eye<br />

clinics need the resource to provide capacity for the<br />

ongoing review and treatment of what is a chronic<br />

disease. Our score card for the management of wet<br />

AMD in New Zealand remains “heading in the right<br />

direction, but could do better” ▀<br />

About the authors<br />

* Dr David Squirrell<br />

David is a specialist whose primary interest is medical retina<br />

and AMD. David has severed as the principle investigator for<br />

numerous studies in AMD, including the key note IVAN trial.<br />

David works at Greenlane Clinical centre and Milford Eye clinic<br />

Auckland.<br />

* Dr Pavani Kurra<br />

Pavani is currently working as a junior clinical fellow<br />

in medical retina at the University of Auckland and<br />

Greenlane Clinical Centre. She also spent time undertaking<br />

ophthalmology electives at L. V. Prasad Eye Institute and in<br />

Alice Springs prior to her fellowship in New Zealand.<br />

Fig 1. (a) Colour photograph, (b) fluorescein angiogram and (c) OCT of patient with classic wet AMD.<br />

Fig 2. (a) Colour photograph, (b) infrared image and (c) OCT of a patient with reticulo-pseudodrusen.<br />

Note there are very few drusen seen on fundoscopy but marked changes are seen on the infrared<br />

image. The OCT image is characteristic with focal subretinal protrusions and a thin choroid<br />

Fig3. Five year outcome data from the CATT trial revels that patients maintain their vision into year 5<br />

with appropriate and timely treatment<br />

References:<br />

1. Blind Foundation. Blindness by cause among New<br />

Zealanders aged 50 or over. . (Blind Foundation<br />

New Zealand, Auckland, 2009).<br />

2. Klein, R., Klein, B. & Linton, K. Prevalence of agerelated<br />

maculopathy: The Beaver Dam Eye Study.<br />

Ophthalmology 99, 933-943 (1992).<br />

3. Kawasaki, R., et al. The prevalence of AMD in<br />

Asians: A systematic review and meta-analysis.<br />

OPhthalmology 117, 921-927 (2010).<br />

4. Worsley, D. & Worsley, A. Prevalence predictions for<br />

age-related macular degeneration in New Zealand<br />

have implications for provision of health care<br />

services. New Zealand Medical Journal 128, 44-55<br />

(2015).<br />

5. Khan, J., Thurlby, D., Shahid, H. & etal. Smoking<br />

and age related macular degeneration: the<br />

number of pack years of smoking is a major<br />

determinant of risk for both geographic atrophy<br />

and choroidal neovascularisation. British Journal of<br />

Ophthalmology 90, 75-80 (2006).<br />

6. Brown, D., Kaiser, P., Michels, M., Soubrane, G. &<br />

Schenider, S. Ranibizumab versus verteporfin for<br />

nAMD (ANCHOR study). New England Journal of<br />

Medicine 355, 1432-1444 (2006).<br />

7. Rosenfeld, P., et al. Ranibizumab for neovascular<br />

AMD. The New England Journal of Medicine 355,<br />

1419-1431 (2006).<br />

Dr David Squirrell<br />

Dr Pavani Kurra<br />

24 NEW ZEALAND OPTICS <strong>Nov</strong>ember <strong>2016</strong>

Glaucoma New Zealand Symposium<br />


The Inaugural Glaucoma New Zealand (GNZ)<br />

Glaucoma Symposium was held on September<br />

18 at Alexandra Park in Auckland. The<br />

Symposium was an initiative of the GNZ trustees:<br />

Professor Helen Danesh-Meyer, A/Professor Gordon<br />

Sanderson, Dr Sam Kain and Dr Mark Donaldson.<br />

It was the first full day optometry education event<br />

in New Zealand focussed solely on glaucoma. The<br />

Symposium was timely given the increasing role<br />

of therapeutic optometrists in the management<br />

of glaucoma. Thanks to our Silver Sponsors, AFT<br />

Pharmaceuticals, Clinicians, and Ophthalmic<br />

Instruments. Other supporters included Device<br />

Technologies and Toomac Opthalmic.<br />

The overall theme of the Symposium was<br />

Glaucoma – from Diagnosis to Management and<br />

the programme was divided into four sections.<br />

Dr Mark Donaldson welcomed the more than 90<br />

delegates, who came from all over New Zealand,<br />

and one who travelled from Australia. The<br />

academic programme commenced with a section<br />

on Glaucoma Diagnosis and was opened by Dr<br />

Shenton Chew, who spoke about risk factors for<br />

glaucoma and the importance of early detection<br />

in order to avoid permanent visual loss. Dr Chew<br />

also outlined the role of ocular perfusion pressure<br />

and intracranial pressure in glaucoma progression.<br />

This presentation was followed by an entertaining<br />

overview of disc assessment (described as a<br />

‘complex beast’) by Dr Kain. His analogies to<br />

the character Homer Simpson provided useful<br />

insight into the importance of looking at disc size,<br />

regularity of the neuro-retinal rim (the donut) and<br />

symmetry between the eyes. Dr Geraint Phillips<br />

of the School of Optometry at the University<br />

of Auckland tackled the challenging topic of<br />

visual field progression in glaucoma, including<br />

the difficulty in determining the optimum<br />

number of visual field tests (always a patient<br />

favourite) needed. Dr Jesse Gale kindly travelled<br />

from Wellington for the Symposium. His first<br />

presentation beautifully outlined conditions that<br />

Jonathon Taylor from Invercargill and Niall McCormack from Hastings<br />

Gary Filer, Dr Hussein Patel and Dr Graham Reeves<br />

may mimic glaucoma, including compressive optic<br />

neuropathies. Dr Alex Buller from Hawke’s Bay<br />

gave a hugely informative presentation, complete<br />

with a number of excellent videos, on the difficult<br />

topic of gonioscopy, considered to be the gold<br />

standard of anterior chamber angle assessment.<br />

The angle theme continued into the next talk,<br />

another by Dr Chew. He informed us of some large<br />

studies soon to be published that may change the<br />

way that patients with narrow angles or angle<br />

closure glaucoma are referred and managed. Dr<br />

Graham Reeves closed the first session with an<br />

excellent talk on the Disc Damage Likelihood Scale,<br />

developed by glaucoma guru Dr George Spaeth.<br />

This emphasised that it is essential to pay close<br />

attention to the rim to disc ratio, taking the size of<br />

the optic disc into account.<br />

Session two was all about Special Issues in<br />

Glaucoma. Professor Charles McGhee gave an<br />

illuminating overview of corneal conditions<br />

associated with glaucoma, particularly the ICE<br />

syndromes. I discussed the management of<br />

corticosteroid induced glaucoma and ocular<br />

hypertension, which is extremely common in<br />

patients on long-term topical steroid therapy. Dr<br />

Simpson was an early adopter of OCT imaging,<br />

and highlighted its importance in glaucoma<br />

management today. Dr Sonya Bennett rose to the<br />

challenge of summarising the critical things to<br />

look for in secondary glaucomas and said to always<br />

assume you are looking for something, rather<br />

than expecting to see a normal eye. Associate<br />

Professor Jennifer Craig brought our attention to<br />

the extremely common co-morbidities of dry eye<br />

and glaucoma. The main culprit is the cytotoxic<br />

agent benzalkonium chloride, so we should strive<br />

to reduce the application of preserved eye drops.<br />

Professor Danesh-Meyer completed the second<br />

session line-up and provided an eloquent update on<br />

the management of ocular hypertension, bringing<br />

our attention to the risk factors that can increase the<br />

chance of converting to glaucoma.<br />

The theme for session three was Glaucoma<br />

Management and a broad range of topics<br />

were presented. Dr Dean Corbett discussed<br />

the role of selective laser trabeculoplasty,<br />

which is increasingly being used as a first-line<br />

glaucoma treatment. Dr Hussain Patel gave two<br />

presentations in this session. The first outlined the<br />

challenge of deciding who to treat and the pattern<br />

of treatment intensification. In his second talk, Dr<br />

Patel spoke on trabeculectomy surgery, its postoperative<br />

management and what optometrists<br />

should be on the look-out for in the late postoperative<br />

period. Dr Gale took the podium again to<br />

enlighten the audience on glaucoma management<br />

in pregnancy (a tricky task!). Interestingly, IOP<br />

may drop during pregnancy. The possibility of<br />

pregnancy should be considered in all women of<br />

reproductive age who have glaucoma. Professor<br />

Editorial: The hard work paid off<br />


When the team from Glaucoma New Zealand (GNZ)<br />

came to see us in early April, just a few weeks after<br />

I joined NZ Optics, there was much excitement<br />

around the idea for a dedicated Glaucoma symposium, and that<br />

excitement has been infectious.<br />

NZ Optics is pleased to support eye-health charities in New<br />

Zealand, and we’ve enjoyed being able to help Glaucoma NZ as<br />

the date was set and the symposium took shape.<br />

When I arrived at the event I was overjoyed to see 92 delegates<br />

from as far as Invercargill and even Australia. The majority were<br />

optometrists but also among the crowd were six nurses, a rep<br />

from the Blind Foundation, some students and ophthalmologists.<br />

There were 17 speakers in total, including Dr Hannah Kersten who<br />

recently had her PhD accepted and was instrumental in getting the<br />

conference off the ground. The speakers and delegates were united<br />

in the cause of in-depth glaucoma education – an event that is a<br />

first not just for Glaucoma NZ but also for New Zealand in general.<br />

Kristine Jensen and Teresa Hsu<br />

Speakers (L to R) Drs Allan Simpson, Hannah Kersten and Sonya Bennett, A/Profs Jennifer Craig and Gordon Sanderson, Drs Hussain Patel, Dean<br />

Corbett and Geraint Phillips, Professors Helen Danesh-Meyer and Charles McGhee with Drs Shenton Chew, Graham Reeves, Jesse Gale and Alex Buller<br />

Danesh-Meyer gave an informative<br />

presentation on lifestyle factors<br />

and glaucoma, including blood<br />

pressure, exercise, diet, stress and<br />

supplementation with omega<br />

three and ginkgo biloba. Grant<br />

Watters concluded the session<br />

by discussing the management<br />

of glaucoma patients who wear<br />

contact lenses. The management<br />

of vulnerable groups (patients with<br />

keratoconus or diabetes) was also<br />

highlighted.<br />

The final session of the day was a<br />

collection of cases. A/Prof Gordon<br />

Sanderson presented a case that<br />

involved forensic optometry,<br />

certainly raising some interesting<br />

questions in the minds of listeners.<br />

I outlined two methods of<br />

measuring IOP fluctuation. Dr Kain<br />

spoke about a rare case of angle<br />

closure associated with an iris<br />

melanoma. Dr Simpson discussed<br />

the diagnosis and management of<br />

twins who presented independently<br />

with narrow angles. Finally, the<br />

question of is it glaucoma or<br />

something else was posed by<br />

Professor Danesh-Meyer who gave<br />

examples of glaucomatous and nonglaucomatous<br />

optic neuropathy, and<br />

ways to differentiate between them.<br />

Overall, the day provided<br />

fantastic glaucoma education and<br />

a platform for glaucoma discussion<br />

between optometrists,<br />

ophthalmologists and<br />

industry. Glaucoma NZ<br />

is hoping to make this a<br />

regular event, so watch this<br />

space!<br />

*Dr Hannah Kersten is a lecturer<br />

and research fellow at the<br />

University of Auckland and a<br />

therapeutic optometrist with Eye<br />

Institute.<br />

Lyn Scott, Brian Appleyard and Bruce Keighley<br />

Glaucoma NZ team from (L to R) Dr Hannah Kersten, Professor Helen Danesh-Meyer, Helen<br />

Mawn, Ana Cunliffe and A/Prof Gordon Sanderson<br />

A B<br />

C<br />

D<br />

“We’re thrilled by the turnout,” said Professor Helen Danesh-<br />

Meyer, the chairperson of GNZ. “To have this many people<br />

committed to a day of glaucoma shows an exciting move forward<br />

for glaucoma care in New Zealand.”<br />

A/Prof Gordon Sanderson echoed the sentiment. “We’re<br />

pleased to have such a good turnout for this event, offering<br />

in-depth discussion on a range of pertinent topics that are often<br />

given a once-over-lightly treatment. This is an opportunity<br />

to go into depth and share cutting edge information, latest<br />

management techniques and diagnostic technology. The way<br />

glaucoma is managed will change dramatically in the next<br />

few years, moving toward a more community based model<br />

that is better for our often elderly patients. The involvement of<br />

optometrists in this game-changing shift is crucial to that new<br />

model.”<br />

Glaucoma is still the leading cause of preventable blindness, but<br />

E<br />

F<br />

A/Prof Sanderson visualises that with education programmes in<br />

the optometry sector, this will reduce remarkably over the next<br />

12 cards in each pack<br />

No message inside<br />

12<br />

cards<br />

in each<br />

pack<br />

Or with your chosen message<br />

for orders of 10 packs and over*<br />

To order online go to<br />

www.glaucoma.org.nz<br />

or call 0800 452 826<br />

<strong>Nov</strong>ember <strong>2016</strong><br />



Focus<br />

on Business<br />



Bringing in a new owner or partner<br />

There are many reasons why you may<br />

want a new owner or partner in your<br />

optometry business, such as;<br />

••<br />

You need additional capital;<br />

••<br />

It’s part of your succession plan;<br />

••<br />

They complement your existing<br />

operations, whether it be from their<br />

personal skill set, a business that can<br />

be bolted on to yours or they have the<br />

contacts or geographical reach you’re<br />

seeking;<br />

••<br />

You just want a running mate and to<br />

de-risk.<br />

All are very valid reasons, but before<br />

you confirm such an important decision, I<br />

strongly recommend that you consider the<br />

points below.<br />

Ambiguity can often lead to conflict<br />

Ambiguity from the outset is more likely<br />

to lead to conflict in the future. So, whilst<br />

it’s easy to overlook and avoid difficult<br />

conversations in the early stages of a<br />

business relationship as you want to<br />

promote optimism and positivity, it’s<br />

essential to discuss exit.<br />

The procedure for exit of either party<br />

should be clear. How much notice do you<br />

need to give, when is exit forced and who<br />

can you sell your share(s) to?<br />

Are the parties aware of their roles<br />

and responsibilities? Relationships can<br />

deteriorate rapidly where roles and<br />

responsibilities are not clearly defined.<br />

Issues can arise if one party carries<br />

out more work than the other and is<br />

not adequately rewarded. If roles and<br />

responsibilities are not to be equally<br />

shared, it’s worth having a conversation<br />

about remuneration and/or profit share.<br />

I can’t stress enough how important<br />

agreements are to successful business<br />

relationships - robust shareholder and<br />

partnership agreements ensure there’s<br />

clarity if a certain event occurs, and<br />

prescribe rules that each party agrees to<br />

and is aware of. Quite simply they are prenuptial<br />

agreements for businesses.<br />

Do your due diligence – do you really know<br />

your prospective partner?<br />

You are giving up power, control and<br />

influence to someone else – and it’s far<br />

easier to give it up than take it back. So it’s<br />

worth checking their background facts.<br />

Understand that you might be taking<br />

on additional risk. The extent depends<br />

on your legal structure and on how the<br />

other party’s may impact you; especially<br />

in a partnership where liability is joint<br />

and several (in the absence of forming a<br />

limited partnership).<br />

Scan the internet, have they been barred<br />

as a director of a company in the past…?<br />

Often employers will undertake checks<br />

on prospective employees, why not for a<br />

prospective business partner?<br />

Expectation – price<br />

Frequently the owner’s expectation of<br />

value is vastly different from what it is<br />

actually worth. So what looks to be a<br />

great business proposition often falls over<br />

because the owner has overvalued the<br />

business from the outset. Suffice it say, get<br />

an independent valuation of your business<br />

and realign expectations (if required),<br />

otherwise conversations with prospective<br />

investors are likely to be short-lived.<br />

Letting go<br />

Ask yourself, ‘’Am I really willing to give<br />

up control?’’ If not, then you may wish<br />

to reconsider other options, such as a<br />


different class of shares with no voting<br />

rights if you need a capital injection,<br />

without having to relinquish any control.<br />

Tax<br />

Tax legislation always plays its role<br />

and has to be considered. Once the<br />

transaction has been executed it is very<br />

difficult to remedy or reverse adverse tax<br />

outcomes. So canvass the tax position<br />

first.<br />

• Shareholder continuity rules for a<br />

company to carry forward tax losses<br />

and/or imputation credits must<br />

be considered if introducing a new<br />

shareholder. It is easy to inadvertently<br />

breach the thresholds and lose the<br />

value of tax losses and imputation<br />

credits;<br />

• If you are encouraging an existing<br />

employee into the business as a<br />

succession plan, price is relevant from a<br />

tax perspective. An income tax liability<br />

will arise to the extent an employee<br />

does not pay full market value for a<br />

shareholding;<br />

• Will the introduction of a partner<br />

change your legal structure from sole<br />

trader to partnership? How does this<br />

impact on income tax and GST status?<br />

Could this give rise to potential tax<br />

liabilities?<br />

• If you are looking to combine<br />

businesses, how will you do this? Will<br />

this require transfer of assets and<br />

liabilities to a new company? A tax cash<br />

cost may arise, even though no real<br />

income has come in;<br />

• Have you considered the operating<br />

structure for tax efficiency? Does the<br />

introduction of a new business partner<br />

change anything?<br />

• At what price will a prospective new<br />

partner/owner be introduced to the<br />

business? To assist in mitigating risk<br />

and to facilitate the transaction, we<br />

often see “earn-out” clauses included<br />

within sale and purchase agreements.<br />

Under an earn-out clause the purchase<br />

price is dependent upon future trading<br />

activities and performance. The clauses<br />

are often coupled with a “lowest price<br />

clause” to reduce the risk of adverse tax<br />

consequences arising.<br />

A common-sense approach<br />

It’s common-sense, but do you like them?<br />

Or would you duck under cover if you<br />

encountered them in the street rather<br />

than enjoy a coffee together?<br />

While you don’t necessarily need to be<br />

great mates you must acknowledge that<br />

you will potentially be spending a lot of<br />

time with them.<br />

This is not an exhaustive check list<br />

but it’s certainly well worth considering<br />

before making what could be one of the<br />

most important business decisions you<br />

will ever make. ▀<br />


* David Pearson is<br />

Managing Partner<br />

in the Napier firm<br />

of BDO, a global<br />

network of chartered<br />

accountants and<br />

advisers. He has a<br />

specialisation in<br />

advice to the medical<br />

sector.<br />

BV secures Falvin<br />

Dennis van der Maas from Beni Vision is excited<br />

to announce they are now the New Zealand<br />

supplier for Falvin, a boutique frame designer<br />

based in Denmark.<br />

“We spotted them at a European optical fair in<br />

February, in the emerging designers room,” said van<br />

der Maas. “We did a double take and went back –<br />

their product is stunning.”<br />

After several months and emails and phone<br />

calls, Beni Vision were able to meet up with<br />

representatives from Falvin in Copenhagen in August,<br />

where the deal was sealed.<br />

“Our samples arrived just a few weeks ago and<br />

we’ve had excellent uptake already,” said van der<br />

FEB31st lightweight wooden frames<br />

Excessive gaming causing<br />

retinal damage?<br />

Concerns that New Zealanders’ increasing<br />

dependence on electronic devices for gaming,<br />

lifestyle and work could be causing eye strain<br />

and long-term retinal damage to their eyes have<br />

resurfaced as a result of new research conducted on<br />

behalf of Essilor’s new Eyezen lens.<br />

A nationwide survey of New Zealand optometrists<br />

found that nine in ten (87%) expressed concerns<br />

about the number of people presenting with eye<br />

damage, some as young as five years old, as a result of<br />

heavy digital device use.<br />

The Eyezen study also showed that eight in 10 (80%)<br />

of optometrists believed those patients most affected<br />

were aged between 30 and 40 and one in five (19%)<br />

said in their experience, teenagers were also a high<br />

risk demographic.<br />

The research also found the most frequent symptom<br />

of excessive device use was dry eyes with almost eight<br />

in 10 (77%) of optometrist’s saying patients were<br />

presenting with this condition frequently. Eyestrain<br />

Stars and their<br />

eyes: Mila Kunis<br />

The 33-year-old Hollywood actress, who starred<br />

in <strong>2016</strong> hit movie Bad Moms, revealed in<br />

2011 that she suffered from chronic iritis.<br />

The disease, which at one point was so bad Mila<br />

Kunis admitted she was practically blind in one eye,<br />

causes inflammation of the iris resulting in blurred<br />

vision. Kunis hid the condition, worried it would<br />

affect her career, but eventually she developed a<br />

cataract. She had life changing surgery in 2010. “I<br />

was blind. I’m not blind anymore,” said Kunis in an<br />

interview with Cosmopolitan magazine in the US,<br />

describing her cataract surgery. “They cut it open<br />

and dropped a new lens in there.” ▀<br />

Falvin Eclipse<br />

Maas. “Their range is quite small, just nine optical<br />

frames and one set of sunglasses, but each comes<br />

in six colours and you can even have them diamond<br />

encrusted. It’s an exclusive, selective and luxurious<br />

range – the designer describes her glasses as<br />

‘jewellery for the eyes’.”<br />

Feb 31st new range<br />

Another Beni Vision supplier, FEB31st, has also<br />

released a new range, FEB31st 2.0.<br />

“They’re the world’s leading manufacturer of<br />

wooden eyewear,” explains van der Maas. “We’ve had<br />

them for about four years and their product is already<br />

very popular, but this new range, just revealed at<br />

Silmo, is thinner, stronger and lighter than before.”<br />

Beni Vision are also expecting new post-Silmo styles<br />

to arrive from Blackfin and TAVAT.<br />

For more on Falvin and FEB31st, see Silmo<br />

coverage p17 ▀<br />

and headaches were seen almost as often at 72% and<br />

52% respectively.<br />

Other common symptoms revealed in the research<br />

were stinging/tired or itching eyes, discomfort caused<br />

by the glare of the screen, and a progressive difficulty<br />

in staring at the device.<br />

Brown’s Bay optometrist Bruce Nicholls said,<br />

“strained vision, headaches and sleep deprivation<br />

are all linked to the high energy blue light emitted<br />

by flat screens and the cumulative effect of regularly<br />

switching between multiple devices.” He claimed<br />

many of us are looking at our phone screens up to 150<br />

times a day along with additional exposure to laptops,<br />

tablets and PC’s, with one study showing that using<br />

multiple devices increases your risk of symptoms by<br />

almost 25%.<br />

“What we are seeing now is that concentrated<br />

numbers of hours spent in intensive screen time<br />

while gaming and even long work days are causing<br />

noticeable symptoms in device users. Essentially overexposure<br />

to that blue light<br />

- which occurs on the light<br />

spectrum next to harmful<br />

invisible ultraviolet light<br />

could cause significant, long<br />

term damage,” he said.<br />

Nicholls, who is backing<br />

a consumer campaign by<br />

Eyezen, said a better-safethan-sorry<br />

approach needs<br />

to be adopted and advocates<br />

blue light protection as a<br />

counter to increased screen<br />

use for patients under 40. He<br />

said he currently prescribes<br />

blue-light blocking lenses to<br />

increasing numbers of Kiwis<br />

displaying symptoms of<br />

digital eye strain.<br />

“The pretext is that if you<br />

stop blue light from entering<br />

the eye then potentially you<br />

stop its damaging effects.” ▀<br />

26 NEW ZEALAND OPTICS <strong>Nov</strong>ember <strong>2016</strong>



Welcome to OCULA. Purveyors of fine eyewear.<br />

We are looking for that unique someone who can take our new<br />

flagship eyewear boutique in Queenstown from zero to hero.<br />

Contact us for more information.<br />

Email danielle@eyesonardmore.co.nz for more information.<br />


WANAKA<br />

Are you passionate about what you do? Do you (or want to)<br />

specialise in contact lenses, paediatrics and therapeutics?<br />

Eyes on Ardmore is offering arguably the most lucrative<br />

opportunity; to live in paradise and develop your career.<br />

Our busy boutique practice is equiped with all the toys you<br />

could want (OCT, Tonoref 3 and digital phoropter, IPL...). In addition,<br />

you will be supported by a trained clincial assistant.<br />

The position is flexible for 3 to 5 days per week and would suit<br />

somebody wanting to make the Southern Alps home.<br />

Email danielle@eyesonardmore.co.nz for more information.<br />



An opportunity exists for an account manager to represent a<br />

number of VMD Eyewear’s established brands in the North<br />

Island. Our collections can be viewed online at www.vmd.co.nz<br />

Industry experience (optical sales or dispensing) or a successful<br />

track record in sales will be an advantage for this role which<br />

involves servicing our existing North Island accounts and<br />

developing new accounts.<br />

If you wish to be part of a successful New Zealand company<br />

that has offices in New Zealand, Australia and the United<br />

Kingdom, please forward your resume to careers@vmd.co.nz<br />

or contact Nigel Butler for further information 09 525 6601.<br />


The personalised plate OPTOM is for sale after 18 years. Asking<br />

price is $1500+GST or make an offer. Additional fees apply to<br />

change or remove message and have the plate made.<br />

Contact stuart.warren@nsoptom.co.nz<br />


Bayer and DelSiTech partner-up<br />

Bayer and Finnish drug<br />

delivery technology<br />

and development firm<br />

DelSiTech have signed a<br />

Collaboration and Technology<br />

Licence Agreement for the<br />

worldwide application of<br />

DelSiTech’s Silica Matrix drug<br />

delivery platform. "Successful<br />

ocular drug delivery is one<br />

of the biggest challenges<br />

in developing novel drug<br />

therapies for ophthalmic<br />

diseases," said Professor<br />

Andreas Busch, Bayer’s<br />

head of drug discovery in a<br />

statement announcing the<br />

new partnership. ▀<br />

Specsavers’ ad wins award<br />

Specsavers has won the Excellence<br />

in Marketing award at the <strong>2016</strong><br />

Franchise Council of Australia (FCA)<br />

Awards for Excellence for its Australian<br />

and New Zealand ‘Beach Volleyball’<br />

marketing campaign, launched in<br />

December 2015.<br />

The campaign, filmed in Queensland,<br />

features a beach volleyball player who<br />

mistakes a seagull for the volleyball with<br />

predictable consequences. The campaign<br />

was backed by an A$2 million media<br />

spend including TV, video-on-demand<br />

and digital media as well as a 12-page<br />

catalogue distributed to 2.3 million homes in Australia. This is the second time Specsavers has won the<br />

Marketing Excellence category and the fourth year in a row it has won a FCA award. ▀<br />

Get to the main<br />

cause of dry,<br />

irritated eyes*<br />

4UP TO<br />

HOURS<br />

RELIEF 2<br />


The 4 days of Optics<br />

06 - 09 October 2017<br />

Optrex ActiMist – clinically proven to work<br />

How does Optrex ActiMist work?<br />

ActiMist liposomes<br />

Natural lipids<br />


silmoparis.com<br />

Optrex ActiMist contains<br />

liposomes (tiny bubbles fi lled with<br />

moisture) that migrate across the<br />

surface of the eyelid and collect<br />

at the edges of the eye.<br />

These liposomes mix with natural<br />

lipids on the eyelid.<br />

ActiMist liposomes<br />

When the eyes are open the new<br />

lipid mixture spreads over the<br />

whole tear fi lm, and helps fi ll the<br />

gaps to restore the damaged<br />

lipid layer.<br />

Hygienic. Can be used<br />

by multiple people<br />

Lasts 6 months<br />

after opening<br />

Won’t smudge<br />

make-up<br />

Convenient and<br />

portable<br />

Suitable for use<br />

with contact lenses<br />

Order stock for your practice today<br />

FREE CALL 0800 393 564 EYELOGIC<br />

www.optrex.co.nz optrex@eyelogic.com.au<br />

Always read the label. Use only as directed. If symptoms persist, see your healthcare professional. †When wearing make-up, it is recommended to apply from 20cm. *Due to disturbed lipid layer of the tear fi lm. References:<br />

1. Lee S et al. Klin Monatsbl Augenheilkd 2004; 221:1–12. 2. Khaireddin R, Schmidt KG. Klin Monatsbl Augenheilkd. 2010; 227: 128-134. 3. Pult H et al. Contact Lens Anterior Eye 2012, 35:203-207. Reckitt Benckiser, Auckland. TAPS DA1541<br />

<strong>Nov</strong>ember <strong>2016</strong><br />




State of the Art Technology<br />

Exclusive Optos Daytona Ultrawide<br />

Digital Retinal Scanner<br />

Corporate Social Responsibility<br />

OneSight Charity– We will not stop<br />

until the world can see<br />

Work-Lifestyle Balance<br />

Flexibility with attractive<br />




ON PAGE 27<br />


Nicholls Optometrists in Browns Bay are looking for a part-time<br />

Dispensing Optician or Optical Assistant to provide maternity<br />

cover for 12 months from <strong>Nov</strong>ember <strong>2016</strong>. Days required are<br />

Mon & Fri 8.30-5.30 and Sat 8.30-1.30. You will become part of an<br />

experienced team in a well resourced independent practice. Please<br />

contact Bruce Nicholls in confidence at nicholls4@gmail.com<br />

For a confidential chat, give me a call<br />

Hirdesh Nair<br />

E: Hirdesh.Nair@opsm.co.nz<br />

P: +64 21 523 282<br />

Location Hours Term Location Hours Term<br />

Newmarket 40 Long Term Wellington Float 40 Long term<br />

Queenstown 40 Long term Ch’ch Float 40 Long Term<br />

Thames 24 Long term Masterton 40 6 months<br />

Lynnmall 16 Long term New Plymouth 40 6 months<br />

St Lukes 16 Long term Papanui 40 6 months<br />



Our modern progressive independent practice requires a<br />

dispensing optician to join our experienced dispensing team. A<br />

dispensing qualification is not necessarily required, but experience<br />

is a must. The main role will be dispensing but also includes<br />

auxiliary testing as the practice has a strong clinical focus. Our<br />

large onsite Laboratory allows for fast and efficient glazing and<br />

adjustment services. Pukekohe is a fast growing area, 30 minutes<br />

south of Auckland central (travelling against the traffic).<br />

John Kelsey and his team are proud of the high standard of our<br />

services and would like to welcome an enthusiastic and motivated<br />

new staff member to join our well established team.<br />

This position is full time with some Saturday morning work. In<br />

the first instance please contact Laurraine at admin@optik.co.nz<br />


Finally, a bustling, central Auckland practice for sale!<br />

The current owner is looking to retire and would like to find<br />

someone to take over this profitable, independent practice and<br />

their loyal customers. There’s tremendous scope for growth for the<br />

right owner who has the skills and the energy, drive and marketing<br />

know-how to make this practice stand out.<br />

This practice is ideally suited to an optometrist who yearns to be<br />

truly independent and is ready to run their own business, make<br />

their own decisions and reap the rewards from the hard work they<br />

put in. Or perhaps you’re overseas and looking to move or return to<br />

New Zealand?<br />

Situated in a very sought after suburb with good schools and<br />

amenities close by, with many high-value customers and a great<br />

team, this practice has it all, and you’ll receive the full support of<br />

the current owner in a comprehensive handover process.<br />

If this sounds like you, please email, in strictest confidence,<br />

info@nzoptics.co.nz, quoting code PFSB20<br />


Euro Optics Ltd, a well-established eyewear wholesale<br />

distribution company, are looking for an outgoing person to join<br />

our small customer service team.<br />

This role is for someone who likes to be up on their feet all day<br />

with plenty of variety. The main responsibilities include:<br />

- Inbound sales calls and enquiries from existing customers<br />

- Picking and packing of customer orders<br />

- Checking off inwards shipments from suppliers<br />

- Invoicing customers’ orders and processing customers returns<br />

& credits<br />

- Warranty assessment and processing<br />

- Processing and sending out customer back orders<br />

Excellent English both written and verbal is required as are<br />

computer skills. Experience in the optical industry will be big<br />

advantage. Would suit someone who has had a similar role in the<br />

past or someone working in optical retail who would like to work<br />

in the wholesale side of the industry.<br />

The company is located in Mt. Wellington, Auckland.<br />

If you think this sounds like the job for you, apply now.<br />

You must be a New Zealand citizen or permanent resident. Please<br />

note there is no flexibility around this requirement.<br />

Please email your CV to: marketing@adidas-ep.co.nz<br />



We see a wide range of ages and nationalities. An interest in<br />

extension learning in behavioural optometry and binocular vision<br />

is essential.<br />

Rolleston Eye is located with access to the outdoors of Canterbury<br />

and the South Island. There is vibrant city life in the suburban<br />

surrounds of Christchurch.<br />

This position would suit an optometrist who likes to work<br />

independently but have advice a phone call away. See our website<br />

and contact leesastuart@gmail.com<br />


Do you have an old manual lens meter lying around gathering<br />

dust? Why not sell, or rent it to a training DO? If you can help,<br />

please email mgr.pukekohe.nz@specsavers.com<br />




As the Specsavers network of 370 Australian and New Zealand stores<br />

continues to experience significant growth, opportunities abound in<br />

many locations across both countries for career focussed optometry<br />

and dispensing professionals.<br />


Last financial year Specsavers New Zealand grew<br />

significantly and already this year we are seeing further<br />

growth – which presents ongoing opportunities for<br />

optometrists in the following locations:<br />


• Lower Hutt<br />

• Masterton<br />

• Palmerston North<br />

• Paraparaumu<br />

• Rotorua<br />

• Te Rapa<br />

• Wellington CBD<br />

• Whakatane<br />


• Dunedin<br />

• Invercargill<br />

• Riccarton<br />

Westfield<br />

We are currently also seeking experienced dispensers in a<br />

number of our New Zealand stores.<br />

To find out more, contact Chanelle Coates on<br />

0800 717 350 or chanelle.coates@specsavers.com –<br />

or visit spectrum-blog.com to review all your options<br />

and currently available locations.<br />

C<br />

M<br />

Y<br />

CM<br />

MY<br />

CY<br />

MY<br />

K<br />

Thinking of selling your practice - we have buyers<br />

Considering buying - we’ll give you all the options<br />

OpticsNZ specialises in optometry practice sales,<br />

we've helped dozens of Optometrists buy and sell their practices<br />

For more information contact Stuart Allan on: 03 546 6996<br />

027 436 9091 stu@opticsnz.co.nz www.opticsnz.co.nz<br />

• Locum Service<br />

• Recruitment Services<br />

• Practice Brokering<br />

• Business Consultants<br />

28 NEW ZEALAND OPTICS <strong>Nov</strong>ember <strong>2016</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!